var title_f31_40_32384="Endovascular repair of popliteal artery aneurysm";
var content_f31_40_32384=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F68952&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F68952&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 485px\">",
"   <div class=\"ttl\">",
"    Endovascular repair of popliteal artery aneurysm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 465px; height: 536px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_40_32384=[""].join("\n");
var outline_f31_40_32384=null;
var title_f31_40_32385="Initial burn management";
var content_f31_40_32385=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F51484&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F51484&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 600px\">",
"   <div class=\"ttl\">",
"    Initial burn management",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 580px; height: 771px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * ABCDE: Airway, Breathing, Circulation, Disability (neurologic evaluation), Exposure.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Practice Guidelines for burn care. J Burn Care Rehabil 2001.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_40_32385=[""].join("\n");
var outline_f31_40_32385=null;
var title_f31_40_32386="Oxymetazoline (ophthalmic): Pediatric drug information";
var content_f31_40_32386=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Oxymetazoline (ophthalmic): Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?9/46/9955?source=see_link\">",
"    see \"Oxymetazoline (ophthalmic): Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?2/0/2052?source=see_link\">",
"    see \"Oxymetazoline (ophthalmic): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block spa drugH1Div\" id=\"F15512121\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Special Alerts",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      FDA Issues Warning on Accidental Ingestion of Imidazoline Derivative Eye Drops and Nasal Sprays",
"     </span>",
"     <span class=\"collapsible-date\">",
"      October 2012",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       The U.S. Food and Drug Administration (FDA) has issued a warning that accidental ingestion by children of over-the-counter (OTC) imidazoline derivative eye drops and nasal sprays may result in serious harm. The eye drops and nasal sprays involved in cases of accidental ingestion contain the imidazoline derivatives tetrahydrozoline, oxymetazoline, or naphazoline. Serious adverse reactions (eg, coma, bradycardia, respiratory depression, sedation) requiring hospitalization were reported in children &le;5 years who had ingested even small amounts (eg, 1-2 mL). These products should be stored out of reach of children at all times; parents and caregivers should note that not all products are packaged in child-resistant packaging. If a child accidentally ingests these products, parents and caregivers should contact a poison control center at 1-800-222-1222 and seek emergency medical care immediately.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       For more information, please refer to:",
"       <a href=\"file://www.fda.gov/Drugs/DrugSafety/ucm325257.htm\" target=\"_blank\">",
"        file://www.fda.gov/Drugs/DrugSafety/ucm325257.htm",
"       </a>",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9504322\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Visine&reg; L.R.&reg; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F10513040\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Adrenergic Agonist Agent, Ophthalmic",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Vasoconstrictor, Ophthalmic",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F10513080\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?9/46/9955?source=see_link\">",
"      see \"Oxymetazoline (ophthalmic): Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children &ge;6 years and Adults: Instill 1-2 drops into the affected eye(s) 2-4 times/day (&ge;6 hours apart)",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F9504462\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, ophthalmic, as hydrochloride [drops]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Visine&reg; L.R.&reg;: 0.025% (15 mL, 30 mL) [contains benzalkonium chloride]",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F10513081\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Instill drops into conjunctival sac of affected eye(s); avoid contact of bottle tip with skin or eye; finger pressure should be applied to lacrimal sac during and for 1-2 minutes after instillation to decrease the risk of absorption and systemic reactions",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F10513041\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Relief of redness of eye due to minor eye irritations",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F9504321\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Oxymetazoline may be confused with oxymetholone",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Visine&reg; may be confused with Visken&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Accidental ingestion: Serious adverse reactions (eg, coma, bradycardia, respiratory depression, sedation) requiring hospitalization have been reported in children &le;5 years of age who have accidentally ingested even small amounts (eg, 1-2 mL) of imidazoline-derivative (ie, tetrahydrozoline, oxymetazoline, or naphazoline) eye drops or nasal sprays. Store these products out of reach of children at all times. Contact poison control or seek medical attention if accidental ingestion occurs.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F9504429\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;display:inline\">",
"     Local: Transient burning, stinging",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F10513042\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to oxymetazoline or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F10513043\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with increased intraocular pressure or glaucoma",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299805\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F9504431\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F10513065\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stimulates alpha-adrenergic receptors in the arterioles of the conjunctiva to produce vasoconstriction",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16036 Version 20.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-180.241.123.62-8D972B75FE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_40_32386=[""].join("\n");
var outline_f31_40_32386=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15512121\">",
"      Special Alerts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504322\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10513040\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10513080\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504462\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10513081\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10513041\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504321\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504429\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10513042\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10513043\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299805\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504431\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10513065\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/16036\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/16036|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?13/14/13541?source=related_link\">",
"      Oxymetazoline (nasal): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?23/25/23956?source=related_link\">",
"      Oxymetazoline (nasal): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?21/52/22340?source=related_link\">",
"      Oxymetazoline (nasal): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?9/46/9955?source=related_link\">",
"      Oxymetazoline (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?2/0/2052?source=related_link\">",
"      Oxymetazoline (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_40_32387="Laceration through the eyelid margin";
var content_f31_40_32387=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F50739&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F50739&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Laceration through the eyelid margin",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 296px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lacerations through the eyelid margin require meticulous layered closure to prevent excessive scarring and notching of the eyelid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Peter A D Rubin, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_40_32387=[""].join("\n");
var outline_f31_40_32387=null;
var title_f31_40_32388="Almotriptan: Pediatric drug information";
var content_f31_40_32388=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Almotriptan: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?20/26/20901?source=see_link\">",
"    see \"Almotriptan: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?22/4/22597?source=see_link\">",
"    see \"Almotriptan: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F131843\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Axert&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F131844\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Axert&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F996818\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antimigraine Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Serotonin 5-HT",
"       <sub>",
"        1D",
"       </sub>",
"       Receptor Agonist",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F996850\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?20/26/20901?source=see_link\">",
"      see \"Almotriptan: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adolescents 12-17 years and Adults: Oral: Initial: 6.25-12.5 mg in a single dose; if headache returns, may repeat the dose after 2 hours; no more than 2 doses (maximum daily dose: 25 mg). In clinical trials, 12.5 mg dose tended to be more effective in adults; individualize dose based on patient response.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in hepatic impairment:",
"     </b>",
"     Adolescents and Adults: Initial:  6.25 mg in a single dose; maximum daily dose: 12.5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in renal impairment:",
"     </b>",
"     Adolescents and Adults: Severe renal impairment (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &le;30 mL/minute): Initial: 6.25 mg in a single dose; maximum daily dose: 12.5 mg",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F131822\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as maleate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Axert&reg;: 6.25 mg, 12.5 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F131809\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F11409495\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May administer without regard to meals.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F996837\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at 25&deg;C (77&deg;F); excursions permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F996819\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Acute treatment of migraine with or without aura (FDA approved in ages 12-17 years and adults);",
"     <b>",
"      Note:",
"     </b>",
"     FDA labeled indication in adolescents is for patients with history of migraine lasting &ge;4 hours when left untreated",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F131878\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Axert&reg; may be confused with Antivert&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F131876\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dizziness, headache, somnolence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Nausea, vomiting, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Paresthesia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Anaphylactic shock, angina, angioedema, breast pain, colitis, coronary artery vasospasm, hemiplegia, hypertension, myocardial ischemia, MI, neuropathy, rash, seizure, syncope, tachycardia, ventricular fibrillation, ventricular tachycardia, vertigo",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F996823\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity  to almotriptan or any component; known or suspected ischemic heart disease (eg, angina pectoris, MI, documented silent ischemia, coronary artery vasospasm, Prinzmetal's variant angina, other significant underlying cardiovascular disease); cerebrovascular syndromes (eg, stroke, TIA), peripheral vascular disease (eg, ischemic bowel disease), uncontrolled hypertension, concomitant use (within last 24 hours) of ergotamine derivatives and/or ergotamine-containing medications or other 5-HT",
"     <sub>",
"      1",
"     </sub>",
"     agonist (eg, triptans);  management of hemiplegic or basilar migraine",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F11409486\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with controlled hypertension; temporary increases in peripheral vascular resistance and blood pressure may occur; significant elevation in blood pressure, including hypertensive crisis, has also been reported on rare occasions in patients with and without a history of hypertension; use is contraindicated in patients with uncontrolled hypertension. Use with caution and reduce the dose in patients with impaired hepatic or renal function. Use with caution in patients with sulfonamide hypersensitivity; almotriptan contains a sulfonyl group which is structurally different from a sulfonamide; however, cross-reactivity in patients with sulfonamide allergy has not been evaluated. In adolescent patients, almotriptan has not been shown to be effective at relieving migraine symptoms (eg, nausea, photophobia, phonophobia). Other potentially serious neurological conditions should be ruled out prior to acute migraine therapy. Almotriptan (given at &gt;2.5 times the maximum oral daily dose) has caused corneal opacities in dogs; other animal studies suggest it may bind to the melanin of the eye; human studies are not available.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F996824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serious coronary events, including coronary artery vasospasm, transient ischemia, acute MI, life-threatening arrhythmias (eg, ventricular tachycardia/fibrillation), and death have been reported with 5-HT",
"     <sub>",
"      1",
"     </sub>",
"     agonist administration; avoid use in patients with risk factors for coronary artery disease, unless cardiovascular disease can be ruled out; consider administering first dose under close supervision to patients at high risk for coronary disease. Patients who experience sensations of chest pain/pressure/tightness or symptoms suggestive of angina following dosing should be evaluated for coronary artery disease or Prinzmetal&rsquo;s angina before receiving additional doses. If dosing resumed and symptoms recur, ECG monitoring is recommended. Periodically evaluate cardiovascular system in patients with risk factors for coronary artery disease. Cerebrovascular events (eg, cerebral hemorrhage, subarachnoid hemorrhage, stroke) have been reported with 5-HT",
"     <sub>",
"      1",
"     </sub>",
"     agonist (triptan) administration. Vasospasm-related events (eg, peripheral vascular ischemia, colonic ischemia with abdominal pain and bloody diarrhea) have been reported with 5-HT",
"     <sub>",
"      1",
"     </sub>",
"     agonists; transient and permanent blindness and significant partial vision loss have been very rarely reported; further evaluation is recommended in patients with signs and symptoms suggestive of reduced peripheral arterial blood flow following 5-HT",
"     <sub>",
"      1",
"     </sub>",
"     agonist (eg, triptan) use.  Potentially fatal serotonin syndrome may occur when triptans are used in combination with SSRIs (eg, fluoxetine, sertraline) or SNRIs (eg, venlafaxine); monitor carefully if the two drugs are used concomitantly.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F131864\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2D6 (minor), CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F131817\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotics: May enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May increase the serum concentration of Almotriptan. Management: Limit initial almotriptan adult dose to 6.25 mg and maximum adult dose to 12.5 mg/24-hrs when used with a strong CYP3A4 inhibitor. Avoid concurrent use in patients with impaired hepatic or renal function.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ergot Derivatives: May enhance the vasoconstricting effect of Serotonin 5-HT1D Receptor Agonists. Serotonin 5-HT1D Receptor Agonists may enhance the vasoconstricting effect of Ergot Derivatives.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May decrease the metabolism of Serotonin 5-HT1D Receptor Agonists. Management: If MAO inhibitor therapy is required, naratriptan, eletriptan or frovatriptan may be a suitable 5-HT1D agonist to employ.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoclopramide: Serotonin Modulators may enhance the adverse/toxic effect of Metoclopramide. This may be manifest as symptoms consistent with serotonin syndrome or neuroleptic malignant syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin Modulators: May enhance the adverse/toxic effect of other Serotonin Modulators. The development of serotonin syndrome may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F11409492\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food does not significantly affect the rate or extent of absorption.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F131819\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F131829\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no adequate and well-controlled studies in pregnant women. Use in pregnancy should be limited to situations where benefit outweighs risk to fetus. In some (but not all) animal studies, administration was associated with embryolethality, fetal malformations, and decreased pup weight.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F996839\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Selective  agonist for serotonin (5-HT",
"     <sub>",
"      1",
"     </sub>",
"     ) receptor in cranial arteries; causes vasoconstriction and reduces sterile inflammation associated with antidromic neuronal transmission correlating with relief of migraine",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F996841\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Note",
"     </b>",
"     : Reported values are similar between adolescent and adult patients (Baldwin, 2004).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Well absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Apparent V",
"     <sub>",
"      d",
"     </sub>",
"     : ~180-200 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: ~35%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: MAO type A oxidative deamination (~27% of dose); via CYP3A4 and 2D6 (~12% of dose) to inactive metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: ~70%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: Mean: 3-5 hours (Baldwin, 2004; McEnroe, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: 1-3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Urine (~75%; ~40% of total dose as unchanged drug); feces (~13% of total dose as unchanged drug and metabolites)",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F996858\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?22/4/22597?source=see_link\">",
"      see \"Almotriptan: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     If pain or tightness in chest or throat occurs, notify physician; may cause dry mouth; may cause dizziness or sleepiness and impair ability to perform activities requiring mental alertness or physical coordination. Report the use of other medications, nonprescription medications, and herbal or natural products to your physician and pharmacist.",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F11409496\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Safety of treating &gt;4 headaches per month is not established; almotriptan is not indicated for migraine prophylaxis; safety and efficacy for cluster headaches have not been established.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Baldwin JR, Fleishaker JC, Azie NE, et al, \"A Comparison of the Pharmacokinetics and Tolerability of the Anti-migraine Compound Almotriptan in Healthy Adolescents and Adults,\"",
"      <i>",
"       Cephalalgia",
"      </i>",
"      , 2004, 24(4):288-92.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/40/32388/abstract-text/15030538/pubmed\" id=\"15030538\" target=\"_blank\">",
"        15030538",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Berenson F, Vasconcellos E, Pakalnis A, et al, \"Long-Term, Open-Label Safety Study of Oral Almotriptan 12.5 mg for the Acute Treatment of Migraine in Adolescents,\"",
"      <i>",
"       Headache",
"      </i>",
"      , 2010, 50(5):795-807.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/40/32388/abstract-text/20546320/pubmed\" id=\"20546320\" target=\"_blank\">",
"        20546320",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Linder SL, Mathew NT, Cady RK, et al, \"Efficacy and Tolerability of Almotriptan in Adolescents: A Randomized, Double-Blind, Placebo-Controlled Trial,\"",
"      <i>",
"       Headache",
"      </i>",
"      , 2008, 48(9):1326-36.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/40/32388/abstract-text/18484981/pubmed\" id=\"18484981\" target=\"_blank\">",
"        18484981",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      McEnroe JD and Fleishaker JC, \"Clinical Pharmacokinetics of Almotriptan, a Serotonin 5-HT(1B/1D) Receptor Agonist for the Treatment of Migraine,\"",
"      <i>",
"       Clin Pharmacokinet",
"      </i>",
"      , 2005, 44(3):237-46.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/40/32388/abstract-text/15762767/pubmed\" id=\"15762767\" target=\"_blank\">",
"        15762767",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15939 Version 20.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.65.114.212-CC23815824-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_40_32388=[""].join("\n");
var outline_f31_40_32388=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131843\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131844\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F996818\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F996850\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131822\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131809\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11409495\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F996837\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F996819\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131878\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131876\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F996823\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11409486\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F996824\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131864\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131817\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11409492\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131819\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131829\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F996839\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F996841\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F996858\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11409496\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/15939\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/15939|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?20/26/20901?source=related_link\">",
"      Almotriptan: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?22/4/22597?source=related_link\">",
"      Almotriptan: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_40_32389="Iloperidone: Patient drug information";
var content_f31_40_32389=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Iloperidone: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/59/35767?source=see_link\">",
"     see \"Iloperidone: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F7731166\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Fanapt&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10029528\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700570",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a higher chance of death in older adults who take this drug for mental problems caused by dementia. Most of the deaths were linked to heart disease or infection. This drug is not approved to treat mental problems caused by dementia.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10029530\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692052",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat schizophrenia.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692181",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It may take 1 to 2 weeks to see the full effect.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10029529\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to iloperidone or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10029534\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a family history of high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697268",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high cholesterol or triglyceride levels, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697320",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have Parkinson's disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are overweight, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698422",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check your blood sugar as you have been told by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10029535\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nose stuffiness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10029537\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698706",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are planning to harm yourself or the want to harm yourself gets worse.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure or a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699055",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shakiness, trouble moving around, or stiffness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       More trips to the bathroom, more thirst, or weight loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10029532\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10029533\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10029538\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10029539\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11698 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-58.240.98.179-9F9DC17642-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_40_32389=[""].join("\n");
var outline_f31_40_32389=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7731166\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029528\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029530\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029529\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029534\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029535\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029537\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029532\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029533\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029538\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029539\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?34/59/35767?source=related_link\">",
"      Iloperidone: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_40_32390="Forearm extensors";
var content_f31_40_32390=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F67466&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F67466&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Superficial extensor muscles of the right forearm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 384px; height: 543px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from Jenkins, DB. Hollinhead's functional anatomy of the limbs and back, 6th edition, W.B. Saunders, Philadelphia 1991. Copyright &copy; 1991 W.B. Saunders.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_40_32390=[""].join("\n");
var outline_f31_40_32390=null;
var title_f31_40_32391="Evaluation of pulmonary disability";
var content_f31_40_32391=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of pulmonary disability",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/40/32391/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/40/32391/contributors\">",
"     Ronald C Balkissoon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/40/32391/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/40/32391/contributors\">",
"     James K Stoller, MS, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/40/32391/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/40/32391/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/40/32391/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 14, 2008.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physicians are frequently asked to render an evaluation of pulmonary disability. Examples include the cigarette smoker with severe emphysema who is no longer able to do his or her strenuous job, the auto body worker with isocyanate-induced asthma, the retired coal miner with pneumoconiosis, the business executive with severe sleep apnea interfering with his or her ability to function effectively in the office, and the asbestos worker with lung cancer. An approach to the evaluation of these patients will be presented here. The evaluation and management of the specific conditions noted above are reviewed separately. (See appropriate topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the terms \"impairment,\" \"disability,\" and \"handicap\" are often used interchangeably by doctors and patients, these terms have precise and distinct definitions with regard to disability evaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Impairment",
"    </span>",
"    &nbsp;&mdash;&nbsp;According to the World Health Organization (WHO), impairment refers to \"any loss or abnormality of psychological, physiological, or anatomical structure or function\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32391/abstract/1\">",
"     1",
"    </a>",
"    ]. When possible, impairment of pulmonary function is measured by quantitative means such as spirometry, diffusing capacity for carbon monoxide (DLCO or Transfer factor), arterial blood gases, and integrated cardiopulmonary exercise testing. Assessment of bronchodilator response and nonspecific bronchial hyperresponsiveness (eg, by",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/32/10756?source=see_link\">",
"     methacholine",
"    </a>",
"    inhalation testing) are also used in special circumstances, such as asthma. Thus, the assessment of impairment is primarily the responsibility of a clinician familiar with these physiologic parameters of breathing function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32391/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/53/4952?source=see_link\">",
"     \"Overview of pulmonary function testing in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/4/1098?source=see_link\">",
"     \"Bronchoprovocation testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Disability",
"    </span>",
"    &nbsp;&mdash;&nbsp;The WHO definition for disability refers to \"any restriction or lack of ability to perform any activity within the range of 'normal' for a human being\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32391/abstract/1\">",
"     1",
"    </a>",
"    ]. The American Thoracic Society (ATS) definition refers to the \"total effect of an impairment on a patient's life\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32391/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. Thus, disability is not only assessed by objective quantitative measures of pulmonary function, but also incorporates such diverse factors as age, gender, education, and both economic and social environment. Two individuals with the same degree of physiologic impairment may have quite different levels of disability, based upon the requirements for their vocational and avocational activities. Disability assessments must also take into account those personal characteristics that may affect an individual's ability to retrain for alternative work.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Handicap",
"    </span>",
"    &nbsp;&mdash;&nbsp;The WHO definition for handicap is \"disadvantage resulting from an",
"    <span class=\"nowrap\">",
"     impairment/disability",
"    </span>",
"    that",
"    <span class=\"nowrap\">",
"     limits/prevents",
"    </span>",
"    fulfillment of that person's normal role depending on sex, age, social, and cultural factors\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32391/abstract/6\">",
"     6",
"    </a>",
"    ]. Thus, this definition overlaps with the ATS definition of disability.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Impairment ratings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physicians are typically asked to provide an impairment rating based upon quantitative objective measurements as outlined above [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32391/abstract/2\">",
"     2",
"    </a>",
"    ]. This is generally submitted to a Social Security Board, Workers' Compensation carrier, or other administrative body. Physicians' impairment ratings are usually given heavy weighting in determining the degree of disability. Other socioeconomic factors are given varying degrees of import in the final evaluation.",
"   </p>",
"   <p>",
"    The most common systems of pulmonary impairment rating are based upon the American Medical Association Guides to the Evaluation of Permanent Impairment and the American Thoracic Society official statements [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32391/abstract/3-5,7\">",
"     3-5,7",
"    </a>",
"    ]. In addition, there are systems for evaluating disability among individuals with a specific predisposition to pulmonary disease caused by occupational exposure. Examples of these groups, and their associated systems, include veterans of the US armed forces (Department of Veterans' Affairs), coal miners (the Black Lung Act), cotton workers (Cotton Dust Standard), and longshoremen involved in ship building (the Longshore Act) (see",
"    <a class=\"local\" href=\"#H17\">",
"     'Other systems'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ASSESSMENT CRITERIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Medical Association guidelines and the American Thoracic Society statement have a significant amount of overlap with regard to the systems for rating impairment and disability. The American Medical Association guide is largely based upon the criteria developed by the American Thoracic Society. Many jurisdictions, including most state Workers' Compensation programs, use these criteria to varying degrees. Physicians should check with the pertinent jurisdiction as to the specific criteria used for assessment of pulmonary impairment and disability.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     History and physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The basic components of a pulmonary evaluation include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A complete medical history, which should emphasize a comprehensive employment history outlining specific toxic exposures, intensity, duration, frequency of exposure, the nature of ventilation and personal protective equipment, and prevalence of disease in fellow employees",
"     </li>",
"     <li>",
"      Description of the temporal relationship between exposures and the onset and duration of symptoms. Particular attention should be given to whether symptoms are markedly improved during periods away from work (eg, days off, weekends, vacations).",
"     </li>",
"     <li>",
"      Identification of possible nonoccupational exposures that may contribute to the patient's clinical presentation, such as those due to smoking, pets, hobbies, or other exposures in the home (eg, bioaerosols from water-damaged ceilings or carpets)",
"     </li>",
"     <li>",
"      Description and quantification of the patient's respiratory symptoms, including shortness of breath, cough, chest tightness, and wheezing",
"     </li>",
"     <li>",
"      Description of any dysfunction of other organ systems which may present with symptoms similar to respiratory disorders, such as cardiac disease, gastroesophageal reflux disease, rhinosinusitis, or neuromuscular disease",
"     </li>",
"     <li>",
"      Documentation of any previous evaluation and treatment",
"     </li>",
"     <li>",
"      Performance of a thorough physical examination, with concentration on the respiratory, cardiovascular, musculoskeletal, and central nervous systems and with identification of physical signs of impairment and dysfunction",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A comprehensive history and physical examination do not always play specific roles in quantifying the degree of impairment. However, they provide supportive evidence for establishing the correct diagnosis and defining possible work-related and non-work-related factors contributing to the diagnosis. In addition, clinical signs of cor pulmonale or pulmonary hypertension are sufficient criteria for a severe impairment rating according to the AMA guidelines.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Physiologic evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main physiologic parameters used in the evaluation of pulmonary impairment include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Forced expiratory volume in one second (FEV1)",
"     </li>",
"     <li>",
"      Forced vital capacity (FVC)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       FEV1/FVC",
"      </span>",
"      ratio",
"     </li>",
"     <li>",
"      Diffusing capacity for carbon monoxide (DLCO)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Normal values for spirometry and single breath carbon monoxide diffusing capacity are based upon height, age, and gender [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32391/abstract/8\">",
"     8",
"    </a>",
"    ]. The spirometry and diffusing capacity studies must be performed in accordance with the American Thoracic Society standards [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32391/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. These reference values are based upon a survey of non-smoking Caucasian Americans; previous anthropometric studies suggest that it is appropriate to multiply these standards by 0.9 for non-Caucasians [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32391/abstract/11\">",
"     11",
"    </a>",
"    ]. There is no need to apply this correction factor to the",
"    <span class=\"nowrap\">",
"     FEV1/FVC",
"    </span>",
"    ratio. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/53/4952?source=see_link\">",
"     \"Overview of pulmonary function testing in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/14/7400?source=see_link\">",
"     \"Diffusing capacity for carbon monoxide\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The American Thoracic Society classification scheme categorizes individuals into four groups, based upon the parameters noted above (",
"    <a class=\"graphic graphic_table graphicRef67384 \" href=\"mobipreview.htm?38/3/38972\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Normal",
"     </li>",
"     <li>",
"      Mildly impaired",
"     </li>",
"     <li>",
"      Moderately impaired",
"     </li>",
"     <li>",
"      Severely impaired",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The AMA guidelines use almost the same cutoff points to designate people into four classes that define different percentages of impairment of the whole person (",
"    <a class=\"graphic graphic_table graphicRef53032 \" href=\"mobipreview.htm?41/51/42812\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Class 1 &mdash; zero or no impairment",
"     </li>",
"     <li>",
"      Class 2 &mdash; 10 to 25 percent impairment",
"     </li>",
"     <li>",
"      Class 3 &mdash; 30 to 45 percent impairment",
"     </li>",
"     <li>",
"      Class 4 &mdash; 50 to 100 percent impairment of the whole person",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are slight differences between the AMA and ATS guidelines with regard to the exact cutoffs for each class of impairment.",
"   </p>",
"   <p>",
"    The patient's percent predicted values for FVC, FEV1,",
"    <span class=\"nowrap\">",
"     FEV1/FVC",
"    </span>",
"    ratio and DLCO (obtained from appropriate charts) are used to determine impairment. The most severely affected parameter determines the impairment rating. As an example, if the forced vital capacity of an asthmatic patient is between 60 and 79 percent predicted, and the FEV1 is between 51 and 59 percent predicted, the latter parameter places the patient in the Class 3 rather than the Class 2 category according to the AMA guidelines.",
"   </p>",
"   <p>",
"    Diffusing capacity is a noninvasive measurement of gas exchange and is particularly useful when considering possible interstitial lung disease. However, it is relatively insensitive compared to more direct measurements of gas exchange, such as arterial blood gases.",
"   </p>",
"   <p>",
"    Simple spirometry has limitations for assessing the impairment from a wide variety of pulmonary disorders.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The pattern of a low forced vital capacity and low DLCO with relative preservation or increase in the",
"      <span class=\"nowrap\">",
"       FEV1/FVC",
"      </span>",
"      ratio is suggestive of a restrictive pattern. However, further evaluations of lung volumes, such as residual volume (RV), functional residual capacity (FRC),",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      total lung capacity (TLC), are necessary to confirm the diagnosis. Interestingly, these parameters are not required by the AMA guidelines for evaluation of restrictive lung diseases.",
"     </li>",
"     <li>",
"      Significant hyperinflation, as seen with emphysema, will not be detected with simple spirometry, since residual volume is not measured.",
"     </li>",
"     <li>",
"      Mixed obstructive and restrictive patterns, as seen with hypersensitivity pneumonitis and some cases of pneumoconiosis, are difficult to interpret on the basis of spirometry alone.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Bronchodilator response and nonspecific bronchial hyperresponsiveness (as measured with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/32/10756?source=see_link\">",
"     methacholine",
"    </a>",
"    or histamine challenge tests) may also be used. These tests typically are reserved for evaluation of impairment in individuals with reactive airways diseases such as asthma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32391/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/4/1098?source=see_link\">",
"     \"Bronchoprovocation testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Exercise tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exercise testing is not part of the routine evaluation of pulmonary impairment. There are special circumstances, however, in which cardiopulmonary exercise testing is indicated.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient's symptoms of dyspnea are greater than spirometry or the diffusing capacity would indicate.",
"     </li>",
"     <li>",
"      Patients report inability to perform specific job duties due to breathlessness.",
"     </li>",
"     <li>",
"      There is some question of submaximal or incorrect performance of spirometry or diffusing capacity.",
"     </li>",
"     <li>",
"      Impairment due to interstitial lung disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Exercise testing is contraindicated when severe impairment is found on the basis of spirometry and diffusing capacity. In addition, there are medical contraindications to exercise testing, such as severe heart disease or arrhythmias, and there may be other physical limitations that may preclude accurate testing. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/35/25144?source=see_link\">",
"     \"Exercise physiology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/39/33398?source=see_link\">",
"     \"Functional exercise testing: Ventilatory gas analysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Results from exercise testing are expressed as the maximal oxygen consumption (VO2max) or as metabolic equivalents (METS), which reflect the maximum workload achievable by the patient.",
"   </p>",
"   <p>",
"    Data obtained from exercise capacity testing should be interpreted by a clinician with expertise in exercise physiology, because the results will be affected by a patient's effort, metabolic state, level of conditioning, and underlying heart, lung, neurologic, neuromuscular, or orthopedic disorders.",
"   </p>",
"   <p>",
"    Although a VO2max of less than 15",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per min is suggestive of severe impairment, this is not absolute and should be considered in the context of additional information, such as the patient's level of general conditioning and other possible contributing diseases. A general empiric rule has been that a person should be able to work eight hours a day at his or her job if it does not require more than 40 percent of the VO2max achieved during exercise capacity testing. In other words, one needs to have some knowledge of what the actual energy or metabolic requirements are for specific jobs to assess whether an individual is capable of performing that job based on the VO2max. Again, this should only be considered as a general guideline, since there are often extenuating circumstances that may make direct application of this rule inappropriate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Arterial blood gases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arterial blood gases, aside from being invasive, are also difficult to standardize and interpret, since they may be affected by such factors as altitude. Nonetheless, in individuals whose degree of breathlessness is not explainable on the basis of spirometry or DLCO and in whom exercise testing may be contraindicated, documentation of the PaO2 is recommended. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/33/15894?source=see_link\">",
"     \"Arterial blood gases\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/8/33925?source=see_link\">",
"     \"Oxygenation and mechanisms of hypoxemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The AMA guidelines require that hypoxemia be documented on two separate occasions at least four weeks apart. While the guidelines do not require that adjustments be made for altitude, it is probably appropriate that the clinician report the normal PaO2 range for the altitude at which the test was performed.",
"   </p>",
"   <p>",
"    Severe impairment is considered present in the following circumstances:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Resting PaO2 less than 50 mmHg",
"     </li>",
"     <li>",
"      A PaO2 less than 55 mmHg on room air obtained in the presence of pulmonary hypertension, cor pulmonale, erythrocytosis, or increasing hypoxemia on exercise",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     ASSESSMENT OF MAXIMUM IMPROVEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maximal Medical Improvement (MMI) refers to the point in time when the clinician feels that the patient's condition is clinically stable and that no further treatment is likely to improve the condition. Improvement may occur simply with the passage of time after there is evidence of a plateau in the patient's clinical condition, but this should not influence determination of MMI. Clearly, there are differences in the duration of time it takes a patient to reach MMI that are influenced by the nature of the condition and by individual variation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SPECIFIC CONDITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The AMA guidelines list a series of pulmonary disorders that require special consideration (",
"    <a class=\"graphic graphic_table graphicRef73018 \" href=\"mobipreview.htm?0/15/251\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Asthma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Asthma is a common cause of pulmonary disability. It is estimated that 38 percent of patients with asthma who are currently employed have partial work disability, while 14 percent of working-age adults with severe asthma have complete work disability [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32391/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In asthma, spirometry can be highly variable and dependent upon the adequacy of treatment with antiinflammatory and bronchodilator medications. Thus, the ATS has developed criteria for the assessment of asthma that incorporate the postbronchodilator FEV1 (the degree of reversibility of FEV1 postbronchodilator therapy) and the degree of airway hyperresponsiveness",
"    <span class=\"nowrap\">",
"     (",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?10/32/10756?source=see_link\">",
"      methacholine",
"     </a>",
"     /histamine",
"    </span>",
"    PC20) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32391/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The American Thoracic Society (ATS) statement on the evaluation of impairment or disability in patients with asthma, as well as other ATS guidelines, can be accessed through the ATS web site at",
"    <a class=\"external\" href=\"file://www.thoracic.org/statements\">",
"     www.thoracic.org/statements",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    The preferred test for rating impairment is dependent upon the baseline FEV1:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the baseline FEV1 is greater than 70 percent predicted, it is usually suggested that the PC20 be used.",
"     </li>",
"     <li>",
"      If the baseline FEV1 is less than 70 percent predicted, the degree of reversibility with bronchodilator should be used.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Minimum medication requirements provide another criterion for assessment of patients with asthma. These requirements should be evaluated during a patient's period of clinical stability with minimum symptoms and optimum lung function. It should also be documented that reduction in medications below this level leads to exacerbations of symptoms and reduced lung function (",
"    <a class=\"graphic graphic_table graphicRef75664 graphicRef52958 graphicRef58723 \" href=\"mobipreview.htm?4/14/4333\">",
"     table 4A-C",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Cumulative scores are obtained by combining the above values to arrive at a summary impairment rating (",
"    <a class=\"graphic graphic_table graphicRef80963 \" href=\"mobipreview.htm?9/27/9659\">",
"     table 5",
"    </a>",
"    ). Impairment classes 0-5 are based upon total score values. Total",
"    <span class=\"nowrap\">",
"     impairment/disability",
"    </span>",
"    (class 5) is defined as asthma that is uncontrolled despite treatment with 20 mg or more of oral",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    per day and is characterized by an FEV1 below 50 percent predicted.",
"   </p>",
"   <p>",
"    The clinician has some discretion in deciding whether the impairment rating may overestimate or underestimate impairment. Individual confounding factors include compliance with treatment, environmental control measures, and coexisting diseases (eg, gastroesophageal reflux disease or rhinosinusitis) or habits (eg, cigarette smoking).",
"   </p>",
"   <p>",
"    In the case of occupational asthma, it is important to state whether the disease is felt to be an immunologic or nonimmunologic (irritant) type of asthma, since management may be somewhat different.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Individuals with immune-mediated occupational asthma due to a recognized sensitizer in the workplace should be removed from all further exposure, since even trivial level exposures can lead to significant morbidity and even death. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/0/34824?source=see_link\">",
"       \"Occupational asthma: Definitions, epidemiology, causes, and risk factors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Irritant-induced asthma (also called reactive airways dysfunction syndrome or RADS) can often be managed by adequate pharmacotherapy and by maintenance of exposure levels below irritant thresholds. Unfortunately, a number of individuals with irritant-induced asthma secondary to inadvertent high level exposures find that subsequent exposures to irritants below typical threshold levels still exacerbate symptoms. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/28/8650?source=see_link\">",
"       \"Reactive airways dysfunction syndrome and irritant-induced asthma\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is appropriate to wait up to two years after the time of last exposure before assessing maximum medical improvement in patients with occupational asthma. Improvement will typically have reached a plateau by that time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32391/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Other disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following disorders also deserve special consideration:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Individuals with hypersensitivity pneumonitis or pneumoconiosis should be removed from further exposure even if they have relatively well-preserved pulmonary function at the time of assessment.",
"     </li>",
"     <li>",
"      Individuals with sleep disorders may have impairment secondary to hypersomnolence, hypoxia, hemodynamic changes, or personality disorders. The AMA guidelines have a series of combined values charts, which allow the assessor to combine impairment values for different systems such as pulmonary, cardiac, mental, and behavioral. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/13/6359?source=see_link\">",
"       \"Overview of obstructive sleep apnea in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Individuals with lung cancer are considered to be severely impaired at the time of diagnosis. If the patient is disease-free after one year following surgical resection or other treatment, then the impairment is assessed according to physiologic parameters. If there is ever any evidence of recurrence, the patient is again considered to be severely impaired.",
"     </li>",
"     <li>",
"      Respiratory impairment due to neurologic disorders is covered in the Nervous System section of the AMA guidelines. Discussion of this topic is beyond the scope of this topic review.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Apportionment",
"    </span>",
"    &nbsp;&mdash;&nbsp;In certain jurisdictions, physicians may be asked to judge apportionment (eg, attributing the relative importance of cigarette smoking versus occupational exposures in patients with chronic bronchitis or emphysema). There are no guidelines to assist in making this decision, and it remains a relatively arbitrary distinction left to the discretion of the clinician.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     OTHER SYSTEMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other systems exist to evaluate patients for impairment and disability.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Social Security",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Social Security disability system defines two categories: \"disabled\" and \"not disabled\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32391/abstract/13\">",
"     13",
"    </a>",
"    ]. Disability may be on the basis of one or a combination of anatomic, physiologic, and psychologic abnormalities including psychiatric diseases",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    substance abuse. It is the clinician's responsibility to document and support evidence from the physical exam and laboratory findings.",
"   </p>",
"   <p>",
"    In the instance of Social Security, physicians are not required or expected to determine whether the patient is disabled. Instead, they provide a written medical report giving an impairment rating based upon the patient's FEV1, maximal voluntary ventilation, and vital capacity.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pulmonary function tests are to be expressed at standardized body temperature, pressure, and saturation (BTPS), and given in relation to the patient's measured height without shoes (",
"      <a class=\"graphic graphic_table graphicRef78704 \" href=\"mobipreview.htm?38/37/39515\">",
"       table 6",
"      </a>",
"      ). Patients falling below specified values meet the criteria for Social Security disability. These values do not take age, race, or gender into consideration.",
"     </li>",
"     <li>",
"      Asthma is considered disabling if severe attacks occur at least once every two months or an average of at least six times a year. This criterion is limited because it does not incorporate objective measures or adequacy of therapy.",
"     </li>",
"     <li>",
"      Gas exchange impairment is outlined in the Table (",
"      <a class=\"graphic graphic_table graphicRef78105 \" href=\"mobipreview.htm?33/28/34252\">",
"       table 7",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      There are also criteria for evaluating the disability secondary to lung cancer depending upon cell type and evidence for metastases.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Department of Veterans' Affairs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Department of Veterans' Affairs has a clinician's guide for disability examinations that provides general guidelines, but not strict quantitative criteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32391/abstract/14\">",
"     14",
"    </a>",
"    ]. The main tests recommended for disability evaluation include spirometry and maximal voluntary ventilation (MVV). Other tests such as blood gases, diffusing capacity, and exercise testing are only to be used in special circumstances.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Black lung evaluations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The United States Department of Labor oversees the occupational health of miners. The Black Lung Act outlines several specific criteria that must be considered in this population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32391/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. The central question for the clinician in these evaluations is to determine whether the miner could presently perform the usual tasks he or she performed when last employed as a miner.",
"   </p>",
"   <p>",
"    The evaluation involves recording the symptoms and findings on physical examination as well as a B-reading of the chest radiograph according to the International Labor Organization classification scheme. Pulmonary function testing includes spirometry and measurement of maximal voluntary ventilation in addition to arterial blood gases during exercise. The normal values used for spirometry in this legislation have been published [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32391/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/62/5096?source=see_link&amp;anchor=H3#H3\">",
"     \"Evaluation of diffuse lung disease by conventional chest radiography\", section on 'Classification'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Cotton Dust Standard Act",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are similar requirements for the evaluation of patients with work-related byssinosis as outlined in the Cotton Dust Standard of the Occupational Safety and Health Administration regulations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32391/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/18/34087?source=see_link\">",
"     \"Epidemiology and causes of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Longshoremen's Act",
"    </span>",
"    &nbsp;&mdash;&nbsp;Impairment rating for longshoremen who may have had asbestos exposure during ship building is outlined in the Longshoremen's Act. This act states that doctors should rate impairment based upon the whole person as outlined in the AMA guidelines. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/5/16472?source=see_link\">",
"     \"Asbestosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The American Thoracic Society (ATS) statement on the diagnosis and initial management of nonmalignant diseases due to asbestos, as well as other ATS guidelines, can be accessed through the ATS web site at",
"    <a class=\"external\" href=\"file://www.thoracic.org/statements\">",
"     www.thoracic.org/statements",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The terms \"impairment,\" \"disability,\" and \"handicap\" have precise and distinct definitions with regard to evaluation of pulmonary disability. Disability is not only assessed by objective quantitative measures of pulmonary function, but also incorporates such diverse factors as age, gender, education, and both economic and social environment. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definitions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The American Medical Association guidelines and the American Thoracic Society statement have a significant amount of overlap with regard to rating impairment and disability (",
"      <a class=\"graphic graphic_table graphicRef67384 \" href=\"mobipreview.htm?38/3/38972\">",
"       table 1",
"      </a>",
"      )&nbsp;(",
"      <a class=\"graphic graphic_table graphicRef53032 \" href=\"mobipreview.htm?41/51/42812\">",
"       table 2",
"      </a>",
"      ). Many jurisdictions, including most state Workers' Compensation programs, use these criteria to varying degrees. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Assessment criteria'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Obtaining a comprehensive history and physical examination does not always contribute to quantifying the degree of impairment. However, this information provides supportive evidence for the correct diagnosis and defines possible work-related and non-work-related factors contributing to the diagnosis. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'History and physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The main physiologic parameters used in the evaluation of pulmonary impairment include the forced expiratory volume in one second (FEV1), forced vital capacity (FVC), the",
"      <span class=\"nowrap\">",
"       FEV1/FVC",
"      </span>",
"      ratio, and the diffusing capacity for carbon monoxide (DLCO). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Physiologic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When a disability determination is based on hypoxemia, the AMA guidelines require documentation of hypoxemia on two separate occasions at least four weeks apart. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Arterial blood gases'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cardiopulmonary exercise testing is not part of routine disability assessment, but may be helpful when dyspnea is greater than either spirometry or the diffusing capacity would indicate, or the results of these tests are inconclusive. Exercise testing results are expressed as the maximal oxygen consumption (VO2max) or as metabolic equivalents (METS), which reflect the maximum workload achievable by the patient. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Exercise tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Maximal Medical Improvement (MMI) refers to the point in time when the clinician feels that the patient's condition is clinically stable and that no further treatment is likely to improve the condition. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Assessment of maximum improvement'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the evaluation of disability from asthma, the preferred test for rating impairment (degree of bronchodilator reversibility or hyperresponsiveness to",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/32/10756?source=see_link\">",
"       methacholine",
"      </a>",
"      ) is dependent upon the baseline FEV1 (",
"      <a class=\"graphic graphic_table graphicRef75664 graphicRef52958 \" href=\"mobipreview.htm?14/43/15036\">",
"       table 4A-B",
"      </a>",
"      ). In addition, assessment of the minimal amount of medication needed to control asthma is incorporated into the disability determination (",
"      <a class=\"graphic graphic_table graphicRef58723 \" href=\"mobipreview.htm?15/59/16315\">",
"       table 4C",
"      </a>",
"      )&nbsp;(",
"      <a class=\"graphic graphic_table graphicRef80963 \" href=\"mobipreview.htm?9/27/9659\">",
"       table 5",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Asthma'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Individuals with immune-mediated occupational asthma due to a recognized sensitizer in the workplace should be removed from all further exposure. Similarly, individuals with hypersensitivity pneumonitis or pneumoconiosis should be removed from further exposure even if they have relatively well-preserved pulmonary function at the time of assessment. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Specific conditions'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     WHO. World Health Organization: International Classification of Impairments, Disabilities, and Handicaps, Geneva, 1980, pp. 10-11, 26-31, 86-87.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32391/abstract/2\">",
"      Rondinelli RD, Beller TA. Impairment rating and disability evaluation of the pulmonary system. Phys Med Rehabil Clin N Am 2001; 12:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32391/abstract/3\">",
"      American Thoracic Society, medical section of the American Lung Association. Evaluation of impairment/disability secondary to respiratory disease. Am Rev Respir Dis 1982; 126:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32391/abstract/4\">",
"      Evaluation of impairment/disability secondary to respiratory disorders. American Thoracic Society. Am Rev Respir Dis 1986; 133:1205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32391/abstract/5\">",
"      Guidelines for the evaluation of impairment/disability in patients with asthma. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis 1993; 147:1056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32391/abstract/6\">",
"      Thuriaux MC. The ICIDH: evolution, status, and prospects. Disabil Rehabil 1995; 17:112.",
"     </a>",
"    </li>",
"    <li>",
"     American Medical Association. Guides to the Evaluation of Permanent Impairment, 5th ed, American Medical Association, Chicago, 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32391/abstract/8\">",
"      Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32391/abstract/9\">",
"      Standardization of spirometry--1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis 1987; 136:1285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32391/abstract/10\">",
"      Crapo RO, Morris AH. Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 1981; 123:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32391/abstract/11\">",
"      Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis 1991; 144:1202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32391/abstract/12\">",
"      Eisner MD, Yelin EH, Katz PP, et al. Risk factors for work disability in severe adult asthma. Am J Med 2006; 119:884.",
"     </a>",
"    </li>",
"    <li>",
"     Disability evaluation under Social Security. U.S. Department of Health and Human Services, Social Security Administration, SSA Publication #05-10089, February 1986.",
"    </li>",
"    <li>",
"     Veteran's Administration. Physician's guide for disability evaluation and examinations. Pulmonary Diseases, 1985, p. 5.1.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32391/abstract/15\">",
"      Standards for determining coal miner's total disability or death due to pneumoconiosis; claims for benefits under Part C of Title IV of the Federal Mine Safety and Health Act, as amended--Employment Standards Administration, Labor. Notice of proposed rulemaking; request for comment. Fed Regist 1982; 47:22674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32391/abstract/16\">",
"      Regulations implementing the Federal Coal Mine Health and Safety Act of 1969, as amended. Employment Standards Administration, Labor. Final rule. Fed Regist 2000; 65:79920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32391/abstract/17\">",
"      Knudson RJ, Slatin RC, Lebowitz MD, Burrows B. The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis 1976; 113:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32391/abstract/18\">",
"      Occupational Safety and Health Administration. Occupational exposure to cotton dust; final mandatory occupational, safety and health standards. Fed Regist 1978; 43:27351.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6966 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-CDD449C725-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_40_32391=[""].join("\n");
var outline_f31_40_32391=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Impairment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Disability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Handicap",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Impairment ratings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ASSESSMENT CRITERIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      History and physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Physiologic evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Exercise tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Arterial blood gases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      ASSESSMENT OF MAXIMUM IMPROVEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SPECIFIC CONDITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Asthma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Other disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Apportionment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      OTHER SYSTEMS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Social Security",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Department of Veterans' Affairs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Black lung evaluations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Cotton Dust Standard Act",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Longshoremen's Act",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/6966\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6966|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?38/3/38972\" title=\"table 1\">",
"      ATS impairment classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/51/42812\" title=\"table 2\">",
"      AMA impairment classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?0/15/251\" title=\"table 3\">",
"      Impairment and lung function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?5/46/5867\" title=\"table 4A\">",
"      Postbronchodilator FEV1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/23/17787\" title=\"table 4B\">",
"      Reversibility of FEV1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?15/59/16315\" title=\"table 4C\">",
"      Minimum medication need asthma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/27/9659\" title=\"table 5\">",
"      Impairment rating asthma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?38/37/39515\" title=\"table 6\">",
"      Disability criteria per PFT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?33/28/34252\" title=\"table 7\">",
"      Chronic impairment gas exchange",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/33/15894?source=related_link\">",
"      Arterial blood gases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/5/16472?source=related_link\">",
"      Asbestosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/4/1098?source=related_link\">",
"      Bronchoprovocation testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/14/7400?source=related_link\">",
"      Diffusing capacity for carbon monoxide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/18/34087?source=related_link\">",
"      Epidemiology and causes of hypersensitivity pneumonitis (extrinsic allergic alveolitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/62/5096?source=related_link\">",
"      Evaluation of diffuse lung disease by conventional chest radiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/35/25144?source=related_link\">",
"      Exercise physiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/39/33398?source=related_link\">",
"      Functional exercise testing: Ventilatory gas analysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/0/34824?source=related_link\">",
"      Occupational asthma: Definitions, epidemiology, causes, and risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/13/6359?source=related_link\">",
"      Overview of obstructive sleep apnea in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/53/4952?source=related_link\">",
"      Overview of pulmonary function testing in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/8/33925?source=related_link\">",
"      Oxygenation and mechanisms of hypoxemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/28/8650?source=related_link\">",
"      Reactive airways dysfunction syndrome and irritant-induced asthma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_40_32392="Anterior mediastinal mass lesions";
var content_f31_40_32392=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Anterior mediastinal mass lesions",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/40/32392/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/40/32392/contributors\">",
"     William E Cohn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/40/32392/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/40/32392/contributors\">",
"     Talmadge E King, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/40/32392/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/40/32392/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/40/32392/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 5, 2009.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anterior mediastinal compartment (also referred to as the anterosuperior compartment) is anterior to the pericardium and includes lymphatic tissue, the thymus, the extrapericardial aorta and its branches, and the great veins (",
"    <a class=\"graphic graphic_figure graphicRef56637 \" href=\"mobipreview.htm?10/31/10743\">",
"     figure 1",
"    </a>",
"    ). Masses in the anterior compartment are more likely to be malignant than those found in the other mediastinal compartments. As an example, one series of 400 patients with mediastinal tumors noted that 59, 29, and 16 percent of anterior, middle, and posterior mediastinal masses were malignant, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lesions most commonly found in the anterior mediastinum are thymomas, lymphomas, germ cell tumors, congenital cysts, intrathoracic thyroid tissue, and parathyroid lesions.",
"   </p>",
"   <p>",
"    This topic will review common etiologies of anterior mediastinal mass lesions. The general approach to and evaluation of mediastinal masses are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/24/31111?source=see_link\">",
"     \"Evaluation of mediastinal masses\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     THYMOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thymomas represent 20 percent of all mediastinal neoplasms in adults; they are the most common anterior mediastinal primary neoplasm in adults, but are rarely seen in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/2-6\">",
"     2-6",
"    </a>",
"    ]. They occur with equal frequency in males and females, and commonly present between the ages of 30 and 50.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Clinical findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 50 percent of patients with thymoma are asymptomatic at the time of diagnosis and are discovered incidentally, usually because a chest film or transthoracic echocardiogram obtained for an unrelated purpose is suggestive of an anterior mediastinal mass [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among patients with symptoms, myasthenia gravis or other tumor-related syndromes are present in 50 to 70 percent at diagnosis, and the remaining patients present with substernal pain, dyspnea, or cough [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/3,7\">",
"     3,7",
"    </a>",
"    ]. A number of clinical conditions have been associated with thymoma (",
"    <a class=\"graphic graphic_table graphicRef69165 \" href=\"mobipreview.htm?22/20/22860\">",
"     table 1",
"    </a>",
"    ), the most common of which are myasthenia gravis and pure red cell aplasia. Invasive thymoma is more frequently associated with symptoms due to local compression, such as superior vena cava syndrome, but encapsulated, noninvasive tumors can produce similar findings. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/17/8474?source=see_link\">",
"     \"Clinical presentation and management of thymoma and thymic carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/51/17206?source=see_link\">",
"     \"Clinical manifestations of myasthenia gravis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/1/17433?source=see_link\">",
"     \"Acquired pure red cell aplasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On thoracic CT scan, thymomas are typically well-defined, rounded, or lobular (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef73685 graphicRef50638 \" href=\"mobipreview.htm?13/62/14308\">",
"     image 1A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/6,8,9\">",
"     6,8,9",
"    </a>",
"    ]. Thymic carcinomas often contain necrotic, cystic, or calcified areas and the tumor contour is often irregular compared to thymoma. MRI is occasionally helpful in the evaluation of thymic tumors, generally for patients who are unable to receive contrast or when vascular invasion is suspected.",
"   </p>",
"   <p>",
"    Positron emission tomography (PET) scan with fluorine-18 fluorodeoxyglucose (FDG) may also be helpful in evaluating the extent of disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of myasthenia gravis or other paraneoplastic syndromes in combination with an anterior mediastinal mass is highly suggestive of thymoma, but a definitive diagnosis can be made only after surgical excision. The histologic diagnosis of thymoma can be difficult. There is a continuum of differentiation from thymoma to thymic carcinoma; primary thymic epithelial neoplasms can have features of both. The pathology, classification, and management of thymoma and thymic carcinoma are discussed separately (",
"    <a class=\"graphic graphic_table graphicRef53024 \" href=\"mobipreview.htm?34/28/35277\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/43/4794?source=see_link\">",
"     \"Pathology of mediastinal tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/17/8474?source=see_link\">",
"     \"Clinical presentation and management of thymoma and thymic carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     LYMPHOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of lymphomas can present in the mediastinum. Mediastinal lymphoma is usually a manifestation of systemic lymphoma, but 5 to 10 percent of patients have primary mediastinal lymphoma.",
"   </p>",
"   <p>",
"    In adults, primary mediastinal lymphoma accounts for 10 to 20 percent of primary mediastinal masses and is the second most common primary anterior mediastinal mass after thymoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/7,9,11,12\">",
"     7,9,11,12",
"    </a>",
"    ]. Most mediastinal lymphomas are seen in the anterosuperior mediastinum, with the remainder being found in the middle mediastinum.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Clinical findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms due to compression of adjacent mediastinal structures are infrequent, but may include pain, dyspnea, stridor, or superior vena cava syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/56/19338?source=see_link\">",
"     \"Malignancy-related superior vena cava syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of lymphoma in the mediastinum requires histopathologic examination. Generally, a larger biopsy piece is preferred to a sample obtained by needle aspirate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/24/31111?source=see_link\">",
"     \"Evaluation of mediastinal masses\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The various types of lymphoma that occur in the mediastinum are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/35/568?source=see_link\">",
"     \"Clinical presentation and patterns of disease distribution in classical Hodgkin lymphoma in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/45/24282?source=see_link\">",
"     \"Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/1/9238?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of primary mediastinal large B-cell lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/25/26007?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of precursor B cell acute lymphoblastic leukemia/lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/20/30023?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of precursor T cell acute lymphoblastic leukemia/lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/9/19610?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of extranodal (MALT) and nodal marginal zone lymphomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     GERM CELL TUMORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Germ cell tumors (GCTs) account for 15 percent of anterior mediastinal tumors in adults and 24 percent in children. Rarely, they are found in the posterior mediastinum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/11,14\">",
"     11,14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/52/10058?source=see_link\">",
"     \"Extragonadal germ cell tumors involving the mediastinum and retroperitoneum\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is believed that mediastinal germ cell tumors develop in rests of cells that failed to complete migration from the urogenital ridge to the gonads during early embryonic development. However, in individual patients, primary mediastinal GCTs must be differentiated from mediastinal metastases from gonadal germ cell neoplasms in adults or sacrococcygeal GCTs in children. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/52/10058?source=see_link&amp;anchor=H2#H2\">",
"     \"Extragonadal germ cell tumors involving the mediastinum and retroperitoneum\", section on 'Histogenesis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/43/4794?source=see_link\">",
"     \"Pathology of mediastinal tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Classification of primary mediastinal GCTs, also called extragonadal GCTs, is based upon cell type, although many neoplasms have mixed cellularity. The most commonly used classification divides tumors into mature teratomas, seminomas, and nonseminomatous germ cell tumors. The nonseminomatous germ cell tumors, also called malignant teratomas or embryonal tumors, are a diverse grouping that includes choriocarcinomas, yolk sac carcinomas, embryonal carcinomas, teratocarcinomas and mixed tumors that contain more than one cell line. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/43/4794?source=see_link\">",
"     \"Pathology of mediastinal tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Teratomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mediastinal teratomas are classified histologically on a spectrum from mature to immature (",
"    <a class=\"graphic graphic_table graphicRef59492 \" href=\"mobipreview.htm?9/52/10060\">",
"     table 3",
"    </a>",
"    ). Mature teratomas are almost always benign, whereas teratomas with greater proportions of immature cells have greater malignant potential. Malignant teratomas are discussed further under nonseminomatous germ cell tumors. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Nonseminomatous germ cell tumors'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Mediastinal teratomas tend to be cystic, although teratomas can be either solid or cystic elsewhere in the body. Unilocular cystic teratomas are sometimes referred to as dermoid cysts. Teratomas contain varying amounts of tissues derived from at least two of the three primitive germ layers: ectoderm, endoderm, and mesoderm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/43/4794?source=see_link&amp;anchor=H18#H18\">",
"     \"Pathology of mediastinal tumors\", section on 'Germ cell tumors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ectodermal tissues generally predominate, and can include skin, hair, sweat glands, sebaceous material, or tooth-like structures. Skin components are identified in over 90 percent of tumors.",
"     </li>",
"     <li>",
"      Tissues of mesodermal origin include fat, cartilage, bone, and smooth muscle.",
"     </li>",
"     <li>",
"      Endodermal tissues encountered in benign teratomas include respiratory or intestinal epithelium, and pancreatic tissue.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Teratomas occur equally between the sexes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/14-16,18\">",
"     14-16,18",
"    </a>",
"    ]. Among adults with teratomas, the typical age range is 20 to 40. Occasional benign teratomas are found in the posterior mediastinum or in association with the pericardium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/11,18\">",
"     11,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Clinical findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;As many as 60 percent of patients with benign teratomas are asymptomatic. When present, symptoms are generally due to compression and obstruction of surrounding organs; symptomatic patients often present with chest pain, cough, or dyspnea, and are frequently found to have bronchial obstruction and postobstructive pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/15,16,19\">",
"     15,16,19",
"    </a>",
"    ]. Expectoration of hair (trichoptysis) or sebaceous debris is pathognomonic of benign teratoma, and results from erosion into an adjacent bronchus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Erosion into the pericardium, adjacent vascular structures, or through the skin to form a draining fistula is a rare but serious complication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/15,21\">",
"     15,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chest radiographs may demonstrate an anterior mediastinal mass, with calcification seen in 26 percent of benign teratomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/15\">",
"     15",
"    </a>",
"    ]. Occasionally, well formed teeth or bone can be seen on plain chest radiographs, findings which are very suggestive of a teratoma. CT and MRI are helpful in localizing lesions and determining the spatial relationships to surrounding structures. They can also characterize densities within the lesion suggestive of fat, sebaceous material, or cystic elements, which support the diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/22,23\">",
"     22,23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of teratoma is often suspected based on radiographic characteristics, but requires confirmation by resection and pathologic analysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/43/4794?source=see_link&amp;anchor=H18#H18\">",
"     \"Pathology of mediastinal tumors\", section on 'Germ cell tumors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Seminomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary mediastinal seminomas are uncommon, representing only 2 to 4 percent of all mediastinal masses, but comprise 25 to 50 percent of malignant mediastinal germ cell tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. These neoplasms are usually located in the anterior mediastinum, and predominantly occur in young males between the ages of 20 and 40. Mediastinal seminoma can rarely occur in women with histologically normal ovaries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is uncommon for testicular seminoma to metastasize to the mediastinum in the absence of retroperitoneal lymph node involvement. Nonetheless, all patients with mediastinal seminoma should undergo careful testicular palpation and ultrasonography with biopsy of suspicious findings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Clinical findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seminomas are symptomatic more frequently than teratomas or other benign tumors. Substernal pain is the most frequent complaint, and dyspnea, weakness, cough, fever, gynecomastia, and weight loss are occasionally present. Superior vena caval syndrome is the presenting symptom in 10 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/52/10058?source=see_link&amp;anchor=H14#H14\">",
"     \"Extragonadal germ cell tumors involving the mediastinum and retroperitoneum\", section on 'Mediastinal seminoma'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Highly sensitive and specific immunoassays for serum beta-human chorionic gonadotropin (beta-hCG) and alpha-fetoprotein (AFP) may help differentiation between seminomas and nonseminomatous germ cell tumors (NSGCTs); approximately 10 percent of patients with a seminoma have an elevated beta-hCG, but never an elevated AFP. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/58/38822?source=see_link\">",
"     \"Serum tumor markers in testicular germ cell tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/52/10058?source=see_link&amp;anchor=H4#H4\">",
"     \"Extragonadal germ cell tumors involving the mediastinum and retroperitoneum\", section on 'Tumor markers'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On thoracic CT scan, seminomas are typically bulky, lobulated and homogeneous [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/6\">",
"     6",
"    </a>",
"    ]. Calcification is rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with other anterior mediastinal tumors, the initial diagnosis is suggested by chest radiograph, CT scan, or MRI. Fine needle aspiration cytology is often adequate to determine cell type, particularly in conjunction with the evaluation of serum markers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mediastinal seminomas should undergo careful histopathologic analysis for cellular heterogeneity. Many of these tumors contain elements of embryonal malignancy, such as embryonal carcinoma, choriocarcinoma, yolk sac carcinoma, and teratocarcinoma. The presence of cellular heterogeneity adversely effects prognosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/43/4794?source=see_link&amp;anchor=H18#H18\">",
"     \"Pathology of mediastinal tumors\", section on 'Germ cell tumors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Nonseminomatous germ cell tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignant germ cell tumors that are not pure seminomas are commonly grouped together as nonseminomatous germ cell tumors (GCTs) because of therapeutic and prognostic similarities. Nonseminomatous GCTs include choriocarcinomas, embryonal carcinomas, endodermal sinus tumors, teratocarcinomas, and malignant teratomas. Nonseminomatous GCTs are found in the anterior mediastinum, often in association with the thymus, and are six times more common in males than in females. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/52/10058?source=see_link\">",
"     \"Extragonadal germ cell tumors involving the mediastinum and retroperitoneum\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Up to one-third of nonseminomatous GCTs contain multiple malignant cell types. Malignant non-germ cell tissue, such as rhabdomyosarcoma, nephroblastoma, adenocarcinoma, and hematologic malignancy, is occasionally found in association with these neoplasms, presumably due to the totipotent nature of the germ cell of origin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast to pure seminoma, the prognosis for nonseminomatous germ cell tumors is relatively poor. These aggressive tumors are usually invasive at the time of diagnosis, with extensive vascular involvement that precludes surgical excision.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Clinical findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonseminomatous germ cell tumors are symptomatic in 85 percent of patients at the time of diagnosis, most commonly producing chest pain, hemoptysis, cough, fever, or weight loss. Superior vena caval syndrome is occasionally seen. Choriocarcinoma and embryonal carcinoma may secrete beta-human chorionic gonadotropin (beta-hCG), resulting in gynecomastia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;As discussed above, the primary objective in diagnosis is to distinguish these tumors from pure seminomas because of differences in therapy and prognosis. In a patient with an anterior mediastinal mass, the presence of an elevated serum alpha-fetoprotein (AFP) is highly suggestive of the presence of endodermal sinus tumor or embryonal carcinoma, and is sufficient to establish the diagnosis of a nonseminomatous malignant germ cell tumor.",
"   </p>",
"   <p>",
"    Elevation of serum beta-hCG is present in 60 percent of these patients, and serum AFP is elevated in 70 percent. However, 10 percent of patients have normal serum concentrations of both markers, and the presence of nonseminomatous elements is only discovered upon biopsy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/58/38822?source=see_link\">",
"     \"Serum tumor markers in testicular germ cell tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     MEDIASTINAL CYSTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary cysts of the mediastinum account for approximately 20 percent of all mediastinal lesions. This diverse group includes pericardial cysts, bronchogenic cysts, enteric cysts, thymic cysts, and thoracic duct cysts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/11,14,31,32\">",
"     11,14,31,32",
"    </a>",
"    ]. Bronchogenic and enteric cysts are collectively known as enterogenous cysts. All of these lesions are benign, but can produce compressive symptoms.",
"   </p>",
"   <p>",
"    Standard therapy for mediastinal cysts has been open or thoracoscopic resection to obtain a diagnosis, exclude malignant potential, and prevent enlargement. However, percutaneous aspiration under CT guidance can also obtain diagnostic tissue and provide definitive treatment with a minimal risk of recurrence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/33-40\">",
"     33-40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Pericardial cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pericardial cysts are sometimes referred to as spring water cysts of the pericardium because they are filled with clear liquid. They are benign and almost always congenital. On pathologic examination, pericardial cysts are thin-walled and lined with mesothelial cells. They rarely cause symptoms and are almost always diagnosed as an incidental finding on a chest radiograph.",
"   </p>",
"   <p>",
"    The most common location is in the right cardiophrenic angle, where the cyst appears as a perfectly round fluid density, usually 2 to 4 cm in diameter, although some are much larger (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75728 \" href=\"mobipreview.htm?31/34/32303\">",
"     image 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/41\">",
"     41",
"    </a>",
"    ]. Infrequently, the cyst arises in an atypical location or becomes large enough to cause cardiac impingement and hemodynamic compromise [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. Rarely, pericardial cysts calcify or rupture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although pericardial cysts have a highly characteristic appearance, surgical exploration has been used to confirm the diagnosis in the past. Now, CT or MRI can identify the water density of the opacity, thus establishing a nonoperative diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/24/31111?source=see_link\">",
"     \"Evaluation of mediastinal masses\"",
"    </a>",
"    .) Herniation of omentum, kidney or liver may occasionally be a source of confusion in radiographic diagnosis. However, the density of such opacities is greater than that of water, a difference easily detected by appropriate imaging.",
"   </p>",
"   <p>",
"    No treatment is required for a congenital pericardial cyst unless the patient is symptomatic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. Symptomatic cysts may be treated by percutaneous aspiration and ethanol injection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. Video-assisted thoracic surgery (VATS) may be useful in cases of recurrent cysts or diagnostic uncertainty [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acquired pericardial cysts are exceedingly rare and can be associated with mediastinal neoplasms, parasitic infection or traumatic disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/58/27561?source=see_link\">",
"     \"Treatment of echinococcosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Bronchogenic cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchogenic cysts are congenital anomalies of foregut origin and account for 60 percent of all mediastinal cysts. They are lined with ciliated respiratory epithelium and may contain cartilage or mucous glands in their walls (",
"    <a class=\"graphic graphic_picture graphicRef55820 \" href=\"mobipreview.htm?42/6/43110\">",
"     picture 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/11\">",
"     11",
"    </a>",
"    ]. Many are symptomatic at the time of diagnosis, as they can cause airway compression, resulting in cough, wheezing, and dyspnea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/49\">",
"     49",
"    </a>",
"    ]. Infrequently, the cysts communicate with the tracheobronchial tree, and may become infected (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69147 \" href=\"mobipreview.htm?27/41/28319\">",
"     image 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/50\">",
"     50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/27/29114?source=see_link&amp;anchor=H29#H29\">",
"     \"Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula\", section on 'Bronchogenic cyst'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bronchogenic cysts can be mediastinal or intrapulmonary. Mediastinal bronchogenic cysts appear as subcarinal, paratracheal, paraaortic, or aortopulmonary window masses. On CT scan, mediastinal bronchogenic cysts have a characteristic appearance of a sharply marginated mass in one of these locations, typically with water density attenuation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/49/30487?source=see_link&amp;anchor=H7#H7\">",
"     \"Radiographic appearance of developmental anomalies of the lung\", section on 'Bronchogenic cyst'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The need for surgical resection in asymptomatic patients is controversial and is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/27/29114?source=see_link&amp;anchor=H29#H29\">",
"     \"Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula\", section on 'Bronchogenic cyst'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Enteric cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of enteric cysts are discovered in childhood. They are uncommonly seen in the mediastinum, but, when present, may rarely result in tracheal or esophageal obstruction. Enteric cysts are lined by gastric, intestinal, or stratified squamous epithelium; lesions containing gastric mucosa may develop ulcerations, hemorrhage, and perforation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/52,53\">",
"     52,53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Thymic cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;True thymic cysts are congenital in origin and represent an anomaly of pharyngeal pouch formation. They are uncommon, accounting for only 1 percent of mediastinal masses. Thymic cysts are often calcified, resulting in a characteristic radiographic appearance. Thymomas can degenerate to produce pseudocysts, but these can be distinguished from true cysts by the absence of an epithelial lining [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/54,55\">",
"     54,55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     THYROID TISSUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Substernal thyroid tissue may develop from the intrathoracic extension of a cervical goiter or from rests of intrathoracic thyroid tissue.",
"   </p>",
"   <p>",
"    Typical CT features of mediastinal goiter include sharp borders, high attenuation in the absence of intravenous contrast, punctate calcification, and also early and prolonged enhancement after administration of contrast [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32392/abstract/56\">",
"     56",
"    </a>",
"    ]. As the goiter grows, compression of the trachea and displacement of the great vessels and other mediastinal structures may occur, causing symptoms of airway, nerve, vessel, or esophageal compression (eg, dyspnea, stridor, wheezing, dysphagia) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef64247 \" href=\"mobipreview.htm?20/60/21440\">",
"     image 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The diagnosis of mediastinal goiter can usually be made based on the findings of a noncontrast thoracic CT scan. Mediastinal rests of thyroid tissue can be diagnosed without biopsy by their avid uptake of radioactive iodine. However, administration of iodinated contrast to patients with goiter may induce overt hyperthyroidism in those patients who have subclinical hyperthyroidism or exacerbate hyperthyroidism in those who have overt hyperthyroidism. The clinical manifestations, evaluation, and treatment of substernal goiter are discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/2/46?source=see_link\">",
"     \"Clinical manifestations and evaluation of obstructive or substernal goiter\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/62/32742?source=see_link\">",
"     \"Treatment of obstructive or substernal goiter\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     PARATHYROID TISSUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parathyroid tissue can rarely produce an anterior mediastinal mass. The approach to and treatment of parathyroid cysts, carcinomas, and adenomas are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/23/13688?source=see_link\">",
"     \"Parathyroid carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/28/40387?source=see_link\">",
"     \"Parathyroid cysts\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/26/5545?source=see_link\">",
"     \"Diagnosis and differential diagnosis of primary hyperparathyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The anterior mediastinal compartment (also referred to as the anterosuperior compartment) is anterior to the pericardium and includes lymphatic tissue, the thymus, the extrapericardial aorta and its branches, and the great veins (",
"      <a class=\"graphic graphic_figure graphicRef56637 \" href=\"mobipreview.htm?10/31/10743\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Masses in the anterior compartment are more likely to be malignant than those found in the other mediastinal compartments. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Thymomas are the most common anterior mediastinal primary neoplasm in adults, but are rarely seen in children. A number of clinical conditions have been associated with thymoma (",
"      <a class=\"graphic graphic_table graphicRef53024 \" href=\"mobipreview.htm?34/28/35277\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Thymoma'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The presence of myasthenia gravis or other parathymic syndromes is highly suggestive of thymoma, but tissue confirmation is needed. The visualization of characteristic tonofibrils and desmosomes by electron microscopy helps to distinguish thymoma from other similar appearing tumors. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Thymoma'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A variety of lymphomas can present in the mediastinum, either alone or as a clinically significant component of more widespread disease. Primary mediastinal lymphoma is the second most common primary anterior mediastinal mass in adults. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Lymphoma'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Germ cell tumors account for 15 percent of anterior mediastinal tumors in adults and 24 percent in children. These include benign and malignant teratomas, seminomas, and nonseminomatous germ cell tumors. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Germ cell tumors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Primary mediastinal seminomas are uncommon. Generally, when a seminoma metastasizes from the testes to the mediastinum, retroperitoneal lymph nodes are apparent. Nonetheless, careful testicular exam is warranted.",
"     </li>",
"     <li>",
"      Highly sensitive and specific immunoassays for serum beta-human chorionic gonadotropin (beta-hCG) and alpha-fetoprotein (AFP) may allow differentiation between seminomas and nonseminomatous germ cell tumors. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Seminomas'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several nonseminomatous malignant germ cell tumors (NSGCTs) also present in the anterior mediastinum. The presence of an elevated serum alpha-fetoprotein (AFP) in a patient with a mediastinal mass is highly suggestive of an endodermal sinus tumor or embryonal carcinoma. Both AFP and beta-hCG are negative in only 10 percent of patients with NSGCT. NSGCTs have worse prognosis than seminomatous germ cell tumors. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Nonseminomatous germ cell tumors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Primary cysts of the mediastinum account for approximately 20 percent of all mediastinal lesions, and include pericardial cysts, bronchogenic cysts, enteric cysts, thymic cysts, and thoracic duct cysts. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Mediastinal cysts'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Substernal thyroid and parathyroid tissue may also present as a mediastinal mass. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Thyroid tissue'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H24\">",
"       'Parathyroid tissue'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/1\">",
"      Davis RD Jr, Oldham HN Jr, Sabiston DC Jr. Primary cysts and neoplasms of the mediastinum: recent changes in clinical presentation, methods of diagnosis, management, and results. Ann Thorac Surg 1987; 44:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/2\">",
"      Mullen B, Richardson JD. Primary anterior mediastinal tumors in children and adults. Ann Thorac Surg 1986; 42:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/3\">",
"      Kurup A, Loehrer PJ Sr. Thymoma and thymic carcinoma: therapeutic approaches. Clin Lung Cancer 2004; 6:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/4\">",
"      Salyer WR, Eggleston JC. Thymoma: a clinical and pathological study of 65 cases. Cancer 1976; 37:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/5\">",
"      Shamji F, Pearson FG, Todd TR, et al. Results of surgical treatment for thymoma. J Thorac Cardiovasc Surg 1984; 87:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/6\">",
"      Strollo DC, Rosado de Christenson ML, Jett JR. Primary mediastinal tumors. Part 1: tumors of the anterior mediastinum. Chest 1997; 112:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/7\">",
"      Silverman NA, Sabiston DC Jr. Mediastinal masses. Surg Clin North Am 1980; 60:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/8\">",
"      Rosado-de-Christenson ML, Strollo DC, Marom EM. Imaging of thymic epithelial neoplasms. Hematol Oncol Clin North Am 2008; 22:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/9\">",
"      Duwe BV, Sterman DH, Musani AI. Tumors of the mediastinum. Chest 2005; 128:2893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/10\">",
"      El-Bawab H, Al-Sugair AA, Rafay M, et al. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology. Eur J Cardiothorac Surg 2007; 31:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/11\">",
"      Wychulis AR, Payne WS, Clagett OT, Woolner LB. Surgical treatment of mediastinal tumors: a 40 year experience. J Thorac Cardiovasc Surg 1971; 62:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/12\">",
"      Lichtenstein AK, Levine A, Taylor CR, et al. Primary mediastinal lymphoma in adults. Am J Med 1980; 68:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/13\">",
"      Robinson LA, Dobson JR, Bierman PJ. Fallibility of transthoracic needle biopsy of anterior mediastinal masses. Thorax 1995; 50:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/14\">",
"      Ovrum E, Birkeland S. Mediastinal tumours and cysts. A review of 91 cases. Scand J Thorac Cardiovasc Surg 1979; 13:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/15\">",
"      Lewis BD, Hurt RD, Payne WS, et al. Benign teratomas of the mediastinum. J Thorac Cardiovasc Surg 1983; 86:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/16\">",
"      LE ROUX BT. Mediastinal teratomata. Thorax 1960; 15:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/17\">",
"      Kallis P, Treasure T, Holmes SJ, Griffiths M. Exocrine pancreatic function in mediastinal teratomata: an aid to preoperative diagnosis? Ann Thorac Surg 1992; 54:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/18\">",
"      ADLER RH, TAHERI SA, WEINTRAUB DH. Mediastinal teratoma in infancy. Report of successful removal from premature infant and review of literature. J Thorac Cardiovasc Surg 1960; 39:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/19\">",
"      Adebonojo SA, Nicola ML. Teratoid tumors of the mediastinum. Am Surg 1976; 42:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/20\">",
"      Thompson DP, Moore TC. Acute thoracic distress in childhood due to spontaneous rupture of a large mediastinal teratoma. J Pediatr Surg 1969; 4:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/21\">",
"      Gunes S, Varon J, Walsh G. Mediastinal teratoma presenting as massive hemoptysis in an adult. J Emerg Med 1997; 15:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/22\">",
"      Graeber GM, Shriver CD, Albus RA, et al. The use of computed tomography in the evaluation of mediastinal masses. J Thorac Cardiovasc Surg 1986; 91:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/23\">",
"      Moeller KH, Rosado-de-Christenson ML, Templeton PA. Mediastinal mature teratoma: imaging features. AJR Am J Roentgenol 1997; 169:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/24\">",
"      Feo CF, Chironi G, Porcu A, et al. Videothoracoscopic removal of a mediastinal teratoma. Am Surg 1997; 63:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/25\">",
"      Polansky SM, Barwick KW, Ravin CE. Primary mediastinal seminoma. AJR Am J Roentgenol 1979; 132:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/26\">",
"      Cox JD. Primary malignant germinal tumors of the mediastinum. A study of 24 cases. Cancer 1975; 36:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/27\">",
"      Shin MS, Ho KJ. Computed tomography of primary mediastinal seminomas. J Comput Assist Tomogr 1983; 7:990.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/28\">",
"      Mondal A, Mittra S, Mittra D, Banerjee S. Fine needle aspiration cytology in the diagnosis of mediastinal seminomas. Indian J Pathol Microbiol 1997; 40:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/29\">",
"      Ulbright TM, Loehrer PJ, Roth LM, et al. The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases. Cancer 1984; 54:1824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/30\">",
"      Nichols CR, Hoffman R, Einhorn LH, et al. Hematologic malignancies associated with primary mediastinal germ-cell tumors. Ann Intern Med 1985; 102:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/31\">",
"      Welch KJ, Tapper D, Vawter GP. Surgical treatment of thymic cysts and neoplasms in children. J Pediatr Surg 1979; 14:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/32\">",
"      Whitaker, LD, Lynn, HB. Mediastinal tumors and cysts in the pediatric patient. Surg Clin North Am 1973; 58:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/33\">",
"      Klatte EC, Yune HY. Diagnosis and treatment of pericardial cysts. Radiology 1972; 104:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/34\">",
"      Unverferth DV, Wooley CF. The differential diagnosis of paracardiac lesions: pericardial cysts. Cathet Cardiovasc Diagn 1979; 5:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/35\">",
"      Friday RO. Paracardiac cyst: diagnosis by ultrasound and puncture. JAMA 1973; 226:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/36\">",
"      Schwartz DB, Beals TF, Wimbish KJ, Hammersley JR. Transbronchial fine needle aspiration of bronchogenic cysts. Chest 1985; 88:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/37\">",
"      Zimmer, WD, Kamida, CB, McGough, PF, Rosenow, EC. Mediastinal duplication cyst: Percutaneous aspiration and cystography for diagnosis and treatment. Chest 1986; 90:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/38\">",
"      Sugarbaker DJ. Thoracoscopy in the management of anterior mediastinal masses. Ann Thorac Surg 1993; 56:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/39\">",
"      Yim AP. Video-assisted thoracoscopic management of anterior mediastinal masses. Preliminary experience and results. Surg Endosc 1995; 9:1184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/40\">",
"      Szinicz G, Taxer F, Riedlinger J, Erhart K. Thoracoscopic resection of a pericardial cyst. Thorac Cardiovasc Surg 1992; 40:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/41\">",
"      Feigin DS, Fenoglio JJ, McAllister HA, Madewell JE. Pericardial cysts. A radiologic-pathologic correlation and review. Radiology 1977; 125:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/42\">",
"      Ng AF, Olak J. Pericardial cyst causing right ventricular outflow tract obstruction. Ann Thorac Surg 1997; 63:1147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/43\">",
"      Borges AC, Gellert K, Dietel M, et al. Acute right-sided heart failure due to hemorrhage into a pericardial cyst. Ann Thorac Surg 1997; 63:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/44\">",
"      King JF, Crosby I, Pugh D, Reed W. Rupture of pericardial cyst. Chest 1971; 60:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/45\">",
"      Pugatch RD, Faling LJ, Robbins AH, Spira R. CT diagnosis of benign mediastinal abnormalities. AJR Am J Roentgenol 1980; 134:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/46\">",
"      Maisch B, Seferovi�� PM, Risti�� AD, et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 2004; 25:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/47\">",
"      Sharma R, Harden S, Peebles C, Dawkins KD. Percutaneous aspiration of a pericardial cyst: an acceptable treatment for a rare disorder. Heart 2007; 93:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/48\">",
"      Horita K, Sakao Y, Itoh T. Excision of a recurrent pericardial cyst using video-assisted thoracic surgery. Chest 1998; 114:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/49\">",
"      Lima&iuml;em F, Ayadi-Kaddour A, Djilani H, et al. Pulmonary and mediastinal bronchogenic cysts: a clinicopathologic study of 33 cases. Lung 2008; 186:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/50\">",
"      Eraklis AJ, Griscom NT, McGovern JB. Bronchogenic cysts of the mediastinum in infancy. N Engl J Med 1969; 281:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/51\">",
"      McAdams HP, Kirejczyk WM, Rosado-de-Christenson ML, Matsumoto S. Bronchogenic cyst: imaging features with clinical and histopathologic correlation. Radiology 2000; 217:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/52\">",
"      Sirivella S, Ford WB, Zikria EA, et al. Foregut cysts of the mediastinum. Results in 20 consecutive surgically treated cases. J Thorac Cardiovasc Surg 1985; 90:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/53\">",
"      Kirwan WO, Walbaum PR, McCormack RJ. Cystic intrathoracic derivatives of the foregut and their complications. Thorax 1973; 28:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/54\">",
"      Rastegar H, Arger P, Harken AH. Evaluation and therapy of mediastinal thymic cyst. Am Surg 1980; 46:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/55\">",
"      McCafferty MH, Bahnson HT. Thymic cyst extending into the pericardium: a case report and review of thymic cysts. Ann Thorac Surg 1982; 33:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32392/abstract/56\">",
"      Buckley JA, Stark P. Intrathoracic mediastinal thyroid goiter: imaging manifestations. AJR Am J Roentgenol 1999; 173:471.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6974 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-0E3ADE63EF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_40_32392=[""].join("\n");
var outline_f31_40_32392=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      THYMOMA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Clinical findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      LYMPHOMA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Clinical findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      GERM CELL TUMORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Teratomas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Clinical findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Seminomas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Clinical findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Nonseminomatous germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Clinical findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      MEDIASTINAL CYSTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Pericardial cysts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Bronchogenic cysts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Enteric cysts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Thymic cysts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      THYROID TISSUE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      PARATHYROID TISSUE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/6974\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6974|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?28/53/29520\" title=\"diagnostic image 1A\">",
"      Thymoma CT I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?15/34/15919\" title=\"diagnostic image 1B\">",
"      Thymoma CT II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?31/34/32303\" title=\"diagnostic image 2\">",
"      Pericardial cyst PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?27/41/28319\" title=\"diagnostic image 3\">",
"      Bronchogenic cyst CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?20/60/21440\" title=\"diagnostic image 4\">",
"      Retrosternal goiter CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6974|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?10/31/10743\" title=\"figure 1\">",
"      Mediastinal mass compartment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6974|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?42/6/43110\" title=\"picture 1\">",
"      Bronchogenic cyst low",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6974|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?22/20/22860\" title=\"table 1\">",
"      Paraneoplastic syndrome thymoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?34/28/35277\" title=\"table 2\">",
"      WHO tumors of the thymus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/52/10060\" title=\"table 3\">",
"      Classification of teratomas",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/1/17433?source=related_link\">",
"      Acquired pure red cell aplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/2/46?source=related_link\">",
"      Clinical manifestations and evaluation of obstructive or substernal goiter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/51/17206?source=related_link\">",
"      Clinical manifestations of myasthenia gravis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/9/19610?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of extranodal (MALT) and nodal marginal zone lymphomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/25/26007?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of precursor B cell acute lymphoblastic leukemia/lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/20/30023?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of precursor T cell acute lymphoblastic leukemia/lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/1/9238?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of primary mediastinal large B-cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/17/8474?source=related_link\">",
"      Clinical presentation and management of thymoma and thymic carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/35/568?source=related_link\">",
"      Clinical presentation and patterns of disease distribution in classical Hodgkin lymphoma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/27/29114?source=related_link\">",
"      Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/26/5545?source=related_link\">",
"      Diagnosis and differential diagnosis of primary hyperparathyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/45/24282?source=related_link\">",
"      Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/24/31111?source=related_link\">",
"      Evaluation of mediastinal masses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/52/10058?source=related_link\">",
"      Extragonadal germ cell tumors involving the mediastinum and retroperitoneum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/56/19338?source=related_link\">",
"      Malignancy-related superior vena cava syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/23/13688?source=related_link\">",
"      Parathyroid carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/28/40387?source=related_link\">",
"      Parathyroid cysts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/43/4794?source=related_link\">",
"      Pathology of mediastinal tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/49/30487?source=related_link\">",
"      Radiographic appearance of developmental anomalies of the lung",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/58/38822?source=related_link\">",
"      Serum tumor markers in testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/58/27561?source=related_link\">",
"      Treatment of echinococcosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/62/32742?source=related_link\">",
"      Treatment of obstructive or substernal goiter",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_40_32393="Pathogenesis of spontaneous preterm birth";
var content_f31_40_32393=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis of spontaneous preterm birth",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/40/32393/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/40/32393/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/40/32393/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/40/32393/contributors\">",
"     Susan M Ramin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/40/32393/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/40/32393/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/40/32393/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 11, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preterm birth (PTB) is the leading cause of infant morbidity and mortality in the industrialized world (",
"    <a class=\"graphic graphic_table graphicRef61346 \" href=\"mobipreview.htm?42/54/43883\">",
"     table 1",
"    </a>",
"    ). While rates in the United States have fallen for four consecutive years, the overall rate remains just under 12 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/1\">",
"     1",
"    </a>",
"    ]. Moreover, the incidence of very early preterm birth and of low birthweight remains unchanged. Given that low and very low birthweight newborns are at the highest risk of early death or disability, major focuses of obstetrical research justifiably include the pathogenic processes leading to PTB and development of preventive interventions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 70 percent of preterm deliveries occur spontaneously as a result of preterm labor (PTL, 45 percent) or preterm premature rupture of membranes (PPROM, 25 percent); intervention for maternal or fetal problems account for the remaining 30 percent (",
"    <a class=\"graphic graphic_table graphicRef74561 \" href=\"mobipreview.htm?7/40/7819\">",
"     table 2",
"    </a>",
"    ). Many epidemiologic and clinical risk factors have been associated with spontaneous PTB (",
"    <a class=\"graphic graphic_table graphicRef68992 \" href=\"mobipreview.htm?27/48/28428\">",
"     table 3",
"    </a>",
"    ). Genetic factors are increasingly recognized as important determinants of PTB. However, the magnitude of effect and the degree to which genetic factors contribute to racial differences in PTB risk across populations remain largely unknown [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/2\">",
"     2",
"    </a>",
"    ]",
"    <em>",
"     .",
"    </em>",
"   </p>",
"   <p>",
"    Compelling clinical and research evidence suggest that a number of pathogenic processes can lead to a final common pathway that results in spontaneous PTB. The four primary processes are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Premature activation of the maternal or fetal hypothalamic-pituitary-adrenal axis",
"     </li>",
"     <li>",
"      Exaggerated inflammatory",
"      <span class=\"nowrap\">",
"       response/infection",
"      </span>",
"     </li>",
"     <li>",
"      Abruption (decidual hemorrhage)",
"     </li>",
"     <li>",
"      Pathological uterine distention",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These processes may be initiated long before PTL or PPROM are diagnosed clinically.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Activation of the HPA axis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stress is a common element activating a series of physiologic adaptive responses in the maternal and fetal compartment. From this perspective, premature activation of the hypothalamic-pituitary-adrenal (HPA) axis can initiate PTB (",
"    <a class=\"graphic graphic_algorithm graphicRef59393 \" href=\"mobipreview.htm?41/30/42478\">",
"     algorithm 1",
"    </a>",
"    ). Major maternal physical or psychological stressors, including depression, can activate the maternal HPA axis and have been associated with a slightly higher rate of PTB [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/3-9\">",
"     3-9",
"    </a>",
"    ]. As an example, a prospective cohort study of women with depressive symptoms early in pregnancy found that these women had almost twice the PTB risk of women without such symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/10\">",
"     10",
"    </a>",
"    ]. The risk of PTB increased with increasing severity of depression, suggesting a \"dose-response\" effect. In addition, data derived from a large New York database provided evidence that mothers with posttraumatic stress disorder were more likely to deliver preterm (OR 2.48, 95% CI 1.05&ndash;5.84) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Premature fetal HPA activation can result from the stress of uteroplacental vasculopathy and has a higher correlation with subsequent PTB than maternal stress [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. In one study, spontaneous PTB &le;35 to 36 weeks of gestation was associated with a four- to seven-fold increased risk of placental pathological evidence of vascular damage, bleeding, fetal vascular disruption, or lack of normal physiologic conversion of maternal spiral arteries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/15\">",
"     15",
"    </a>",
"    ]. In another report, severe preeclampsia was associated with a threefold increase in the risk of spontaneous PTB [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/16\">",
"     16",
"    </a>",
"    ]. In contrast to women with uncomplicated first pregnancies, a third study found that women whose first pregnancy ended in spontaneous PTB were at increased risk of PTB, preeclampsia, and fetal growth restriction in their second pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/17\">",
"     17",
"    </a>",
"    ]. The earlier the PTB, the higher the risk of one of these complications in the second pregnancy.",
"   </p>",
"   <p>",
"    The mechanisms by which HPA activation are thought to cause spontaneous PTB include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased placental production and release of corticotropin-releasing hormone (CRH), which appears to program a \"placental clock\" [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/18,19\">",
"       18,19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Increased release of fetal pituitary adrenocorticotropic hormone (ACTH) secretion, which stimulates production of placental estrogenic compounds and prostaglandins that may activate the myometrium and initiate labor [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Corticotropin-releasing hormone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Corticotropin-releasing hormone (CRH) plays a role in both term and preterm birth. CRH is released by the hypothalamus but, during pregnancy, is also expressed by placental and chorionic trophoblast, amniochorion, and decidual cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/21-23\">",
"     21-23",
"    </a>",
"    ]. It stimulates the secretion of ACTH from the pituitary, which then promotes the release of cortisol from the adrenal. In the maternal HPA axis, cortisol inhibits hypothalamic CRH and pituitary ACTH release, creating a negative feedback loop. In contrast, cortisol",
"    <strong>",
"     stimulates",
"    </strong>",
"    CRH release in the decidua-trophoblast-membrane compartment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. CRH, in turn, further drives maternal and fetal HPA activation, establishing a potent positive feedback loop.",
"   </p>",
"   <p>",
"    CRH also enhances prostaglandin production by amnion, chorion, and decidua [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/25\">",
"     25",
"    </a>",
"    ]. In turn, prostaglandins stimulate CRH release from the placenta [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/24\">",
"     24",
"    </a>",
"    ], creating a second positive feedback loop for CRH secretion.",
"   </p>",
"   <p>",
"    In a normal pregnancy, it is hypothesized that maturation of the fetal HPA axis and development of the fetal zone of the fetal adrenal gland beginning in midgestation cause a physiologic increase in fetal cortisol secretion and enhancing CRH release from the placenta [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/26\">",
"     26",
"    </a>",
"    ]. The effects of CRH are augmented near term by a reduction in maternal plasma CRH-binding protein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/27\">",
"     27",
"    </a>",
"    ]. As noted above, the CRH-induced increases in maternal and fetal adrenal cortisol synthesis and placental prostaglandin production promote positive feedback loops that lead to even higher levels of CRH, cortisol, and prostaglandins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/28\">",
"     28",
"    </a>",
"    ]. There is also some evidence that CRH can directly augment myometrial activation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rise in prostaglandins ultimately results in parturition via the elaboration of genital tract proteases (eg, matrix metalloproteinases [MMPs]) and enhanced myometrial contractility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/30\">",
"     30",
"    </a>",
"    ]. In vitro studies in human myometrial cells suggest that prostaglandins act to increase the progesterone receptor (PR)-A to B expression ratio [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/31\">",
"     31",
"    </a>",
"    ]. Since the PR-A isoform can antagonize the antiparturition effects of the PR-B isoform, these findings suggest that prostaglandins can induce functional progesterone withdrawal. Indeed, since prostaglandins can induce labor at virtually any point in gestation, their generation is an integral part of the common final pathway of PTB.",
"   </p>",
"   <p>",
"    If the sequence of events outlined above occurs too early in gestation, PTL and PTB may result. This was illustrated in a prospective cohort study that measured serum CRH concentrations between 17 and 30 weeks of gestation in 860 unselected pregnant women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/32\">",
"     32",
"    </a>",
"    ]. The median serum CRH in pregnancies that subsequently spontaneously delivered preterm (37 women) was twice the median value of women of the same gestational age who went on to deliver at term.",
"   </p>",
"   <p>",
"    Increased fetal adrenal zone size correlates with enhanced adrenal activity and increased fetal adrenal gland volume, as measured by three-dimensional ultrasound, is a potential predictor of stress associated prematurity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/33\">",
"     33",
"    </a>",
"    ]. However, since the fetal adrenal zone is not well developed until the third trimester, fetal stress-associated PTB is more likely to account for later PTBs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Estrogens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Activation of the fetal HPA axis also leads to PTB through a pathway involving estrogens. Fetal pituitary ACTH secretion stimulates adrenal synthesis of dehydroepiandrosterone sulfate (DHEA), which is converted to 16-hydroxy-DHEA-S in the fetal liver. Placental CRH can also augment fetal adrenal DHEA production directly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/34\">",
"     34",
"    </a>",
"    ]. The placenta converts these androgen precursors to estrone (E1), estradiol (E2), and estriol (E3), which, in the presence of estrogen receptor-alpha (ER-alpha), activate the myometrium by increasing gap junction formation, oxytocin receptors, prostaglandin activity, and enzymes responsible for muscle contraction (myosin light chain kinase, calmodulin) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/35-39\">",
"     35-39",
"    </a>",
"    ]. Moreover, the functional progesterone withdrawal noted above is expected to be accompanied by rising concentrations of myometrial ER-alpha, thereby mediating this estrogen-induced myometrial activation.",
"   </p>",
"   <p>",
"    In the setting of infection-induced fetal stress, the fetal cortisol-to-DHEA ratio remains low, with no direct correlation between the fetal adrenal gland volume and either cortisol or DHEA levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/33\">",
"     33",
"    </a>",
"    ]. This suggests that infection-mediated PTB may act via alternative pathways.",
"   </p>",
"   <p>",
"    The potential predictive value of estrogenic compounds was suggested by a prospective study in which serial measurements of salivary E3 were obtained [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/40\">",
"     40",
"    </a>",
"    ]. Mean salivary estriol was higher from 24 to 34 weeks of gestation in women with singleton pregnancies delivering preterm than in those delivering at term. A surge in salivary E3 occurred three to four weeks before the onset of labor in both groups. Predictably, this surge forecasts only later PTBs (&ge;34 weeks).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Inflammation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammation is a highly coordinated process set in place to protect the host [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/41\">",
"     41",
"    </a>",
"    ]. When properly controlled, inflammation is beneficial, but when dysregulated, it becomes harmful [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Laboratory and clinical data show a link between spontaneous PTB and the presence of both systemic and genitourinary tract pathogens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/43-49\">",
"     43-49",
"    </a>",
"    ]. For example,",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a large retrospective population-based study of 199,093 deliveries, 2.5 percent of patients had asymptomatic bacteriuria, which was independently associated with PTB (adjusted OR 1.6, 95% CI 1.5-1.7) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/43\">",
"       43",
"      </a>",
"      ]. Conversely, the diagnosis and treatment of asymptomatic bacteriuria appears to reduce the risk of PTB [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another study of 759 women who underwent first trimester assessment of their vaginal flora, those without abnormalities of the vaginal flora had a 75 percent lower risk of delivery before 35 weeks than women with abnormal vaginal flora (OR 0.26; 95% CI 0.12-0.56) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/45\">",
"       45",
"      </a>",
"      ]. Absence of lactobacilli and the presence of bacterial vaginosis (BV) were both associated with a two-fold increased risk of PTB, while gram positive coccus-associated aerobic vaginitis was associated with a three-fold increase in risk of PTB (OR 3.2; 95% CI 1.2-9.1). Unfortunately, treatment of BV does not appear to consistently reduce PTB rates in low risk patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/50\">",
"       50",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/56/30602?source=see_link&amp;anchor=H18#H18\">",
"       \"Bacterial vaginosis\", section on 'Pregnant women'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Similarly, periodontal disease and subsequent systemic inflammation may play a role in triggering PTB [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/51\">",
"       51",
"      </a>",
"      ]. Intervention studies have not consistently demonstrated a benefit to treatment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/46,47,52\">",
"       46,47,52",
"      </a>",
"      ]. However, it remains possible that the putative beneficial effects of periodontal treatment may be dependent on time of initiation and success of therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/53\">",
"       53",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/45/11994?source=see_link&amp;anchor=H21#H21\">",
"       \"Prevention of spontaneous preterm birth\", section on 'Treatment of periodontal disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Lastly, both clinical and subclinical chorioamnionitis are much more common in preterm than term deliveries, and may account for 50 percent of PTB before 30 weeks of gestation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/54\">",
"       54",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/3/35898?source=see_link&amp;anchor=H10#H10\">",
"       \"Risk factors for preterm labor and delivery\", section on 'Infection'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These studies, and others, suggest that disorders of maternal innate or acquired immunity, rather than the mere presence of certain genital tract bacteria, are the primary causes of inflammation-associated PTB.",
"   </p>",
"   <p>",
"    There is a significant racial disparity in inflammation-associated PTB, with African-Americans disproportionately affected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/55\">",
"     55",
"    </a>",
"    ]. This may be explained by the observation that multiple maternal and fetal inflammatory pathway genetic polymorphisms linked to inflammation-associated PTB have been found in greater prevalence among African-American mothers",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fetuses than among Caucasians [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. For example, African-American mothers harboring both a polymorphism of the tumor necrosis factor-alpha (TNF) gene and bacterial vaginosis are at significantly greater risk of PTB (OR 6.1; 95% CI 1.9&ndash;21.0) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/58\">",
"     58",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/3/35898?source=see_link&amp;anchor=H15#H15\">",
"     \"Risk factors for preterm labor and delivery\", section on 'Genetic factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Binding of bacterial ligands to toll-like receptors (TLRs) in decidual, amnion-chorion and cervical and placental cells and resident leucocytes induce the transcription factor NFkappaB which, in turn, triggers a maternal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fetal inflammatory response in susceptible individuals that is linked to PTB (",
"    <a class=\"graphic graphic_algorithm graphicRef50691 \" href=\"mobipreview.htm?0/30/494\">",
"     algorithm 2",
"    </a>",
"    ). Activation of the TLRs is dependent not only on the presence of bacterial molecular wall motifs, but also on a palette of intracellular signaling adaptors (eg, MyD88), co-receptor molecules (eg, CD14",
"    <em>",
"     )",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/59\">",
"     59",
"    </a>",
"    ]",
"    <em>",
"     ,",
"    </em>",
"    and soluble receptor modulators (soluble TLR2, soluble TNF receptor-1, soluble IL-6 receptor, soluble gp130 and soluble RAGE) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/60-63\">",
"     60-63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This TLR-mediated response is ultimately characterized by the presence of activated neutrophils and, to a lesser extent, activated macrophages and various proinflammatory mediators (eg, interleukins [IL] 1,6, and 8; TNF,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/13/23767?source=see_link\">",
"     granulocyte colony-stimulating factor",
"    </a>",
"    (G-CSF), colony stimulating factor-2 (CSF-2), and MMPs). The key initial mediators of this response are IL-1beta and TNF, which enhance prostaglandin production by inducing COX-2 expression in the amnion and decidua while inhibiting the prostaglandin metabolizing enzyme, 15-hydroxy-prostaglandin dehydrogenase (PGDH) in the chorion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. Moreover, IL-1beta",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    TNF directly enhance the expression of various MMPs in the amnio-chorion, decidua, and cervix to degrade the extracellular matrix of the fetal membranes and cervix [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/66-68\">",
"     66-68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Furthermore, chorioamnionitis is associated with intense decidual immunostaining for IL-8 and CSF-2, which recruit neutrophils capable of releasing additional PPROM-causing MMPs and IL-1beta",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    TNF greatly augment the output of IL-8 and CSF-2 in term decidual cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. TNF-alpha plays an additional role, since it can induce apoptosis (physiologic cell death). Elevated levels of TNF and increased apoptosis in amnion epithelial cells have been associated with PPROM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/71\">",
"     71",
"    </a>",
"    ]. Chorioamnionitis is also linked to increased decidual and membrane IL-6 production [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/72,73\">",
"     72,73",
"    </a>",
"    ], which further enhances decidual and fetal membrane prostaglandin production, and G-CSF expression, which recruits and activates neutrophils [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/74,75\">",
"     74,75",
"    </a>",
"    ]. Complement activation also appears to play a role [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/76\">",
"     76",
"    </a>",
"    ]. Thus, both maternal and fetal inflammatory responses to infection are processes that can lead to PTL and PPROM. In contrast, the presence of bacteria, without a host response, does not always cause an adverse outcome (see below) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Elevated proinflammatory mediator levels have been demonstrated in the amniotic fluid of women with PTL with intact membranes and these levels correlated well with positive results from culture of the amniotic fluid and fetal membranes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/78\">",
"     78",
"    </a>",
"    ]. In a review of 17 primary studies compromising 6270 asymptomatic women, elevated cervicovaginal and amniotic fluid IL-6 levels at mid-gestation predicted PTB with odds ratios (OR) of 3.05 (95% CI 2.00-4.67; number needed to treat = 7) and 4.52 (95% CI 2.67-7.65; number needed to treat = 7), respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/79\">",
"     79",
"    </a>",
"    ]. In addition, patients with intraamniotic inflammation destined to deliver preterm appear to present unique amniotic fluid, vaginal-cervical secretion, and serum proteomic profiles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/80-84\">",
"     80-84",
"    </a>",
"    ]. In one study, 104 amniotic fluid samples of patients at risk for PTB were analyzed using surface-enhanced laser desorption ionization (SELDI) proteomic profiling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/80\">",
"     80",
"    </a>",
"    ]. Patients with intraamniotic inflammation that delivered preterm were found to display neutrophil defensins-1 and -2, and calgranulins A and C. The presence of more than two of these proteins had greater than 90 percent sensitivity and specificity for detection of intraamniotic inflammation. Although the measurement of proinflammatory mediators is possible, these tests have not been sufficiently studied to be clinically useful at this time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Bacteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to inducing an inflammatory response, bacteria may also have a direct role in the pathogenesis of PTB. Some organisms (eg, Pseudomonas, Staphylococcus, Streptococcus, Bacteroides, and Enterobacter) produce proteases, collagenases, and elastases that can degrade the fetal membranes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/85,86\">",
"     85,86",
"    </a>",
"    ]. Bacteria also produce phospholipase A2 (which leads to prostaglandin synthesis) and endotoxin, substances that stimulate uterine contractions and can cause PTL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Metagenomic techniques, including surveillance of the 16S-rRNA gene, have increased understanding of the spectrum of cultivated and uncultivated human microbial agents involved in the pathogenesis of PTB [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/88\">",
"     88",
"    </a>",
"    ]. By using metagenomic tools, several groups of investigators reported that in pregnancies complicated by PTB secondary to infection approximately two thirds of the amniotic fluid bacteria detected by culture-independent methods were not isolated in cultures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/89,90\">",
"     89,90",
"    </a>",
"    ]. These included both uncultivated and difficult-to-cultivate species, such as Fusobacterium nucleatum, Leptotrichia (Sneathia), Bergeyella, Peptostreptococcus, Bacteroides, and a species of the order Clostridials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Proinflammatory mediators unrelated to infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Noninfectious etiologies, such as placental hypoperfusion, also appear to increase production of proinflammatory mediators [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/91\">",
"     91",
"    </a>",
"    ]. This may be another mechanism accounting for the slightly higher rate of spontaneous PTB among growth restricted infants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/92\">",
"     92",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Decidual hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vaginal bleeding from decidual hemorrhage is associated with a high risk of PTL and PPROM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/93-95\">",
"     93-95",
"    </a>",
"    ]. Decidual hemorrhage (placental abruption) originates in damaged decidual blood vessels and presents clinically as vaginal bleeding or retroplacental hematoma formation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/96\">",
"     96",
"    </a>",
"    ]. In a case-control study of 341 patients, vaginal bleeding in more than one trimester increased the risk of PPROM sevenfold [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/93\">",
"     93",
"    </a>",
"    ]. In another series, occult decidual hemorrhage (manifested by hemosiderin deposition and retro-chorionic hematoma formation) was present in 38 percent of patients with PTB between 22 and 32 weeks of gestation due to PPROM and 36 percent of patients experiencing PTB after PTL; these placental findings were present in only 0.8 percent of term deliveries (p &lt;0.01) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/95\">",
"     95",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As noted above, PTB is strongly linked to histological evidence of maternal spiral artery hemorrhage and damage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/15\">",
"     15",
"    </a>",
"    ]. In a prospective cohort analysis of maternal genotypes, pregnancy outcomes, and placental pathology among 560 Caucasian and 399 black women, the factor V Leiden and angiotensinogen-6G&gt;A mutations were positively linked to abruption-associated PTBs (OR 4.8; 95% CI:1.6-14.2 and OR 3.8; 95% CI, 1.3-10.5, respectively), but not with other causes of preterm delivery and only among Caucasians [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/97\">",
"     97",
"    </a>",
"    ]. This suggests that polymorphisms predisposing to decidual vasculopathy, thrombosis, and abruption also predispose to PTB. This finding helps account for the predominance of abruption-associated PTB in European populations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/98\">",
"     98",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The development of PPROM in the setting of abruption may be related to the high decidual concentration of tissue factor, the primary cellular mediator of hemostasis. Following intrauterine hemorrhage from placental abruption, decidual tissue factor combines with factor Vlla to activate factor Xa, which in turn complexes with its cofactor, Va, to generate thrombin (",
"    <a class=\"graphic graphic_figure graphicRef80402 \" href=\"mobipreview.htm?28/43/29372\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/35/27194?source=see_link\">",
"     \"Overview of hemostasis\"",
"    </a>",
"    .) In addition to its hemostatic properties, thrombin binds to decidual protease-activated receptors (PAR1 and 3) that regulate the expression of proteases such as MMPs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/99-101\">",
"     99-101",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Abruption can be accompanied by an inflammatory process in the absence of infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/102\">",
"     102",
"    </a>",
"    ]. Proteomics studies provided evidence that proteases and free hemoglobin chains activate innate immunity and a feed-forward mechanism that reinforces the inflammatory process, leading to PPROM and PTB. In addition, thrombin is a potent inducer of IL-8 in decidual cells, accounting for the dense neutrophil infiltrate observed in abruption-associated PPROM in the absence of infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/103\">",
"     103",
"    </a>",
"    ]. The interactive effects of thrombin-enhanced MMPs with neutrophil-derived proteases promote degradation of the fetal membrane extracellular matrix, which can result in PPROM (",
"    <a class=\"graphic graphic_algorithm graphicRef54338 \" href=\"mobipreview.htm?10/33/10782\">",
"     algorithm 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Decidual hemorrhage results in intense local thrombin generation. Hormonal factors such as progesterone play an important modulator role [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/104\">",
"     104",
"    </a>",
"    ]. Thrombin also induces synthesis of elements of the fibrinolytic system in decidual cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/105\">",
"     105",
"    </a>",
"    ]. However, the primary effect of thrombin is to inhibit fibrinolysis via generation of type-1 plasminogen inhibitor (PAI-1) to avoid hemorrhage in the setting of abruption, suggesting that abruption-associated decidual proteolysis and PPROM are mediated primarily by thrombin-enhanced MMP expression.",
"   </p>",
"   <p>",
"    In laboratory studies, small quantities of thrombin produced during coagulation increased the frequency, intensity, and tone of myometrial contractions; an effect that is suppressed by blood containing thrombin inhibitors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/106,107\">",
"     106,107",
"    </a>",
"    ]. Interactions of thrombin with PARs lead to activation of the phosphatidylinositol pathway. Abruption-associated generation of thrombin also appears to initiate functional progestin withdrawal in the decidua by inhibiting expression of progesterone receptors in decidual cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/108\">",
"     108",
"    </a>",
"    ]. This may be a mechanism for PTL in pregnancies complicated by antepartum bleeding. However, the main effect of thrombin released at the site of decidual hemorrhage is to maintain hemostasis, rather than to stimulate uterine contractions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/105\">",
"     105",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thrombin activation (measured by serum thrombin-antithrombin complex levels [TAT]) has been noted in women with PTL and in asymptomatic women who subsequently delivered preterm. A pilot study of 23 gravidas at 24.0 to 32.9 weeks of gestation hospitalized with PTL found significantly higher blood TAT levels in those who subsequently delivered within three weeks compared to gestational-age matched nonlaboring controls or PTL patients who did not deliver within three weeks (TAT levels 7.8 &plusmn; 2.86",
"    <span class=\"nowrap\">",
"     ng/mL,",
"    </span>",
"    5.77 &plusmn; 1.43",
"    <span class=\"nowrap\">",
"     ng/mL,",
"    </span>",
"    and 5.57 &plusmn; 1.69",
"    <span class=\"nowrap\">",
"     ng/mL,",
"    </span>",
"    respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/109\">",
"     109",
"    </a>",
"    ]. A TAT level of greater than 8.0",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    in symptomatic women had sensitivity, specificity, and positive and negative predictive values of 50, 91, 80, and 71 percent, respectively, for delivery within three weeks. A TAT level greater than 6.3",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    had sensitivity, specificity, and positive and negative predictive values of 75, 73, 67, and 73 percent, respectively. In another study of women undergoing second trimester genetic amniocentesis, amniotic fluid TAT concentration was statistically higher in women who subsequently had a spontaneous or indicated preterm birth (median 87.6 and 117.7",
"    <span class=\"nowrap\">",
"     mcg/L,",
"    </span>",
"    respectively) than those who delivered at term (66.3",
"    <span class=\"nowrap\">",
"     mcg/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/110\">",
"     110",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These results should be validated before TAT levels are used to manage patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Pathologic uterine distention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple gestation, polyhydramnios, and other causes of excessive uterine distention are well described risk factors for PTB. Enhanced stretching of the myometrium induces formation of gap junctions, upregulation of oxytocin receptors, and production of prostaglandin E2 and F2 and myosin light chain kinase, which are critical events preceding uterine contractions and cervical dilation (",
"    <a class=\"graphic graphic_figure graphicRef55323 \" href=\"mobipreview.htm?34/30/35309\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/111,112\">",
"     111,112",
"    </a>",
"    ]. Myometrial distention also increases expression of genes with important roles in collagenolysis and inflammation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/113\">",
"     113",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/0/6153?source=see_link\">",
"     \"Physiology of parturition\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Distention of the fetal compartment also contributes to myometrial activation. Cytokines, prostaglandins, and collagenase are produced from excess stretch of the fetal membranes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/114-116\">",
"     114-116",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Pathologic cervical change",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervical insufficiency refers to pathological dilatation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    effacement of the uterine cervix unrelated to labor and leading to previable pregnancy loss, as well as PTB. It may occur with or without coexisting distention of the corpus, and cerclage may be helpful in select instances [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/117\">",
"     117",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/22/4457?source=see_link\">",
"     \"Cervical insufficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cervical insufficiency due to intrinsic cervical factors is probably a rare event. It is more likely that progressive cervical shortening prior to viability results from activation of the inflammatory of hemorrhagic pathways at a point in gestation when both myometrial quiescence, as well as amniotic fluid, fetal membrane, and decidual antiprotease activity are maximal. Thus, cervical change occurs without apparent antecedent PTL and PPROM.",
"   </p>",
"   <p>",
"    Genetic factors may also play a role in the PTB phenotype. For example, the enhancing G13 allele in the anti-inflammatory IL-10.G microsatellite occurs more frequently in women with cervical insufficiency compared with controls, suggesting that constitutively increased anti-inflammatory modulators may produce cervical insufficiency rather than PTL or PPROM phenotype in the face of inflammatory or hemorrhagic stimuli [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/118\">",
"     118",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Even putative mechanical causes of cervical insufficiency may have other etiologies. In a retrospective cohort study of 624 women who delivered after a loop electrosurgical excision procedure (LEEP), the risk of PTB was increased two-fold and the risk was even higher following repeated procedures or larger biopsies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/119\">",
"     119",
"    </a>",
"    ]. However, this apparent effect may reflect ascertainment bias since another retrospective cohort analysis of women with CIN3 compared to women with no record of CIN found the former were significantly more likely to have spontaneous PTB (OR of 1.52; 95% CI: 1.29-1.80) and that LEEP did not alter these pregnancy complication rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/40/32393/abstract/120\">",
"     120",
"    </a>",
"    ]. This suggests that immunological, clinical or social risk factors associated with the development CIN rather than cervical surgery alone may increase PTB rates in women who have undergone LEEP.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Approximately 70 percent of preterm deliveries occur spontaneously as a result of preterm labor (45 percent) or preterm premature rupture of membranes (25 percent); intervention for maternal or fetal problems account for the remaining 30 percent (",
"      <a class=\"graphic graphic_table graphicRef74561 \" href=\"mobipreview.htm?7/40/7819\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are four discrete mechanisms for the pathogenesis of preterm birth:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Premature activation of the maternal or fetal hypothalamic-pituitary-adrenal axis",
"     </li>",
"     <li>",
"      Exaggerated inflammatory",
"      <span class=\"nowrap\">",
"       response/infection",
"      </span>",
"     </li>",
"     <li>",
"      Decidual hemorrhage",
"     </li>",
"     <li>",
"      Pathological uterine distention",
"      <br/>",
"      <br/>",
"      These mechanisms share a final common pathway involving the formation of uterotonic agents and proteases that weaken the fetal membranes and cervical stroma. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although each mechanism has distinct epidemiological, genetic, and clinical characteristics, they are not mutually exclusive. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     file://www.cdc.gov/nchs/data/nvsr/nvsr60/nvsr60_02.pdf. (Accessed on November 28, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/2\">",
"      Muglia LJ, Katz M. The enigma of spontaneous preterm birth. N Engl J Med 2010; 362:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/3\">",
"      Berkowitz GS, Kasl SV. The role of psychosocial factors in spontaneous preterm delivery. J Psychosom Res 1983; 27:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/4\">",
"      Lobel M, Dunkel-Schetter C, Scrimshaw SC. Prenatal maternal stress and prematurity: a prospective study of socioeconomically disadvantaged women. Health Psychol 1992; 11:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/5\">",
"      Copper RL, Goldenberg RL, Das A, et al. The preterm prediction study: maternal stress is associated with spontaneous preterm birth at less than thirty-five weeks' gestation. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1996; 175:1286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/6\">",
"      Wadhwa PD, Sandman CA, Porto M, et al. The association between prenatal stress and infant birth weight and gestational age at birth: a prospective investigation. Am J Obstet Gynecol 1993; 169:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/7\">",
"      Kogan, MD, Alexander, GR. Social and behavioral factors in preterm birth. Prenat Neonat Med 1998; 3:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/8\">",
"      Murphy CC, Schei B, Myhr TL, Du Mont J. Abuse: a risk factor for low birth weight? A systematic review and meta-analysis. CMAJ 2001; 164:1567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/9\">",
"      Dole N, Savitz DA, Hertz-Picciotto I, et al. Maternal stress and preterm birth. Am J Epidemiol 2003; 157:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/10\">",
"      Li D, Liu L, Odouli R. Presence of depressive symptoms during early pregnancy and the risk of preterm delivery: a prospective cohort study. Hum Reprod 2009; 24:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/11\">",
"      Lipkind HS, Curry AE, Huynh M, et al. Birth outcomes among offspring of women exposed to the September 11, 2001, terrorist attacks. Obstet Gynecol 2010; 116:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/12\">",
"      Arias F, Rodriquez L, Rayne SC, Kraus FT. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993; 168:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/13\">",
"      Ott WJ. Intrauterine growth retardation and preterm delivery. Am J Obstet Gynecol 1993; 168:1710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/14\">",
"      Salafia CM, Ghidini A, Lop&egrave;z-Zeno JA, Pezzullo JC. Uteroplacental pathology and maternal arterial mean blood pressure in spontaneous prematurity. J Soc Gynecol Investig 1998; 5:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/15\">",
"      Kelly R, Holzman C, Senagore P, et al. Placental vascular pathology findings and pathways to preterm delivery. Am J Epidemiol 2009; 170:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/16\">",
"      Kramer MS, McLean FH, Eason EL, Usher RH. Maternal nutrition and spontaneous preterm birth. Am J Epidemiol 1992; 136:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/17\">",
"      Lykke JA, Paidas MJ, Langhoff-Roos J. Recurring complications in second pregnancy. Obstet Gynecol 2009; 113:1217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/18\">",
"      McLean M, Bisits A, Davies J, et al. A placental clock controlling the length of human pregnancy. Nat Med 1995; 1:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/19\">",
"      Korebrits C, Ramirez MM, Watson L, et al. Maternal corticotropin-releasing hormone is increased with impending preterm birth. J Clin Endocrinol Metab 1998; 83:1585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/20\">",
"      Challis JR, Hooper S. Birth: outcome of a positive cascade. Baillieres Clin Endocrinol Metab 1989; 3:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/21\">",
"      Zoumakis E, Makrigiannakis A, Margioris AN, et al. Endometrial corticotropin-releasing hormone. Its potential autocrine and paracrine actions. Ann N Y Acad Sci 1997; 828:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/22\">",
"      Petraglia F, Potter E, Cameron VA, et al. Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. J Clin Endocrinol Metab 1993; 77:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/23\">",
"      Jones SA, Brooks AN, Challis JR. Steroids modulate corticotropin-releasing hormone production in human fetal membranes and placenta. J Clin Endocrinol Metab 1989; 68:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/24\">",
"      Petraglia F, Coukos G, Volpe A, et al. Involvement of placental neurohormones in human parturition. Ann N Y Acad Sci 1991; 622:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/25\">",
"      Jones SA, Challis JR. Effects of corticotropin-releasing hormone and adrenocorticotropin on prostaglandin output by human placenta and fetal membranes. Gynecol Obstet Invest 1990; 29:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/26\">",
"      Lockwood CJ, Radunovic N, Nastic D, et al. Corticotropin-releasing hormone and related pituitary-adrenal axis hormones in fetal and maternal blood during the second half of pregnancy. J Perinat Med 1996; 24:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/27\">",
"      Perkins AV, Eben F, Wolfe CD, et al. Plasma measurements of corticotrophin-releasing hormone-binding protein in normal and abnormal human pregnancy. J Endocrinol 1993; 138:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/28\">",
"      Majzoub JA, McGregor JA, Lockwood CJ, et al. A central theory of preterm and term labor: putative role for corticotropin-releasing hormone. Am J Obstet Gynecol 1999; 180:S232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/29\">",
"      Grammatopoulos DK, Hillhouse EW. Role of corticotropin-releasing hormone in onset of labour. Lancet 1999; 354:1546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/30\">",
"      Gibb W. The role of prostaglandins in human parturition. Ann Med 1998; 30:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/31\">",
"      Madsen G, Zakar T, Ku CY, et al. Prostaglandins differentially modulate progesterone receptor-A and -B expression in human myometrial cells: evidence for prostaglandin-induced functional progesterone withdrawal. J Clin Endocrinol Metab 2004; 89:1010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/32\">",
"      McLean M, Bisits A, Davies J, et al. Predicting risk of preterm delivery by second-trimester measurement of maternal plasma corticotropin-releasing hormone and alpha-fetoprotein concentrations. Am J Obstet Gynecol 1999; 181:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/33\">",
"      Buhimschi CS, Turan OM, Funai EF, et al. Fetal adrenal gland volume and cortisol/dehydroepiandrosterone sulfate ratio in inflammation-associated preterm birth. Obstet Gynecol 2008; 111:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/34\">",
"      Smith R, Mesiano S, Chan EC, et al. Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J Clin Endocrinol Metab 1998; 83:2916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/35\">",
"      Chakravorty A, Mesiano S, Jaffe RB. Corticotropin-releasing hormone stimulates P450 17alpha-hydroxylase/17,20-lyase in human fetal adrenal cells via protein kinase C. J Clin Endocrinol Metab 1999; 84:3732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/36\">",
"      Lye SJ, Nicholson BJ, Mascarenhas M, et al. Increased expression of connexin-43 in the rat myometrium during labor is associated with an increase in the plasma estrogen:progesterone ratio. Endocrinology 1993; 132:2380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/37\">",
"      Bale TL, Dorsa DM. Cloning, novel promoter sequence, and estrogen regulation of a rat oxytocin receptor gene. Endocrinology 1997; 138:1151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/38\">",
"      Windmoller R, Lye SJ, Challis JR. Estradiol modulation of ovine uterine activity. Can J Physiol Pharmacol 1983; 61:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/39\">",
"      Matsui K, Higashi K, Fukunaga K, et al. Hormone treatments and pregnancy alter myosin light chain kinase and calmodulin levels in rabbit myometrium. J Endocrinol 1983; 97:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/40\">",
"      McGregor JA, Jackson GM, Lachelin GC, et al. Salivary estriol as risk assessment for preterm labor: a prospective trial. Am J Obstet Gynecol 1995; 173:1337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/41\">",
"      Ramos GC. Inflammation as an animal development phenomenon. Clin Dev Immunol 2012; 2012:983203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/42\">",
"      Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell 2010; 140:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/43\">",
"      Sheiner E, Mazor-Drey E, Levy A. Asymptomatic bacteriuria during pregnancy. J Matern Fetal Neonatal Med 2009; 22:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/44\">",
"      Smaill F. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2001; :CD000490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/45\">",
"      Donders GG, Van Calsteren K, Bellen G, et al. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG 2009; 116:1315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/46\">",
"      Offenbacher S, Lieff S, Boggess KA, et al. Maternal periodontitis and prematurity. Part I: Obstetric outcome of prematurity and growth restriction. Ann Periodontol 2001; 6:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/47\">",
"      Khader YS, Ta'ani Q. Periodontal diseases and the risk of preterm birth and low birth weight: a meta-analysis. J Periodontol 2005; 76:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/48\">",
"      Lockwood CJ, Kuczynski E. Markers of risk for preterm delivery. J Perinat Med 1999; 27:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/49\">",
"      Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000; 342:1500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/50\">",
"      Nygren P, Fu R, Freeman M, et al. Evidence on the benefits and harms of screening and treating pregnant women who are asymptomatic for bacterial vaginosis: an update review for the U.S. Preventive Services Task Force. Ann Intern Med 2008; 148:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/51\">",
"      Han YW. Can oral bacteria cause pregnancy complications? Womens Health (Lond Engl) 2011; 7:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/52\">",
"      Polyzos NP, Polyzos IP, Mauri D, et al. Effect of periodontal disease treatment during pregnancy on preterm birth incidence: a metaanalysis of randomized trials. Am J Obstet Gynecol 2009; 200:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/53\">",
"      Jeffcoat M, Parry S, Sammel M, et al. Periodontal infection and preterm birth: successful periodontal therapy reduces the risk of preterm birth. BJOG 2011; 118:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/54\">",
"      Gravett MG, Novy MJ, Rosenfeld RG, et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA 2004; 292:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/55\">",
"      Hitti J, Nugent R, Boutain D, et al. Racial disparity in risk of preterm birth associated with lower genital tract infection. Paediatr Perinat Epidemiol 2007; 21:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/56\">",
"      Anum EA, Springel EH, Shriver MD, Strauss JF 3rd. Genetic contributions to disparities in preterm birth. Pediatr Res 2009; 65:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/57\">",
"      Menon R, Pearce B, Velez DR, et al. Racial disparity in pathophysiologic pathways of preterm birth based on genetic variants. Reprod Biol Endocrinol 2009; 7:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/58\">",
"      Macones GA, Parry S, Elkousy M, et al. A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth. Am J Obstet Gynecol 2004; 190:1504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/59\">",
"      Miyake K. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin Immunol 2007; 19:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/60\">",
"      Menon R, Velez DR, Morgan N, et al. Genetic regulation of amniotic fluid TNF-alpha and soluble TNF receptor concentrations affected by race and preterm birth. Hum Genet 2008; 124:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/61\">",
"      Dulay AT, Buhimschi CS, Zhao G, et al. Soluble TLR2 is present in human amniotic fluid and modulates the intraamniotic inflammatory response to infection. J Immunol 2009; 182:7244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/62\">",
"      Baumann P, Romero R, Berry S, et al. Evidence of participation of the soluble tumor necrosis factor receptor I in the host response to intrauterine infection in preterm labor. Am J Reprod Immunol 1993; 30:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/63\">",
"      Buhimschi IA, Zhao G, Pettker CM, et al. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation. Am J Obstet Gynecol 2007; 196:181.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/64\">",
"      Van Meir CA, Sangha RK, Walton JC, et al. Immunoreactive 15-hydroxyprostaglandin dehydrogenase (PGDH) is reduced in fetal membranes from patients at preterm delivery in the presence of infection. Placenta 1996; 17:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/65\">",
"      Challis JR, Lye SJ, Gibb W, et al. Understanding preterm labor. Ann N Y Acad Sci 2001; 943:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/66\">",
"      So T, Ito A, Sato T, et al. Tumor necrosis factor-alpha stimulates the biosynthesis of matrix metalloproteinases and plasminogen activator in cultured human chorionic cells. Biol Reprod 1992; 46:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/67\">",
"      Fortunato SJ, Menon R, Lombardi SJ. Role of tumor necrosis factor-alpha in the premature rupture of membranes and preterm labor pathways. Am J Obstet Gynecol 2002; 187:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/68\">",
"      Oner C, Schatz F, Kizilay G, et al. Progestin-inflammatory cytokine interactions affect matrix metalloproteinase-1 and -3 expression in term decidual cells: implications for treatment of chorioamnionitis-induced preterm delivery. J Clin Endocrinol Metab 2008; 93:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/69\">",
"      Lockwood CJ, Arcuri F, Toti P, et al. Tumor necrosis factor-alpha and interleukin-1beta regulate interleukin-8 expression in third trimester decidual cells: implications for the genesis of chorioamnionitis. Am J Pathol 2006; 169:1294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/70\">",
"      Arcuri F, Toti P, Buchwalder L, et al. Mechanisms of leukocyte accumulation and activation in chorioamnionitis: interleukin 1 beta and tumor necrosis factor alpha enhance colony stimulating factor 2 expression in term decidua. Reprod Sci 2009; 16:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/71\">",
"      Lei H, Furth EE, Kalluri R, et al. A program of cell death and extracellular matrix degradation is activated in the amnion before the onset of labor. J Clin Invest 1996; 98:1971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/72\">",
"      Lockwood CJ, Murk WK, Kayisli UA, et al. Regulation of interleukin-6 expression in human decidual cells and its potential role in chorioamnionitis. Am J Pathol 2010; 177:1755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/73\">",
"      Lee SY, Buhimschi IA, Dulay AT, et al. IL-6 trans-signaling system in intra-amniotic inflammation, preterm birth, and preterm premature rupture of the membranes. J Immunol 2011; 186:3226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/74\">",
"      Dudley DJ, Trautman MS, Araneo BA, et al. Decidual cell biosynthesis of interleukin-6: regulation by inflammatory cytokines. J Clin Endocrinol Metab 1992; 74:884.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/75\">",
"      Fortunato SJ, Menon RP, Swan KF, Menon R. Inflammatory cytokine (interleukins 1, 6 and 8 and tumor necrosis factor-alpha) release from cultured human fetal membranes in response to endotoxic lipopolysaccharide mirrors amniotic fluid concentrations. Am J Obstet Gynecol 1996; 174:1855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/76\">",
"      Lynch AM, Gibbs RS, Murphy JR, et al. Complement activation fragment Bb in early pregnancy and spontaneous preterm birth. Am J Obstet Gynecol 2008; 199:354.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/77\">",
"      Sbarra AJ, Thomas GB, Cetrulo CL, et al. Effect of bacterial growth on the bursting pressure of fetal membranes in vitro. Obstet Gynecol 1987; 70:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/78\">",
"      Andrews WW, Hauth JC, Goldenberg RL, et al. Amniotic fluid interleukin-6: correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery. Am J Obstet Gynecol 1995; 173:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/79\">",
"      Wei SQ, Fraser W, Luo ZC. Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review. Obstet Gynecol 2010; 116:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/80\">",
"      Buhimschi IA, Christner R, Buhimschi CS. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG 2005; 112:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/81\">",
"      Romero R, Espinoza J, Rogers WT, et al. Proteomic analysis of amniotic fluid to identify women with preterm labor and intra-amniotic inflammation/infection: the use of a novel computational method to analyze mass spectrometric profiling. J Matern Fetal Neonatal Med 2008; 21:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/82\">",
"      Esplin MS, Merrell K, Goldenberg R, et al. Proteomic identification of serum peptides predicting subsequent spontaneous preterm birth. Am J Obstet Gynecol 2011; 204:391.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/83\">",
"      Pereira L, Reddy AP, Jacob T, et al. Identification of novel protein biomarkers of preterm birth in human cervical-vaginal fluid. J Proteome Res 2007; 6:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/84\">",
"      Lee DC, Hassan SS, Romero R, et al. Protein profiling underscores immunological functions of uterine cervical mucus plug in human pregnancy. J Proteomics 2011; 74:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/85\">",
"      Sbarra AJ, Selvaraj RJ, Cetrulo CL, et al. Infection and phagocytosis as possible mechanisms of rupture in premature rupture of the membranes. Am J Obstet Gynecol 1985; 153:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/86\">",
"      McGregor JA, Lawellin D, Franco-Buff A, et al. Protease production by microorganisms associated with reproductive tract infection. Am J Obstet Gynecol 1986; 154:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/87\">",
"      Gibbs RS, Romero R, Hillier SL, et al. A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992; 166:1515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/88\">",
"      Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature 2007; 449:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/89\">",
"      Han YW, Shen T, Chung P, et al. Uncultivated bacteria as etiologic agents of intra-amniotic inflammation leading to preterm birth. J Clin Microbiol 2009; 47:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/90\">",
"      DiGiulio DB, Romero R, Amogan HP, et al. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One 2008; 3:e3056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/91\">",
"      Pierce BT, Pierce LM, Wagner RK, et al. Hypoperfusion causes increased production of interleukin 6 and tumor necrosis factor alpha in the isolated, dually perfused placental cotyledon. Am J Obstet Gynecol 2000; 183:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/92\">",
"      Zeitlin J, Ancel PY, Saurel-Cubizolles MJ, Papiernik E. The relationship between intrauterine growth restriction and preterm delivery: an empirical approach using data from a European case-control study. BJOG 2000; 107:750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/93\">",
"      Harger JH, Hsing AW, Tuomala RE, et al. Risk factors for preterm premature rupture of fetal membranes: a multicenter case-control study. Am J Obstet Gynecol 1990; 163:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/94\">",
"      Williams MA, Mittendorf R, Lieberman E, Monson RR. Adverse infant outcomes associated with first-trimester vaginal bleeding. Obstet Gynecol 1991; 78:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/95\">",
"      Salafia CM, L&oacute;pez-Zeno JA, Sherer DM, et al. Histologic evidence of old intrauterine bleeding is more frequent in prematurity. Am J Obstet Gynecol 1995; 173:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/96\">",
"      Buhimschi CS, Schatz F, Krikun G, et al. Novel insights into molecular mechanisms of abruption-induced preterm birth. Expert Rev Mol Med 2010; 12:e35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/97\">",
"      Gargano JW, Holzman CB, Senagore PK, et al. Polymorphisms in thrombophilia and renin-angiotensin system pathways, preterm delivery, and evidence of placental hemorrhage. Am J Obstet Gynecol 2009; 201:317.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/98\">",
"      Strobino B, Pantel-Silverman J. Gestational vaginal bleeding and pregnancy outcome. Am J Epidemiol 1989; 129:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/99\">",
"      Lam, H, Hamar, B, Rosen, T, et al. Thrombin effects on endometrial stromal cell levels of matrix metalloproteinase-1 and metaloproteinase-3 may provide a link between bleeding and rupture of the membranes. Am J Obstet Gynecol 1999; 180:S3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/100\">",
"      Mackenzie AP, Schatz F, Krikun G, et al. Mechanisms of abruption-induced premature rupture of the fetal membranes: Thrombin enhanced decidual matrix metalloproteinase-3 (stromelysin-1) expression. Am J Obstet Gynecol 2004; 191:1996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/101\">",
"      Rosen T, Schatz F, Kuczynski E, et al. Thrombin-enhanced matrix metalloproteinase-1 expression: a mechanism linking placental abruption with premature rupture of the membranes. J Matern Fetal Neonatal Med 2002; 11:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/102\">",
"      Buhimschi IA, Zhao G, Rosenberg VA, et al. Multidimensional proteomics analysis of amniotic fluid to provide insight into the mechanisms of idiopathic preterm birth. PLoS One 2008; 3:e2049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/103\">",
"      Lockwood CJ, Toti P, Arcuri F, et al. Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin-enhanced interleukin-8 expression in term decidua. Am J Pathol 2005; 167:1443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/104\">",
"      Lockwood CJ, Murk W, Kayisli UA, et al. Progestin and thrombin regulate tissue factor expression in human term decidual cells. J Clin Endocrinol Metab 2009; 94:2164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/105\">",
"      Norwitz ER, Snegovskikh V, Schatz F, et al. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition. Am J Obstet Gynecol 2007; 196:382.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/106\">",
"      Elovitz MA, Saunders T, Ascher-Landsberg J, Phillippe M. Effects of thrombin on myometrial contractions in vitro and in vivo. Am J Obstet Gynecol 2000; 183:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/107\">",
"      O'Sullivan CJ, Allen NM, O'Loughlin AJ, et al. Thrombin and PAR1-activating peptide: effects on human uterine contractility in vitro. Am J Obstet Gynecol 2004; 190:1098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/108\">",
"      Lockwood CJ, Kayisli UA, Stocco C, et al. Abruption-induced preterm delivery is associated with thrombin-mediated functional progesterone withdrawal in decidual cells. Am J Pathol 2012; 181:2138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/109\">",
"      Elovitz MA, Baron J, Phillippe M. The role of thrombin in preterm parturition. Am J Obstet Gynecol 2001; 185:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/110\">",
"      Vidaeff AC, Monga M, Ramin SM, et al. Is thrombin activation predictive of subsequent preterm delivery? Am J Obstet Gynecol 2013; 208:306.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/111\">",
"      Ou CW, Orsino A, Lye SJ. Expression of connexin-43 and connexin-26 in the rat myometrium during pregnancy and labor is differentially regulated by mechanical and hormonal signals. Endocrinology 1997; 138:5398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/112\">",
"      Word RA, Stull JT, Casey ML, Kamm KE. Contractile elements and myosin light chain phosphorylation in myometrial tissue from nonpregnant and pregnant women. J Clin Invest 1993; 92:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/113\">",
"      Sooranna SR, Engineer N, Loudon JA, et al. The mitogen-activated protein kinase dependent expression of prostaglandin H synthase-2 and interleukin-8 messenger ribonucleic acid by myometrial cells: the differential effect of stretch and interleukin-1{beta}. J Clin Endocrinol Metab 2005; 90:3517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/114\">",
"      Maradny EE, Kanayama N, Halim A, et al. Stretching of fetal membranes increases the concentration of interleukin-8 and collagenase activity. Am J Obstet Gynecol 1996; 174:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/115\">",
"      Kanayama N, Fukamizu H. Mechanical stretching increases prostaglandin E2 in cultured human amnion cells. Gynecol Obstet Invest 1989; 28:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/116\">",
"      Nemeth E, Tashima LS, Yu Z, Bryant-Greenwood GD. Fetal membrane distention: I. Differentially expressed genes regulated by acute distention in amniotic epithelial (WISH) cells. Am J Obstet Gynecol 2000; 182:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/117\">",
"      Owen J, Hankins G, Iams JD, et al. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynecol 2009; 201:375.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/118\">",
"      Warren JE, Nelson LM, Stoddard GJ, et al. Polymorphisms in the promoter region of the interleukin-10 (IL-10) gene in women with cervical insufficiency. Am J Obstet Gynecol 2009; 201:372.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/119\">",
"      Jakobsson M, Gissler M, Paavonen J, Tapper AM. Loop electrosurgical excision procedure and the risk for preterm birth. Obstet Gynecol 2009; 114:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/40/32393/abstract/120\">",
"      Shanbhag S, Clark H, Timmaraju V, et al. Pregnancy outcome after treatment for cervical intraepithelial neoplasia. Obstet Gynecol 2009; 114:727.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6785 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-61.234.146.186-AFBC45AB80-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_40_32393=[""].join("\n");
var outline_f31_40_32393=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Activation of the HPA axis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Corticotropin-releasing hormone",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Estrogens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Inflammation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Bacteria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Proinflammatory mediators unrelated to infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Decidual hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Pathologic uterine distention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Pathologic cervical change",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/6785\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6785|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?41/30/42478\" title=\"algorithm 1\">",
"      Pathogenesis preterm birth",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?0/30/494\" title=\"algorithm 2\">",
"      Amniochorionic inflammation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?10/33/10782\" title=\"algorithm 3\">",
"      Decidual hemorrhage and PTB",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6785|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/43/29372\" title=\"figure 1\">",
"      Tissue factor generate thrombin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?34/30/35309\" title=\"figure 2\">",
"      Uterine distension and PTB",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6785|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?42/54/43883\" title=\"table 1\">",
"      Causes neonatal death",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/40/7819\" title=\"table 2\">",
"      Proportion of preterm birth by etiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?27/48/28428\" title=\"table 3\">",
"      Risk factors for preterm birth",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/56/30602?source=related_link\">",
"      Bacterial vaginosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/22/4457?source=related_link\">",
"      Cervical insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/35/27194?source=related_link\">",
"      Overview of hemostasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/0/6153?source=related_link\">",
"      Physiology of parturition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/45/11994?source=related_link\">",
"      Prevention of spontaneous preterm birth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/3/35898?source=related_link\">",
"      Risk factors for preterm labor and delivery",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_40_32394="Ht age boys z 2 5";
var content_f31_40_32394=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F53829%7EPEDS%2F64531%7EPEDS%2F56071%7EPEDS%2F67900&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F53829%7EPEDS%2F64531%7EPEDS%2F56071%7EPEDS%2F67900&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 629px\">",
"   <div class=\"ttl\">",
"    Height-for-age boys: 2 to 5 years (z-scores)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 609px; height: 407px; background-image: url(data:image/gif;base64,R0lGODlhYQKXAfcAAP///5ilnWBgYOCUnz8/P9w6UxeHS8LTynOqjZeXl9Dh2FBQUA8PD6CgoC8vL5XDq1Sbdba2tm9vb7UvQpG7pBh4RSAgIGSjgYGzmLHKva5VYnxJUHBwcIqKijmXZcVFWAAAAMnJybaYnMhicYmek7V5gxwcHM3Z03eYhr5odGVlZeLi4pmZmU5OTklJScQoPzKMXNV8iTAwMN13hoitmtQiPNXV1emDkhAQELSoqdpoeKysrFpaWiWEUWpqaurq6lVVVTU1NdUvR0VFRct/is00S1qlfTo6OoaGhqGyqUxMTJSUlKauqisrK1JSUsagpiUlJRsbG7+/vxUVFVlZWYKCgoCAgEBAQIODg8DAwJ2dneUZN/Dw8NDQ0LCwsODg4JCQkOYnQwCFPq+vr+g1UO5vgvrT2Z+fn/WotN/f319fX+/v7/3w8u1gdfB9julEXKSkpPvi5n9/f/Oap8/Pz4+Pj/a3wPKMm/jFzetSad/v5k+rei+bYh+UVp/Rtg+MSm+6ks/o2l+yho/Jqn/Cnu/38q/YwsPDw1xcXD+jbr/gznh4eODT1bKysuJWa21tbcLCwtLS0teYodqao923vN/FydLa1qKiotuosNJSZcXFxd0rRdwdOd8gPHV1ddiMlyWRV+Bgc9u0uqqdn9VvftFeb+yToJycnJGRkTIyMnp6eu3T18pwfqamptBDWAaBP5KSknJycqE4R2JiYuFIXuGhqsetsdmmrdbW1o1BTOVZbtnZ2fLM0qWlpaiPk0GXaefb3KNkbdNgcdK4vIyMjHx8fNCqsN6Fkr2kp+aapbW1tVGkeGaviEJCQnq0lSZxScXNyd7R08HBwcjg0+fN0c2Nl7GLkMZUZdhMYLi4uNpabQiFQtPHyYq8odaJlNknQcF0gFWofLXGvVyFb+Kvt8W4ukJzWalDUl6Ud71wfEWgb+/Jz76xszx2V8KCi8OQmEeKZre/u0qecb6kqK5ud6VyeuZzhEViU5u0pqTBsoGBgdzDxs+co3yuk4t+gCxvSyH5BAAAAAAALAAAAABhApcBAAj/AAEIHEiwoMGDCBMqXMiwocOHECNKnEixosWLGDNq3Mixo8ePIEOKHEmypMmTKFOqXMmypcuXMGPKnEmzps2bOHPq3Mmzp8+fQIMKHUq0qNGjSJMqXcq0qdOnUKNKnUq1qtWrWLNq3cq1q9evYMOKHUu2rNmzaNOqXcu2rdu3cOPKnUu3rt27eJ96aTBwgQwZHARasXDlSuC8iBMrjrm379/DWXAUvkLyCggrA7sItKDZCubFoEOLHmn5MwDNADgDyEL5pGeDMrIAsCIgC5fRuHPrnvi6YOzVsb+Y7D0wiwyBDaxwsCB7t/Pn0GebFmhcYBcOg8GUJH5aNUEvraOL/x+vmHsX7wO5gNhu+jzq7wsI7lhUpb79+/bp499f5RH//fr9Z59/AuZXYH4BFpiggAQeuOB/izzIn4T4PULFgfVRWCGGVWh4X4QcejhgiCGKmCGHDSrIIRUpQshhfyRi2KKLGIJYI4oxHjgjjQVa+GJ+OxBEnHsGcYEDSVkIUBsAX+AARhZZCCdAA17I4IV8NjSUJUNBMrTlQl0u9KVCNoyZkJkIhUmmlmge1GZBO1ChZUNqnsnmnFziKeabBfEpn54KUVGnmw4NSmieXt6ZKKJi0umQnwLFGZENYSa5ZJNPRgkAGFZkscBhInn22heidsokp+9FCqlAqwJgqEGtvv/ap6KNMrqml62uKumiYAJ6Zq6O8komsLbayZCgwiokK0Gx+opQmc4etOxAzUYLp5wQUTpQqUyWKhsXyV2Z0w7E9ppsmtb2Wa6y6TK7bprY1mquvMO2O9C0rNJ667z7Bopvq67aG6nAAEB7rrQE45svmPE+qjBQ5CYs8cGwvosuxeoKvCu9CSmcq8UIY+zuxBwjhGzJF6NskMf6Gsuvy+xq3LBAdSxAgBp0wPrwTxGLfC/J/f4KNMxC++zqzM8Gq3LGRgfctMFL/9n0yUF3PHTSuF596MtES4s0CARYAIIFOjfVc9Q/N81y1moTDHXVKyO9dcxoswryym7fDSfBVHf/nTLceD+tt9R1O230xgOlIRAIDJTN1BiHrCD55JRPLkXlmEuuReaYX8455Zt/brnolntOuumih3466ZJLgfrnr2cOhwqsrxB75qqLfnvnu1feO+i1/1568LXnDnvtKsDBuvCTG8858ys4nzn0rhPPuvSdF1+77aQ30sIRB53hAAhjOL7U2YDv3bbgWsPaMtbKyu1+sfDXu37hb/sdeOF91093+oQDILUGl7bCPexNY5CA2GQQhINIQQ4McMAa+rQzn6BPf+ozYN7aNyu21Q1xGAxgCAfIQWa9b25Wm9q/ClVCap1wflxD4d/6tYYzqIEBDFDDGNYAwjVMEADjkwIF/81GwIHdT4B2a+HC9iQzJRbshR2MIQztp0EVNs1wSMTiCJN4xC1q0U5pOMMCxiYBId5rZlIA2/gY8ENqVbAnF/TfDOUYMvwV8YsydFMRQUjH/WUxf33M4B/vuLaF9C+PdcxiIamoSCfSgQPjc4Accha3gqxBAgS4meKGyJQ4IlKQXlxk0apoxyZ2MZAjO+UnU0nKLB5yiv8L5QZVCcs5EiSBYhtCHTYJr0m9kSeQsx7psOc77S0veNQz5uqWl0zSzU6YqYMm7Jo5TGk+j5rRPCbrkqfN61kTd9/kXTgrR0zKQc95kWDBDRmwgCpEgnlwQIQviejEapWSllFk5Bb5uP/KAg6ynlA0If36KZBX5jOWqPSnFwFJUDzWso5hHKMFJFA+FzJsnp0kJEA92Ej2HU5+B7XlQyu2USbiU6CGXKHSOnrPVoaSDnWI5CQJyk8y/XInnhwpKBNqxJay9J8fLak+eerQkOpRqAkxKEqlaFQ/LlSjPpOCAkGwgF0isaZnuqlOctrUnTZUlM+Cqk/3CdKlpnCsRAXrUU9q0ZReUa1OJSpDdSrCPo5hnQsQQBuvWlY3aXVcYv3pU5EaVlO6VK6BHSxbl+ivtxJ2rYedWw0lqsOefrCv5lMKV80q0q7WtaFz9axCEWtYwZJ2sU/kqCytWLiicjaRio2s+9JQBwL/gMABEqDkaHmK1Wf9FSfB7GY2l1lN4U5znMAz7jWRK7lnKheczxVndMnJ3NZh83PlHN02lUfc4nYXu9W13XU5l90VNEIJYnNAB6RB3u3BU57Z+u1NNttWhH51lrIVLRcv+1iSovZj/S2IUutrX7ru1sD7Ne1A7prLM+wVtmTF6PkSm1b8KhjBBdsjZlPL1Nf6N78eZhqICWwylQ4Uw3AVsWBruM7K2pO/8aXnf1ca2wvrN8OlXS1a7+vRETM2qSbuMIkhDFqo0laiZQzxZ2m6YWbJ1yb0/XFnlXzgG4eWypatcYRnrNoK99jGWAbAgKU85SHHtcgEA4McZKrbMB+Q/0tNdqOMfczhAluZwmgOKpdNSmcA77mxrU3xku/cLqmKbQFn4CWP9fwQbWU0wIMO85XN7FUMT5rM14I0Cf88SjBTmiBjrrOd3Wzhrq3hrjhUwxlO4URRe03CSgnud9s73eTOenrjhe6tpbtryjm317bWHTLDW17uMZPY4eUmsIN9PG/WenjdjEQVUjE2HTYP2dWNJ6xrwgXhWMcKYPA2AJLTnHvhGcWl9vKOEdzbT1dZ0ucmNKdL7Nh5Q5ZMtI1kbs+M7hx7SU3dzgy4xZ0FK/AFSVcwzQL2goPb0MY45XZVvEn9ZR0DFcZ9Dqi7s3zajB8ryKPeuGtFPmk6SGAKYP+zapkxXWl2x5lVlUp4Xxh+G4gLYDogsYLMC3IF2chAOA0AlcQ1zfE8e5zPfCU6ju39YU+zHNQgP6vTXX3vW6rh0B14MJH7zWiHbWvnBOk5ADjAly8chyTcAYCRhLOe1YRn6ExvObyVfmmqZzrurJy6n48O6CyO/OnvJvmYJpvqir7Y4kmP8bZwvnYAiB0AbR9J2m++OOq8Pcp2l7vIBb1pvnd6y54vLN47r/eGhBpgnC+6pbN0ZDKacfOt1tXLC6amyX/m8ZEP1XSUNJAjrSY+90rADoZP/OITX/jGT/4OqqD85CO/+cRnPvSPP/3jP3/614e+9Kuf/eYnoPvKB7//8asgqOrvQPzjN//51f999qt/+9hnP/qLP//ou9/8FzJ//e2v//ffv/pIAEkggANHUAze53/9Z37wF3/VR37GF3EC8QP0V3u7JwB90Ry+J3mmwXszN3baYW5Kl3pLF3pVx1sbdngdV3pdtmiuFHUrl3mR9mkm12CKxoKIB3pet3gDwYECAQaB4QXAJxJXYAGEsRogMBl80QUyUBi3AYKjp3ryRoJNh4M3aHQqiHRViGGnx0L2hmrsdAaaMHGw529iEiZDWIRZcISFwRdcUBgykCo1gXkoaIMpmIVRmHhSqGJ2OHdPKGYuuHU3VkiEl0MVNYJXGHIbx0d3EAZbEAZo/5BZSSGHNKZuF3eIn2eCdCeGgJdgeyhyWziJdOgmtGVbE9VmnEiJnZiISNMGbuAGW7AFccBJExaC6RaKq0eGXFeJqQiDpLeLrfKJJxaIC0EHa3ZbKleCtiiM9mIHpZALCZEHW4AHsqhZmsiLUMiHeZh3VIiKdciNVuiLpveH/KaMBmFoVGUFNYiMubiLVBcHaNAGjfgBG4AQcbAFZACJSCFrwuZsy6Y54VU9z+aPASle2UY7A1ls1JNrmIOQw3aQycZd+8iPETlckgMLC5BqqBAJxnY6CkldDglNmKADb7AFb3AHlLAC2mYQcfAGYWAG+HgUkhiMFLdu5KiLmNiHdf83h7fYh8AoZJsYMJNVbYX4kzkJiut4JmyABmUQBmHQBmgQi2dkEGYQBmTgki9pFDHpk9b4d1tZlDIpeLhYk1rmjTuZjQPRk4hojWmgAqS4b99IlmJ5EGZwBwVAkm4gja9WEK+4l3cwjZFYjTp5h+C4gi6XiYbJk+KoeSxHjOMTBcfYjck4kwXBBnZQBmSwBW1wDFDZMUhzB57pmXgpZ4/WhyLolVq5d3hoiaJnlqcYmZ6YmDEoZeaIaGlQmoBJY3EwB9BIBm5gB5vYbldZFFmZloGJjaqpjvoFnFtpm4fJmn5Yb/LihYjWRsxJmgJhB25wmXkwB1apituGFMMpdYP/iYVwaZzb6JpEeZuEGZcNhZbiiRCaIEZCCYjmWZ4bFwesAI9hUAZ2wAY32WhPVhP62GzeNZHgNZAA2Y/R848dOTm/ZqC0pqAJCqG6RqG8ZqEeqaDKhqEZmjmQwAFQQEYhQJEEqjsNem3ThQnCIARbIAR3wAsBmZIAOmfHOY71iZ5dqWHNWaN6aJ8/6Z62BFORVAcQ+IKoOZ4CkZRL2ZRP+WYXpXizaJ0V56M5GpaSOZY4eqRU+ouw6U8zSFUqV5xgyWVzOZK8GZpcaY3K6WQ0iqTv+ZZZqnG/eYJGKZhbKqfLyTddOjBeqGoPJqbpqURsIAmWiZlzsJmxOaffCZPq/3maeAqoVdp1brqaPKqNd/pxRlNDMlB4k4qcV0oQuQmNm8Cf/vmmTLaoWNmoxPmodXqjhYmTqnqJcYqpSxNRY7MApjir5EmH2HmZb8CdkKqms+doSzGgz6NMHIqiEnqiArmsBYltzvqR0aqgDLldytUFMQUCUTALjbCg0pqs1oVtq/COYdAJmfAJjKBdBQquMpqDUeqc1emcpsmZO9qpU3ipbiUvX0oAjymC8ZpFInAHI/kGd4mjwoqqwhmrRsqqXxmokoqvQ6WrEXuU7fkvuERVDkafY0iTIUaZS4mZTzl1Bwul1EiLUyqxsvqq8qqwnrqxLagQfTqUGvuT/9o1Zv+gm/bYm/76KHCGsEQRngvbsJG6slbqslhKsWVZqWc5KEE5UR8otJCqpVvTq1uwnZu5s0UbnD/LsjY6pkT7sChLqfbao2F7EFTTeqX4k1wZtXg6DO/YiGWABqWaqMEqez47FEA7s3l6skhrp6cKq/UKsUCWb8ZYg6gXuARhBm4wsHfQnXpbtz1LsklhrNODrCV6oNMKrt6auZcrOwZJrQwKrZo7oZ1boaVbOY2wqWCzXsdqua27rq9ropjDCJ8QCkzZBslgC65buRLJrvA1o6MJr7XYt66anHQKtQzrqOv5qZ90sVHgCVp3Y2vbql57s2bam0ZLpSMLvDfRGAPxBaD/MhiFIXR527U0O7zsmbTnSbxeq7Styb5SFrNrAKSPS73pSbVWC797C7Y29R0HJxDgWxySURiVcRkDwQGSoYMrw7WKObTua4jrm75+q79SS8ECMYiVtbTQqbTu6Aj2SKpjm6jb666lccAJbHkowR2ssS210YROKLx8K8HFi2XKybbLm71wqr/xiWS5+pyB1l+KO7AzIAomy79ZJSTTscLUERzDkcThkRzLEXHl28A2vKsWfMOKCrhaDGKEK0k9rME//GdKershO6+mKsM0PKwUSBBKfBrYYQFPq3ts/HYCAR7yEQFlksd6rMd4vMd+bAMJ8Md+3MeCnMeBXMh5TMiI/xwBilzIjSzIh4zINvDIf8zIklwmlLzHCUAFlzzJnRzJi9zJlnzJmazJoizKpczHn/zHIZCtOKACoFzIVBDLldzJgHzKl0zLtbwOOFsD11ANezzKkpzKhozLkqzLtXzMnGzLmLzGxUHHapd7IaHC0AyEd2zMiIzMwbzKpIzK2FzI2qzKpEzMmJzLyzzM3IzO4/zNkMzOlUzOnpzLetwLQ8AAKRcC5XzJs9zN6RzK8izJ1fABNVC1c0ANgizM/nzM7uzH4SzO2XzOthwBzozCBWEkSKIkzdEFYBAbtzElVSIuqlLENlm29/q3X3vSjfSlC6AFfxqOG5yF7qif2tCfVv+MxuebtbJoKRm90baxKZ3yKWgnKsghKsLxBagCJwxMt8m7qlg8wiHci4Irtjw1BkFgAV8YvVtJv+a7vwIRxCTZuA781NeYxhLGLeNG1GoXLluV1IHnsCgdwcyrvlHdsiznhS4gsxX70hU2xkyKqBVs01ydmloSoDQxxUqNvE1dxRNrvIh7xTVtVqfWYuUjglpNxQyBn7uJvTkM2JD7pNxbslLKsTgs1yb9wGYctI9tUU3rlmP9o3s6vQhBtQXAnaJ903Tm1P/WFJSbPb0bu5g7usy6ucD9rN96ur4T3NXKkbUTAfKJA07QrQv5kAMp3Jc7rm1QrufKCMktu8Xt2xH/2o/tOthtOtdb/ddxPcGMvcWm7Se2iltf3NpZ/dprU6Z26bg1S94NjNtlON4kbdmJbb9h/Z/rjbhdTKQAzqV6bRCDWqhtcKj1+9+IrZX63b/B+8D33d+WWtpiDcH4nXcFvkmKDWQJLhC5CY9kwJ/Km9q2LbJ2K7ngydbwbd6jjd5krd4bDi0fztkuHcYEgQfZ+dVmEOJSjeFtncWf/ZcifbQ6DuHx09hLvhBeIIAO8JjnHWaVLTV87ZRzK+R0Hdja2+JH/uJJDpmOvdg1/tYd/qVDkLEPfOUDYQ04y5u+WeYp++RpOeFH/DiR0928C7t9zt2gi6DM+qDGzWzejWui/1u6jcADh4YKXoDc0r1sk6AD2mkKlaC5231cfM7bfv7nnBPeuV3hG37hdD7kKjvgf6bSbH7aD56vcBPTTMmfOeDkVT7j6R3mjDrmm13rbi3YHQ7VcarqfwrjPtwv9E2w3Ym1te3lBgvm7graMLzsXF7Sp37jmkgHjI6xWM3q5b3ja1KZl9ngiBrjB77UZ8zrRv7sSB7aI13qXe7s1s5Bas7mdY7uCJ4QuenBJz7nqM3UKs7s+ovnvsXf7t7tTO7vZu6dNs6Nwi7jK+5Fr+TVbzADjnvutt6+o86znq3uYs7uSm7v5p6XaL5otHVo9O7wAH9jVOOxjOiUsXi4C0/k8P8t8H6l23se6Dg/3JteTMcWo5+L6aF7kJAQC1GAsbvA6YAO9AOZPJUQA67wwXbA873t6d9d6NCW81bfrOD9uxyf6x5P5nZe7wo/8gZGW0VPAPRO2gWfuLLAoiVZ8SIH2yme8A//5ZGL66mq62of9qZ+66iuMl2sAum49yB/ECwfBhNABOOOYXKP8GJf981+912f91+/6xff63B9+QGOQjlO6mFf4jnrm25O7hFO9ymP7jSvtXhL7J5f+P8O77/+vh0UlFOuaK2v+Vsi8bQNxn6n7O3O93qb+n7Z8dH++65v+rAv8xx+EDs8NlRO+q9vvwtOxnMLdSMO/NSO/fmd/BT/Xqw3r/RYf+gXmvXULf7HTdzhT/WILjpjMEbODd1Vb/7mBOmcswpzAI81IAyTQDobChArBA4cKIXgwYNaEC40uDChw4MNIQqUInGiRYgKJ1LcKFBjR4wL4SACUNLkSZQlbexI2dLlS5gxZc4EsMPGzJsyWcrMGXNnzJ4wbQR9SdTlT6E4jbZcinIHFZwzkRZV6nKMGgYWJHiRGpVnU5RgT04FYMbNmy1v5pgRa5IK2ZRtTcKN25Vn1bs6vfqkKfdpSz2K9DClS9Pw4ZNcvqDscrKBlSxO5QKYXPhk5b1CJ2POC3SzTqidYVo2uZnoVQYM1NBRaRco3td6S9opQ2ZL/xs0cUrPfCt6dOaXpFt/BX60eEvhw0eHPilIzHNBcZEqZnwyi5UGiLWXzHLFiskuHK6YtCIgi4zIcz/Ljs3Xt8uhx1MmNy1/LPOk7PN7LklHggXVxgjLtf00s++kUdBoY4swyrCDKd6Em6ymA+eqUKX13Gvvtwv/OikQMfgAgA8xAgnrp+6+Kym88bhDTwAVtzPMCu9MakCAFgGQYbEGOBgrQw43DO5CyoAc8j2mjEQOP6r0axKoXv4DYQEBIXQSPtgKTMmMOdB6ww0ztHSpNyGPLBM5IuNDcj4ik6MMNJQIEYMQAOSk87KfaIzxxhw5yO4LGWREzIoYAejOJBC4y/+xJiXRXNOpNBtl89HLJL2vzQrTqMOBKc9YQ0xHz4yrUTvcsK2NOZAhkkxQQ20VUkpLs3QsTDtk0s465zzxJEKty/GK9BIVdMZCDy1JWGNLsqlWUWFttlJmX4U21pqYxPJKK1Na4wxOHbCCNWopDFfN9thAo4wwGkSDDWVXlZAm+gh80sBw48U22+Bu1RVXPHkt9tdghyXWV5Nw4G6BsRLYYWGGG2ZYYYcj3qEKiSOGuGKGKcb44Y0fvnjjjzHWuOOQK06gZIlRdriKtzreQeWVXX7Z4VMEGAIEB3gg5mWYG+45Y5l/XvjkoH1JwZEtyCiFnohHBllmKpw2WeaJg5b/WeqpXSZa66utdhnrrCtGAR0Y/tkhPQBAFJFEE036QWF/CS5pgfQMFnimXk1KdgGuOADjx2jnNVNaWQO/lj9qPXzWws6uAkErcDE0HN+i2jLjjgLSuiNM48JlVfDBQXdV9FEnr+ve0z8cZI8/xEgEnXtScg466eLWO0cwfPQC4btjusICC1rkQAYcrmisCxmuuIILwOs1fUDinB93VmWtpbxzoOjASrXIp1283eldKvXUAXTTkPCSPj/8fNKdRb/I5y+Tt0k9Vm89EUIUqR4wwQgz6ffglWR4xWsMF5Qng8b0ToGSid9uUCe/6H1PXBIkF/oU9z7S+AdAaqgSfKgH/z4KBsVc6GqQHdjFGQmq73rYw2CkGqicIMFEDxgQRB9ClL/5WE8oblpgD4/ywQm2MHzSC6GtTKcpTi3ACp9CnATtxZ84KChpbsAD9Ni3vpeoMHVXXOGkikhEIbakEH6oYYgAYYhC5AsxK/FhG7WzLDC2j1ZDdKILE6dDK8YQANtaAM7q8Kn6xBGLLhFFDLy0uUGOLpEp0WIe9bhI98mxcILsYiQLYQhAkKgPZyyEX/AIHx660Y1wrCMlt1i5F74pghb8pAM15DgLyCENEGxiGKVlFts4Yg7mkyQI39dIWnLxlCzsJfxM6UjjXDKTYuiDIPwwGFeq8TBsFGU1YzKGQ/90ZAUhWchHLqJNb0KEmwipiDbH+RCQmPOcBFmnQOCgAnOCsxEESI0EQsAQdcazI+F0CDcnkYlOhAE35WgnR/apz42oAA7pBCdCJ8JPfIKkoNtsKEMnkg949ICZzlRAPzsykjWG0poLJKUti/lEepXyi9+7oCTTIAcLgICD76vgSfdirjaky0GTVOkv3zW/Ss5xpSZdpCIIkQgx/AEGg2gbK0M6UqjOB4goDR0kvUfUoPLUqWvaFqcIIAAm0nSqOInigsgAptIdM5hZ/OkDo1nVrEpOrdEMhP3+sAemBnGrhqFmVP1aUpvOFYaoFKwqa9nLlg7yDH20QB1mSVUPNjD/DnPInFo4l6RUTgaYb4XrMBUZV2P2tCh1ZZ3rcChUlraydn7961gLG0jRWlWriFWtYbVXz+5BFrOmNAta8nAMXhI2tqDd7GA7i8zPejatwzWJHshoQ/zpj5i0fSprowpY2foysEPdrliNyJOXxnSmXvRuHPFgqtusy7ApxapyUVLc9T4StLpdLlGdW0Y+AIICaRSme+dS235ZF6rYdGhGCuwQiJIznxZ96IEZMtGCvnMjuzgDFEDQhCpEwsAMFieEK0qbMHQiE5NgBDsXvJGJJjgi2lQohzeM4orCWKIORohG0oBJEhkAAhSwhEE3ouIVbwSk0xSpgLeD3flmNkvd/y1mTbObWJPAUhWz7O9aI0stNoCDhDsFrZOT7Lm2VpmzyUVufXtZCBQss5nP9C/j7lhdI1cTyW3Wbnb1amcv0/nOXf5gYv2D2/hOl8/2wekWNkFF7tqZvu8Ns3z1vOirts+oSDWAM6Gp6L7AichxtuacyxxJTNOxvZ+O9JOZg8QpdTDQZLbybstU1imaAdKzDXUKG33cVpO3yUaqK1LvytRZ19nUcOZ0Gz2da1B/OdHKLm9qAbBYnHnq0XZsz2S9tEs3N3vUyD4JfCcU7D3rOc8DIm3r8NrUcJM623vtS5GLDS/XMlfdcpU3t2kdVzAASCtUZvauydqltGA72eKOt/9Pw5Vuewub4DFxrgfud1pd19rZm363sQvOZDxfPOP20VRMLaBqifsbJpfLXB4EzuoxmznkdvY2vJS8yuY+N0TMkK6j543whEN5hxVvI4Fd3E0ao1PGKPbwQX9OzqIfBBV9dEAVlgDPowv9mzNeCCXQqwsilPjHQWdn0hscdYK0eOhbB/tAgFyQE1viAYCwIR+MwGOKGn3sL567SEhCcZ6TVOP93vhrl7y+2+57f36HOS7Te0KgLpzwMWl54m8ObhtAA8cb9QN/Uz7wx2faJwAujbvzHpy9T1vUGB/0XTouU5DrPPNDNDxu2HV51Iq83rB3y60FLfrFGdUDlL807rf/nXPOq8Tzn0dO6Fe/bN/LHiZWYLq0c/hyoBjDVAJVb/L7PnvjtqTxbs1+xFcYiKMmdQ8IyAD0bT5v1YOS+Ao8Nu0Vfnxtk17xLvkzAyTA7yWZvyXnJUMJsb9qleM74rI9lOs+zKOlchODc6O33zPA2KMuvFu/YWk/B1y3lSu9/4Otk1iDTUk1T9I/k+C/BpEE40u40GpAAGS0gwO35DgAMnq4mrs36xPAuEo//5FAgaHAFHxAGry5cTNByDsNpvujCqwW/QMx/ztB+fPBEnQ/ANg+MSvCdBsj/Doj9lpCINS85SA2HNwOn6s7oCs7j+C6gvA6uhOnBYOEWcAB1bgn/xMTMqgDwxrTp38KKAeJCDNEMDKkiDwMQzk8CLGbOrkTxK8bCEugAAgwADMyhHg4MUI8Q48axEe0Oy7sQsTQQRRCQQ3EQie0AU04AwIAAQI4g2ErrFtwA516EFfTxL/rQROEwvNzwp0wKk2ytE5sQil0kw+MQAn0guwoiQaQARnwEQCwguC5AmJUFlzcQQvEQFaMiS4AgseRJXbDQlziBC4Trmc8rAvUM1jENfdTBAjwtT1gs/nbxlh0PxtcrZLwRRsRRmLMguJRHqi6AhCIERxgHgQqxkJRDxAsQGZkQE40QA7kFBc4he8aLlwqoU3sRib8R0YiQO9TrnL7Aw/Iq//4c8gsTMh2+597LBh9bIxkiaq86YIWsYK/KY8sYJ7myUDHM8EflMXjkAI18KM1iMkiXMeADKKFzMaGdMVbhEgVlCCcgyHnKq3oKsqdxMmdZEEtlCa+QoqSPMm/OY8sWAySVBFj6ZXH4AALQBtGEUoePMeBXK/w4h4ZRL/awozWq76gXLwr1Egn/MbbC4v7ajtAiEGl/MkZ7Es608kAK4m82crvCA9j/BuoGsyTLBQvWJSZ4Zqv8ZqOARuLCRqheczJ9Bow6CMcUIJTcJitIZmvaRnR7JgnKAXbmAANGIWwAZnLvEzKBE3LlMyNiU2fgRrbHBqqsU0moABAAAUxqID/ZxiHAKiY3NRNrXnNroHMzKRN4yRNqoEb8tDKxUwMYRmpvOECCygJAeAKk9idlkRHcJRCpszEl8gCmLI//Cu1GlzLl7C2LXAFt7w+8bwyl5QJuvwsWtyobui9uoTJZTRPCIxK29FO7vTOkuACu5GJL8AR5VkUmcgCATCPkrgCMPACC2AeAWgAL5ABBA1LuBzPpWxCUBRFUozL9iwO+HS9IBTLtNxIW1tBkwA/chwEaBJQZyxLHE1RvJNQCgUAC8VQ5gEDyFiAZIyJPgIBJb1OvCEUFeECIsXKLyDSBPLHEP3Pt2SuNJCAelKGVvxL9ywJ+FQLXmrRK11FHY2QgyMB//tRQIyE0YwEylx8yqMIPsrIEydN0ChN0Mf4UCQNFOvCxJeUydFbuRKlEvLss7U0lzwIuOB6PwB1UYGUSynMz5K4S9PSS/hTvjTlvpy0075yoy74yiwo1esK0EFNVGbZ0qygxiytxpQwF6QhUxHly02lz05lvFu7pCo0BKcsVDltSjrNP170oQZYUiU9VUndyy/NvEMFOVV9M5eQIjLQgcuq1WaFU06l1J3cvslrJjRqRr+M1DOdSDCtxB66Ahxw0n4UpS+cRD+E1zkUw23qw4OAhCHICh+ABDSkuj8cCAk7iFpAl2qlhLgju38twz1cgbPzsYuwV6nr14RaqI2ggf/w+4NlwIADiFeJLUR5xcOFbdiD9diPBdi7I9BqsgJAZS1B9dQdfUhKKdEjgFayLMWy2LIqIlTku9Uc5VbNootye4UFTEdhBdZx1dmJQ1lROtYHhVBRatkoLNqdbbWzvD8zTa2eVEWerdlgtVVtZTmkuC8Y/LZlLc9Uldqk7ciURVYmlTNUddlsfasx6KNRFFeYXZw4YIUaOLxcRdGjjdb71FVexUtDMEFmhVuY89mzDUjA7DxLFBSoJdqXJdfYWIP0vL8DfFXSYQOAK4JceL36RFPFTdyulQlFeAZFBFfLM9xfnVqkLUvGBdXhmwkwwIHFSB5lLdfMBVyhoMloC6v/sbxbLSk0MtXJydXc0eXG0m0JGk2qCkAA/9Szw41ar31dbo1ddF0gZGzHtn3at6XeuN2WKZCp7jFXyt0P2piiMg1T8CXdvx1R86uf0lpAS91dtN3W5Y1a7C3WdCVGL+heN3rXjoXEiELYklVYh4AEerIAVdgFSYxEojMnSgCoMHADXkCIgE3YMaTXcqJXkYUwiCWID7YEDPgFReSD/AFEij1gswvZhe1gDWZYF97DIVNaNwIDEIARHOCdkYpcbEVc5T1UKbhfXE2JOHCDTUhCYg1cv91a4eVETALOTQpX7ZNI+z1e3u1bEd1fG24jA1JSHKjSTvteyc0SywUQVyXi/54VU4BrgwEA3TotWzLWRtJr3mbCgOiNSBnVXfZ8Xyz+1OztoS4Ayx6eYyyNVt91gBP92hwl3jlAvM2TY0kmIvk1N4z82T1mYjpOXqLlYrV93DcyZIDcjE/klNXgZOECsbMKrl3UZPsM3QDUswCQORTWVEwmytaNUz9e3Fb+ZFA+DB8+ZDWmszRQgcchQi32ILPQqWtVR/YtY/d14vOVI0VQM04qpvoNXkbm2l32VE/GidntQgGGYJIlZwJWMIjIhj4yASSYYQ1ehWPYhPicBBbOYBaWYQ4O4RbO5wObhkFAqm34BQwIgIUNxAE+5yAz4IN+MHe+Z5EdWYeoYV+2Jv+WhKpgHuWzXYpt2aA0MFsgjlU0aNQCeGNpdWXRzd8mhiCxdZ03BbdsttttfmJUFuZv5olwNgwcEACsHONlpSpWbSwm8uj2RYn0JYM7iAOhhkpYDgtRjuWTKATfJJH8KlzznUsr1mbrXeNu1t9eBme/WgAc+Eie5mOYdiUpoFuQS+ofLomevCy1XuKl7mNpRt4ZDb81W92qrtSrLus5Ndq57uuSjlU8wAM4DtU2+oIEQuwu8FOL6+mo4BbVWM9JLd0VRQOnBr5JNmkzO0pLDoQ/vuX3mV5oVt6t7uSuNgkz2ALVDgO3vunla5EsAODGJmtILYk08IRWBV6mTqUBWBD/tYBjucZs2lbCmcYsZcLLGPxsNcXlzI5rvgbklrgcPCiD23BcUfqdeYyp3NXsA9SeC1vkTXZFM0CXQ3vUy3bm5k7mlsgABECqu0Zptspk557s0t7i0ybq6ha+amJbsR6pcS7gcgbwc0aFUFyARgDhhh6ISjAF2wiFSUBwMbTnhZ7XGIZhhw66A3gAQWidXyC/GP5gFlvhCafwC+dnD07wETdZk8gDFneDk2jUnL1Ta+oRAbvovL5fDkRjKqtewC6JkE6L6uPxmobvV07mycsvRXhrjMbPva7tHsff+qbpVr4DKrdsAGCDBbFy/Z5xdkUM6tBTK9jpxyBkG79i1/hp//CGX+mZ7jAw6kcV8vuO8pPuZtJKKluk77/u1iYX7bVO6ax+3xTkktqQBZeIA7SgohgP1S8HACgNc73Bjhlh28NIkf+50AwtRvNAj/BUbzbxXQKgWTifCRGYA9vIRpnmUe4O7j9/agooI/xBtxdd9Vfc81yG8jz/4/ViAzu4g0bdgjy4gxLQoTtQbWK3bkOpkQq1dOaxShihCXX1glIl5JjQkwTdTgDoTh3hkSMtc6yWQk8IxVMu4qySojeYT25Wy/R2SPDLMUGg4iIvbj1m7uFW8hvHdRsQdNsggzJYi/8q9MH+d2Ondka3dmz3EwAAFJoQD0FRTMH8DmRxzKYuif8cB4E0FnflWuazEgFqg1Uin/NNXWm80oNQ/+j4lvdUj/Un10hd53XV/nUTgmuvnk5FaXggDZiY6Mp7zNPDYHh+BICH33R4t9ysOAMt2HjB4Vy0aANVvFqOl/Pz7utqlmorpGunH8rQrnWLv/X5wfek2XdR0DQb5vleAZZjkQl75O9BURGTFMy/sZss4OGaUM7IZE6GIYaYIoAOWJjjxEzXlMxgmICkMYUcaJi9f025r03oxBjYdE6TOXyMIQFzqIBXuKtuSIKUmU26FxnGl5ioyXzN93yJKXzML83mJP3a3IFRCAZZeIGWdwNJQAaOmczE5xrbWfti/Bu6KYkFfYn/QY72aE97kNSRxuAbAPAboEdpKQD3IX5uOI+DO+i/MmhmJ1fztOX03X6UyTMAiMv6mJ51+bZ+VU/5rDIDNNAGtCADVIlxdI/AvAGAfBR+AMgdAADPmfgC319JwwCgFgnGYQQIAAC6yLhyhYtAgTtsJGzoEADDhw93SHwY8YwDBmrSTKzoMKJHgTZAekTjaEseNGw8Ugwp0qVIkh5lStxBBSZEnC1d0pQ4EqdMPYP2iPkjyE+hnSF7WmT6USdQnFSUVnTqkGpVqDCtJvy5VSvPh2zw3MkTBuU1O3G+urSJs6GNnVcsWLgisIEMGRwEcjEoo8tbKyAGE/by9vBEri9h/2KVqOmMBQZy1lRsbBGo0zhuwoTRsbZt1K2Kc7a9yRb06aWjIxoC1EcMH0KBGlp+Kjo06rAwp6YOWRsu2KWYcfsObQZNmTdbyLSZg0fhW8VuEcdFbB2AlStWsue1cN36QuIsXa6Rw8DCGcrje1elyQaN8jZ2SOcWfpv9RNO6688c7lKPM0QZhVRN4rVnYIH4PcTbfvxlxRiCTUV4lUtjzWDWFm+4oVZHEyY03WHVfffWAlYIlAUOXoAw4mHhKUhhRWmowQABHQTX330CmVFGGGTc8Rl9xb0I12qM6Wefgz75J5EirokBimxJXpYjkkI26BGDVVqpZWUedlUkhA/Fgf+GG8qF4cgdz23JZX7WiciiSwukmMUCIGSxIpwwjXHICn36+aefUgA6aJ9aEJqNGiA0cckKghIKqKGP/umopH1KISgw8G2RySSDUlpppJU2Kqqln0pqKqFwqEDqqKSGWimqhF4KqAJ+7PHHNr9gYEmsg756KquzktorpMGyqgIcw7K6wq+PEvtns7IG+2ygrIZKVhtnCSHMJ5W0Kmq00ooKByJu/pYnAHcSxgEY3qHrG5j8SUEACBt1deODPBnDIxlzrKRkmFceOKRCR+IopW08RdQkH7BFeW/AbEpIMHQUA5DlwQgDF3HGM8XrURzglLlFGG2kOaXGG/tm8Fbnovv/xXaGvcvYx+sBgJFGHKm8Zr4VvadcGWp23KXFXgncpsUuB+nRCRjc+scefugBcMqLKexlxUcv6PJoACg92tdLSozHHNluIUQZaABJNc89V8YyT0p/18UXX2Rx990zt1Vzl5BJpl7CbaP80I49xhAN1l4nbrTEtME9uM2NAxAIIQ3zAYgiWsOoOZGJh70b1299XvXSA+8Xhx1u5EFyHmmyMbrgkNf0+ExyX6edYIThqXdlfD+0hhJ0pTd0ggL/vEXQEPneIedfYg2i5B8aWIghgvwhxh6DiLP85tHH5HniGLsdOfHMe688TreUTcZyaZvRffnwx/8h7VXZbl0Dd2+3/z/vLHEPQHnOc4akEadw/foX+ghYtP8VDHynEUoixNAHQBjCeQps3vcueD7xsS12OyPf+HzCFDbYoSxbQInrQNhBolEMekC539yskIUGyKx/iYmQjGg0Btip8DLHS95HGJi18zFufg3U4Exa85pEDGI2QXQgBhMYRR5WhIOyY+H5qCjChphhDmVgHxnKMAczgA2KGHRhy2zYEBWBwArtUuND9mQsQEEiUUdoQKHmCC5W2WIzZJgBI5xFLUtZS4+wGuS3JKUqQ0oqXH06wAOetoxdnQqRiHTkpKbFyEdhslqkQpayChnKPY4SVuzARFnOkgcdTCKQniSlqC65rEGSy/9ccBTIAmQgABnu7pZe+5gUErUAKdDGjBJBw+rkczUkhnBiZ6wfxJJEOcsBIh9iM+IQsSnFLIYvdPhaYfEkd5zkLKc5Qrui+bQpN+lA0yIwtA7urNCAXt7SRbqZV710VkxmCiQOdyBDGO4wjGs2U37gdKb30HjQzVFPEK/J3tRKt0V+ovOJFA0clrzJsYLuU2BkwZCGJLEPY3JUes9r50feiRgr4MAgOFiALz+0GnzaK5zqfAge2oASNFhNNSRdaOdaiFKwCYUofRBEBTFqOm4u8KcVbYgVlYrFm35lTCMr2ckyOEWnPvWIIVLpYbggg8HgADAx/aWemiAZfdq0pFn/ew9Ay7C21QhRcU0VqpcCAQhQOMyJQLXgVu8a2ChG9YM9lGo6cToHR7DvDWlbG2CZOthn2jKmXcjCWWUaEr95AnCHNWyB4sAvf3VVq5IlohAVesWGXm8P6IgoarkKWoRSlbAaJV0ZHUJC1bFuBnhA4FJre9qEohQuYIUJF/Cm3Mza0yF+m0xuo0iEZJ4TsRadrDaL6FbVBq6oEkRqNt26TeFmt65a3JrF7BrYLn6xfWPsqcdkG00PztZxlbWhunRHTzjKEVBVoMsiIkFIV23yT5WYARk4cQNvwUqTpWxkgT1lSVItUlkZuIDlCJGBYj1YkBHmcCwdHGICd5hQoBwx/4lR/ChGYEIDq0NhLVyZyWFNOMUNtvGNK1VLiaxhDHKQAx2MC8cuGMQCIDCIXc5qzzVABj3W7ejYyrDT8153uOLV7l+91k5DhOOhUpvqlc27ODFbrLDzpS98dYQc5ZABG++N7UXrC2XiVkQOuiOmSI4bmP36MjwBdHJp1cslTZXhfYIur3zTPFHKSqQQtiqKPJKKZonSVrxUDip2xWtmRbeVatg6i4Y4dOnIktfS0TFSRaTAkUTJoSt6xolgMvshTZgH0Fk+dL782aM7AHfUpi31rbFcWhcGYhDUnE104ZzpYJPZtul1WRy8cVWTVRfXzE40pQ2aZe4CQA4OsIA+3//UPyLP5cgGyawWQGBrU38FD1JOSacDLewnmzSK85bzEZu0xEHANttzDjO26RpwqdxWcGRrA/sK4L5JCzzOZwbzdvVDGAIkhAB0CXKe4Zhf3WW2FTZyuEC8ATRDx5vev2a3vYXIhHtYb0CFuLWvx4tyZVv51pv2d0dJaEIU/jbZiAY5zsMb8YRcSgoYF4gUQEDxjKsxucrN21n7q2IISwoYdwjDN0ghY05+eFI1hmWOD/nhWgkIAhSYOtdLLOGu+6mTA47l10HF9j6dOOyVssaat/CNTMSAEoCSpdr/Hneqo51Qbn87oLrgYwIwoAkVWYAavF0vV8u68s0FNgB2lCH/NPgc4EBvuMCKnWESDPWb8m42zTFv8osV3CEfVeWGIItvoZ9+4BvNV4/lwHgQOEANddDH48wzGDUATtyV7zPqBYJM5Kmp89f+PEGpptd9R5TbDy/57GUO8zHb3iU3lwnqpp2mmMf83tdP7PZhsoYGyGEBRrbAAuQgBcBZ353HhxMHriADMAjECnW5wl5o1gWxwRwA1I9kX/kln+fxRPX8AdQQiH1BH5WoXvaZH6dp2+p9X+atT4Y81r+lX8p1X+xIQR24n7rF3/y9TWVxwQLoH2YBgP4ZRAPc30N4QZJZAGBsR02ImWj1iEoEWgKKYHx5hKPtwSsYhaQhzbLVngQu/9MSZmBt6BwtnFDr2AFwfSAQcl8TbgkJqoEDgACNyMEYpAE7VRYHmMgX4IBAXMEL0uBD6CB2mIgVCEAWIARt1FUJ6FQeVNv5YWAFKuDzOYR3TVAGoNoWDuET/qEQVhFVjAk5MUcMkBzDmd7qWWDQWVuggcEZSAC9KJ0YslXQ1V9KreELsiEMgkEbumFCZIEMcAEX7BIANIAVcIAFpOLllRShyd7qBeEhLpVQWE4TXSD9LOKi1RwTJmIfQhVFHByoxZ4wYuEuaiEychodnIHuDQYBSMAZHN22FRflYYcAAMAXyABmbYcAWIAdquJdXMECLAD/JYQN0kYC7AA91qM91v/jPN4jPebADSTYOfiDPgZkPgakPVYBQd7jQB7kDiRAQh5kQxKkQSokPT6kQM4jPjhJBbQDCSCkRO5AFUxFR1KkPkakRIokQpqkPaJkPZKkQqrkRLrkQnakR8qkSuaAJMhCAWwBJ7yALNSDQMrkTIakTLKkQ9IkTMIkURLkQDYAGOgeA4AADljAERRDUiplR34kUOJjS3BBdgjAXzTEGarjQ1jAF6wRTAmgwPQgGfAUJkajYBnj6j2AEXjZy3UjMVYaCKbezBHPOIHRBLCCJN5aWyKgNMJlQqxf+z1l79UBntUbo32VQ3yBuyQEu4jlidBJAAoADclADaFVargbSpz/E/kVJgUmYwO+Qjgk4dD1YjGW5jOeXF4ezKdliDNqICUS5ltiHgma4BSgoGf54eyJopAJhBd4AWeuoRc0AFlaZixagVmJIxg451WAyfLJFfplYW7u5fgU4R8clSFYYhmyJl5iZwiCHBtIAm9hVbXZ5u2Rp16CYBd+YRjOn/PZJXXshBuVpUB0QX4yJ2LcokRwAxoY4BU6pmteInjeZjQVoQQBgl8laGncZZUdKOgZY19uwSYsXEY9m4RimvfQgQ9IwBd64hi6JV7dp3/yDoA2hD9xwloWKDTiZnlOI0R41+X4FamtJo1WKIVGn3vOZqjFwWiwJ24p6Gtq3xWlwRhw/+JgNIE2cqN70hmKpujMrCgAiBZKDICRXiIvIqNQ8BUf8BsiSumO+qiJvmegjUIJrU4YtE51DWnrQVyULqB9KKlT8p7vBdlontR9UWmeSN2fYIIubEEbkEMiEZ7dpV3hrV3gQcujHAACWA4CHACNzV2FLSqIJaqsDJ6iaiqjYmolfEIosFkZmILfOcuxJAumZiqw4BiqVmqlRMIlAIELPKUFtEAHMAqrvirYeeqf7Bhk+im6XF51Akl9nunPYdc0YY+Y8qiOGmYy5mhs0mnHdBHC0SYaIEM3cah4TijS1YEavN8QyN9vAueRrpMhBquwwok9DWhAXeGxyiiauuX0Yf8PBB4phK5Mh0rrnAaicLwezyFQzBHpJLZnJUZENXohGBKAGFJGvEYr7Q2bNzLdurLIQrDB1b3otG7sMZ5PADhJ1NTlwfJpt3poj06gbqXOFJaMc8gpFHJrmboEHXQAD3RiNp4BKHIptoXixELEq61rDuhAGLwBW2onx47skNRryM5rcJaewSpiyeaoI5LqAAQm9kEs68EstCqane4eFKjANsYs6fBsn1bsdcyDI/AhshptxxKP0vpBAJDms56sE24tgkaEtTaWM+psmcXp1Z5raKyBFCQmnjImkq7t0ZqccH6j2X4HoLZqr/Kq3DVqoMTdNDgJDFASs8xdo3DqoFz/qq86KuWWCuceHiLdwgyYTRGQQit5iiitqp/UHeRGrrjQ7t+pggniQCrMwiUImNeVLvBaarlMaeNeh5XKK9361Fe8rchGLNQ+pt06a+L24UfpJC1kVfJuaBQNJtY2RnyCYRCQq/KK7aSRLfEW738CYr+2rUQEwlzaa/PGKNbmK0s4bZGi7PT21G6ZSXOQkfq+7PbuaTUyqdJJQIlK7/oirn2qK/q2yP8iL7U2hB4Qwmuow7267POSafSaKQT7hFWRqtqYLNsC8Plw7zMqKRDsngM8KfvmL9+eKAM3sE48cPfK7S/C78Pia2rZb8HWLQU6ot6GcGuOcPYR7Gc9nOC2/9/7XYHhMm0NA535xrAM782+Ou/8gsQN88G95vDdkiz5jmmpsZfeSgKMeqsLw6nW4kgXvp9vmnAXR60VQ+ziUuwU00wVuzFdORow9hvgZucCbzD+Yqe1qlIKvfEXM2IaP0Q1uoB8MmyJmqshA/LYhqcU13FFPK7kIursanImE4ol9IMHwMakbnKnkvKmWuqqjO7mqrKwwO4KYEIKmE0ekAIm1K7YqbLppqoqr/KfQAILEDABKEEVNILt/p2IhW7bBe/oAmt0/KywHu8TH3JDGAJRGAAz4CgRX7EXS/L4js3OFQD2RvAZExyH5p4K52kfzyg3H7Ec96zxWXLv3LEWNf/gBAUC/bJzJGOTKHIxAgdO9bLs+3TpOiMyBpGgDLCx/I1zICswQyuuOzuzn0JzOnOzXjkgeMFmAmewPvMwPvczXPxz/0KyR0fzBsUpHYBrIwNBCg70ECv0JKdrM8OzHcMxHgPABD+Uah5uB7ewxN7xvYH0m/1tPmfzkdqmkgKzAevMnqpz9mJw05atTN8QTbsMgDTM0rZ0RmszDLN0pQG1KGzpSE+0NplZj/nAOYftdTa0VktzWjs0VEf1HcozET4aKIhpNzc1Vrs1TXsFUJMcP3MwSY81Vuzm+x1BE/cwYoMxUb8w9L4QXHsEJtsyJ0t2KfcJBSxDdwLCAViS5/r/Cue2MjKvAOiasmer8juMAJu2galStuF9dmfvKmsPCig1QhUsQCPLQe8e6mS7rqvGtuApc2jzsiszs2M/9g7KdUJMn1E8KGCLtTj3dLdWLyc4QlAvdlgzthEpaRM0ATZqY852zVI7sXO7cBTHtAx/ARiAQTrKYip6JltTyA3vQU5f918v9FMfYl/fs1Pr8CIm8QIopgWoAJQGWk0/7VpzNSSXd3EPhDwlBBdEp36KpWQmJzqCIyvaIg2/ZiEgAFFocfweOF6Pp16XaV+LsEvftXV/q8LCn/ga8X5j93Or9Xj/cXEbZxZwwFleARh4QYWLJRhk5gzKQFk2QAAqRIb7/5siWM8rAAIf87SMDzWNZ3MXOcJZhHRe7zTSImManEHNdvcjK2Min7hii/mLK3gaAcACyAxZcoG7CEBnuuGP95+J4EkWJJmRE6MeuIZRKIJAh7gZQ/eyDTJK+JZ9B3aMQ3ASq7ALoLX2lnB4JyuCy287V1aak2Kdy7llsjkHcIAMzPmJ2LnXRMBIjDqpk7qolzqq20ACpDqqn/pInIAfNEwPIAA0jMSqs7qp47qpu7qu8zqu37qu24Cvs3oEDHuqG3upJwAVBPtIIHuyjzo1lM1ZvMAI8EOzM7uwO3uuMzuw9zq2F/u3Y/utrzEYQgEQLMG1MzsVdDuxY7uqhzu3w/97sIM7s2v7qLN7u8e7vP/6srt7s7dEFljAHNbipcehf2ZBF7g5AKhhupylQth7ugc7vh/7SNAADEjQIJzAs9f7t0O8sIv7vuM6vc87t/c7yTO7LxDBB9RAhqRJq3d8yLP6xL98vXu8vSuDJ8jAFGCjGIYAzQf7unM8yAu9xMf8sdv80J980Rt9spu8u0fATiSXZHIBkfXfOzJnF7hLpVcmWtqtOOi5IGCzgR66ofvrRk/Ie7RXqJUxlGc1f+PH4P437y36gJOwNhX4/fpwihv4pJ8vAIBBOC48QnylZQoAO5oVQRhEOrq3YeqxveY9ipP5lff9lezvcmzIKMit5Iv/+MactMIyQBsPrN+2ddk7OZaf/n2ra0EIgB3ihV5YskTDuEAkOcYfAFg3t+ybPuXbBx6MTBgJMd5Hvtu3/WGOgVl7ec6KfpgPP33fPt+/5hz7rHEfNxLd9HLPeJZHOr+OuEfgwYWQjAeS/tu/t4kTtroBwWG/OBoHsE8fORebedxMv1QPlh9EUCJccH3r/eb/OfcDBACBAMzMaRMmjKM5ZgY2bLjDYUSBNiRGtEGxYkOMGQVC5Djx40SMacZIIACCAQE5Y9YA2MjR48eXGanEzDgzo82bIQHorIhT4kWeQCP6DMrT6NGPO6jw1JjUaVSpUyWOObQCa1atWaVs9YpV/0sGQX/6MDvwtevXrVrUbk3bFquUt3DntmULNy7euHXV8vUKR4XWSsnKhNmShxSmFX693sXL2C1krZKzOqard0UHHwsYgHCwoEojr5TBYia9QgUcvadXWG572nVf06dhm8YcWzZeOIim2oBKFXjwpUQdEhdYyI8BMXsMcTQ+8PfA5yKHIq0eUij2kEzZ2ClDZssbN3iKW9eOfbpL8zIrpjkjQQYIEEHkSGm5c/v1jzXP5+8PUz/n0ksvOpD8+68ipnorULgGG9xhwIwUEUSMPi4oBMEEA7wpwgOdG6rDjOwo5YUtyCjDDjZ+Wu9D9DbU8D8p5ODMMzXOoAMXXF6UiP/B9Phjj0X8ltrRohABzJBHp6ZTUCrfHHwSSocgfFGPQfr4Q5BAeiJSSi41MjInL6UDUyAz7shjizA+yCUOJIsSkzo3uwwpi/ccQGmB+u6LE8gh5WzoxxY9FPLIPgWEc8s/oVNyu6aaZDDKSIcL0JA9xODDDww7QrRHEDlFNLs+4zDIsDYW6slRQ8NUlE9BC41IRhodkOBGDj9lFYBACX11VxhV/YnMJHGFdMlUlYRU0mSLilAPQq4ERI83hwU1WGl/DSo9btD47rA7yHvI2F6FvbbIWwUiSYI7GchTigGrnZNch3RdMUh6/Yz3S3NdXZVVJqNyUtmAo5oyJAwsTcT/D3739XVhbPUVt1wR3XgjPDdSTDBce3nV2NZhpahjAQtqrFU6T6fFdV6lBuWYYYiLe/ehh12GLmOZkBVYWavgOsCIP/4A5Cy4cBvtNttWo63o1WbzihJS0AyjjGRs0Qswo/Ea2q2llVYrElh4OCklOS6JJLfHkNYL68kwS21rtK0W+u3Xzr46brXSVls33h7FmW+YiPIjETEQJlBmlQ89Gd8xBYoDjYO2MJUhA2Gq2aJ6De9YVTrOUENkC9SoAwxqC688pJRJX/nylll2GPGGrU0c1QX7nn1Zh/QAxGdoJd849XFdf3n08kKKRhJuxftW+MmD18hkmdaQkYDOCJBg/4w0FsU11N9jRrnA9BKF/XvtFW995uv7pfymm2l/kmAAABc8YeZRP513+jEXf9M/zaT4xIvLj518q4tYe94DBTzVR3W9GyD+wve/XHXPKZ2aX/IOBz4J3gt2/jrW+jgIoWY9K1r2S6AIfefA7DnwggNh3EHCYKphwKwj6JMfBk2IEzrUgXM16oD1aChA4AVQgfKCoOVI+LoaLq9kE6QgxmTHQdolwQPwY2AKFXZEIJKuO24Azxu8Nb4MyjCJPQxivgAAPfmohCW7q6IPyWhBRJluiWsco/kYeEI20hGFjFoKGC2iPicGhwnMCOEUkahGYBUSAKI4k4nKgAYV/fCLiP+cThpYwAN1LaAOUphj/sBnx0028I4CgeMMxVhEeNURhpwkJJw0OBQ//pEqOmsb3GZpl7qhZW60/EolPuGKTjxuDrygSy7VUrVa2u2WK2hELFKBAxBAAQhn6MJjkkbNoyVzLdjUCtus6bZjfuVuebnmNxujzcpgZjFU09u/XglLqbRvlW7EXipBiYeJVQwP7mIlH9WjxDCWUQ7RAwEa1+BJU26vk/SkYkVG+c/6xbGEoXSJQhHZT+XtzZ04g2cerwjRBXJ0VG1IUyPbZEjWRbKjDaFDScDGLkjGE5WS5ElDTRrRTy70pDDl6PmamNGAbVSiODWiRA3q0YawoQRaDM//HSJn1Dbir5VBzYh7cug5kuV0pzFNqUMZOkR/1vSUVpTnWFHKTp8KDKg3lamL5FQQNG0CRY8kaiqjqlaVgkxksxqDMpqn07mudT9eLaVT8fjXrYIVoWXd4FmVldaDFtauCd1Qd7iVh4UI9aX/q+tjNwU96emJq1iV6jwByxGaWnSwpJQjZyda2tVydrPpY2zOrkLObNpWK+FM5zitSQlToIkMoZgEI86JW64Q8yvG7OZXIsECOTQBJS6YxSXKNkxzlsa4e7lua7bLzctU87t0y+5ikAvO7ep2t3DZTU9nGyXHElaVWRVrRthQPPBYtqmJna9m+YkT96QLBJ7jAR1I/3tY1N5PvhI9rfcwq1/DkjXBoYztT9rZ3gRR1MD6rEhIGem/EcK3tTw9D1XzaiMeNtiLfv1kUVX74RZLZMERdO0hM0xE2PLzKRYOiRVkIIMFcAEAVrDAFa7AgYdgGMIPHogdlIpfwhVYsRWhgypkRb09QZa1LA7tUFeMZAbG2MYv5nKWvRzhTU44KB7hggB6bGQAXEEGRG4AY7sgA4FwIHRWsAKPyjxayQJghSN15JbDqmT+ViRWnaGPJh8q5sz6WatJ/iSYv3pgFxP6qWYGMbEa1UQwuFkGXXhzFiz8BRyQWgBztoIAsgDkI8/Yplk2xj25mF9MYxnEWkZsDBtixv91IfDJf5Y0mWEdEUqn9tbxNTSkNQ1fNPdRIA2QwRcAYAFqXwEMpG4vj+McbStwwALa7kifI6s9ypYKDSVl9rLP7ASW4qkOBHa0g7tc7EeX24HHbnSyQVnvGlfa0kXBsXRiAmcZ7DnIq7aAq32ahSsAYM0IF4gXHg6dBOwA4xnXeMYvvnGP76AKH/d4x0We8ZCXnOMf90UKHGGiUgSD5CiPeclPjvIdzFzkCcD5x3eO8VOoYAEGtIALBFCMkvd84zWXuc0xrnOm3/zpSj/6053OdKRrXOo5fzoVsj7yp4Oc6lEPu9WvnnKmd93rZ/962UFek6833SN6BsAXZCBuAHD/QOIZ/bZAHN4QLyzg1f9G9u7MQOtThXjYuQYTVe/kOQG0wN6ZXre/Ez/vgej7tZZXNuVVzFpO77GJV/CCQOQ+EDwz9gsWaEAWZDD6VHuh9YGvPL97dO4WDlry+GZ35UjsGeqduL9h5reuAz5mxUf+8oLd9643T2zBL5/5zy6OR2DvBS9Y+81eaAD2UQ8GK4h67t4HP3TI7fmPjKrlZLAYgifv/KmewQV5tbLAkd+qZg+//CDG/KWZ32/3d37T9OiizEogusAKwIDaAMAAEVDHkCL/NM//9ic8ZsDWREv3OG8gbihkPEMF0igngq/SNGz2+o/4gu3LlC/zaE90ni8F/5NN+nKsAdnnAVWwIZgMPEylTUQQACEwVDTws9KoWOoP8XYQ/4Rw/2ItAKGMCPvv8wZwsWLwQWaQCQGADbYFIRpJrorv3swPe3oBZD6L0TRP+kxwv9rv+Fiwq3DF/5JQ2JZQC+ntzAZuIioMCgVClpbLlrKLEdLBFUxkPKpLbs5Lm5YpFcAwvNpCuQ4xD/GwL8qrnMZLLgRxvLzrNdBJt2oDEh3xthjRvK5rvTCqDoPjvSAQs0aFYoTADSrwDEfQ0nxwoOTgDOgKBAfvDVPs/khQCmtRlFCQ/3RxDXkwF8nw0EAxFKliFGnwVwqPYt5gDuIAxezPDOXHFVUiDEuw0//Q0AK5sA1v0ReP0PhIcQVZURglTA5dgg7r8BinsD8K7wZx7xeL8LCmjEaoMRudbRahTwe5MR+jkd+8sdAu8P/0UfhcsBwBphiNMRi9A92ysPlWsfNccdFkQhaF0BpDsK8EsnR4EQnBUQkxkhZ18QUJ7iCBIx19MToUEmrsAB8vEtJ6jx73MQ4pMhhZEiD1TyO/ERkjzQ3HMSaJcSSd4g4VEZm8ghFqoTCCyx3AqxJ5SyjBCRJQIYccgAdgIWuYcinVKzDG6xK1hhMfsSsjQxK/cptUQyxzKyybcjQ00Sy1Ep1I4xMJ8CcHxsuqUKTUL3J40iFnZg02Zwp8zwMDkhz/ZVIwsdHYbvIftVEnPRL6QLIgzxEKS5Jw6NIPbQ0vgfFF1qAkGk8NOODKds8eB1McaRIx880w4ZANE5Mf1VHE4DIuHRBO2CAF6jIVU9MXKxKgNPMMTiwcoeoeW7A2Z5KtQjMj1fAZ3xEXhbAJP5C9WnNS5EQy7VI4JZInvCCg4I2HTNMyV3MnRfM0y7AmIdAfsTMnvXM0aZMxl5M5c4JMnjMVi7M4iyoNvhAEMEneehEmbww0tzM49TOwiDM/FdM3z9Mn0/PC9IM9m8o9dxMA9jIq66My4THKaPM+u9MzORJ8whPXLBQ1v3M8h5E1CbQigvI1GOETdMEPKcEr0XIT/1V0MtLCa+5kVliAbMRJvMpSu7IrEa9Sl1j0uM5SRwORLSeRLHm0uGyUuzLRRwFxKHF0nZ4QRAuUI6oQGybTNx+0/7yAA8DGxDj0OLUTQGksOiuIP02rNDO0QzFQQgcy+hrzSf1GRI7SHlTxMCk0iKhK0eItTNmvJ/MUTMdUT8tz0sq0ITWUPOkUUPfUSdtUSnBCIaHTSk3yRUpC/toFOKXTS9N0P7+0HglVwQTVOCG1IzH1I4NwQBV13AbCDAojJTmVS/vphk7CqvbENlcyUwOTMLfQUPNSVMnUP2819w41Vz+zVE0VQthxVYGVVR1iDTpADaQHTz9qV/9UWPl0U//PFDBb1Uc8NUFDFVvVVEA/1FQF4gk24XHQwE8/TEbuBAqox1KpFVoRVVPfFVkh9FxhTFv/M1p78VsTNVwBIAcGABiC1EhdAxKqoBAZoAWkiTbUskiJlLw8MSsHdrsiUWAdlmIlVkjH60gx1kgv1mG30puYFD3DFTLV9MmkQAImNTvdFVfFsDftkzuTVVe7dTjB51MfdUJlVmdddmTrkAvEbyAawArsricqdao8gTMYwEY6s0tZ9lentV7lNVjpNV6FqFed1hbzdSN5FhS/4AAT8GetIAHPigtUD/ZIbdVYz+5K1iJDFMCiQA7qs0KtdWbx01ezlmbbNWqt1ma3dRv/tRYnCbKJWE/7Fu7NwOD6GC6jWI/09mzaAKAB3OxUWdA9knZp39NopZVrsRYa81ZMqxZQ7vVuO3deVTNCbYb03OwKWs0CBEIARo+xiIziqA0E+K7iJlc46UAOYFQC5BZz8RVeAbdl6XZl9zZ0r9Z48bZ0QfVSUXfuLOB1H67vEo6xuGABsDTUAKB2AWB6O4LtoE7tbK4VPKFZQcAElIAYPg7tNu57q87mvnd9Na592/fs3O59xc7qqI5+w/d+yW7sbC5+zc7muC5/8bd/Afh/ZW5/EbiAGbiBac5+184juuB6BeAKuGB6S8+nPm3iAA8H+A7wyC94XjXAJAB2qzRm/4mXam2Vc4cQdJV3avsPQwdVhZs2eWlYcDHqeu8MDLqg4g6QsRqg4sBAAABgh09PhAMIZUWGAOINZ1PYdAt1c2/YhYX3aXdWhkW3hWcVhQGOVAlQABBuAeYMB4AsexmLA+LsxxQwzi5Y9lZpLy33DGTVZKGYeTfUbrc4c/v0hXcRefu4ij03QL94saw3ztxM2mRAcuOSbT8CCeqg8SQgDLH4N4E3j6mYi2G2VgU5DfvWkmP4jnmzZxW1kasiZQeqDq6Tk6s1iud2TT+ZknO2hrtRizF5j7c2h8GVZMkEM5tVac+gFWB5lmX5lUc3kJeXmEO5U//YimE4lr2VkF2pX/8dQkTLpmBdoIRZoGF/dEktlmGxq2O/OUeVtBPDOUnRgis/truGlJu7uZ1T9J3BsmLjeS1FdlhJeUBuCEbjNnCVGU1XWWqnGJAzGZcr2Zhn+GbreJORGZqvUZeJ9TnoQAL6EpNUeU6feaFBOZmjuZlJV6Pt+IlrloESum31FpCTk4nuuU0dawx8eQE6gGn7OaRNuqOPGWoH+pYDephnqpZxGjkFUDlV+knhKY4ZQGnHoJUBeniT+lov2aeNmaBlmqeZWamveKe92KH5dZcX9AwWoITl1p8ZOqMxmqaDt6qd+arLWqz705OhOqcvWqCxwzFjsBWy1PfAOq1pVa0/eqz/c9mWhZmpbZKq1/pzaxqleYRNpzloHaAOpkmd55mc0/KcicYqI1srxhmdQ9abJ7sqzYaz8QYvKNGyV5Set3m0exSyM7tGbfQttRqif5pbCVtz/fqp9dgIe7qmoxquA/um5Vqxk7iFf9et9wmww7pu+ZqtR9pv8Ri5F5Ojnfe3S7mLaXGjFXqv4/qsPZqsCzu7H2iwm3u2eXuW91Waf7toYftvu1u3aaa4Z5q7ZbuTlbu9rdu5s7q8o/utxdOGa1uUh9u/Wxihl1uK83qQ7du3zbuaVXtHSxucNzu1KduzcTRiH9ucH7yzrcvCQRsuRFvBF/y0G5zBHzbDuUIpGby1/+9bsaVbk6kbpOk7vMk7t/MbrcU7i797u1/cvQsc9IQaRFW8oHOcj2OcuP/7rw8at9VbxnG4mB8an9GbuW88yM0avlnZuIsXkAN8vku6vnecyVc6yUn6ugk8yp1ayIn8yo98ynWaxqscu51jrhvQx6Vay3Hcxce8t5E8y1lcpB0IzPX6vcFbX5/bzc37vI1ZuG27edN8qdl8v2say83csIE6pbv8SaUBCy4d0zNd0zed0zvd0z8d1ENd1Eed1Evd1EtdAqjg1Fed1Vvd1V8d1l2dCiQg1mvd1m8d13Md01P91KWB0H8d2JGiHIO9X0+L2KN72I9d2ZU9JJfdVI3d2f+JNdmjndpTfNqrPS6hHdsJtNm33dtJ+dq/PRS1Xdx/stvLHd3NPdzTXcfInd3Rcd0lpQHmLNro/SO4APw0OKP+DtuihAvyTjj4/UmEeIcDfmwpbgHGLzhwYa65gAOuQAAU3kG8gGiDQ+Ad5N8hXuKnggvsfc2uAOCnYgd05En4PXSihOKfxOGvwN6DI+MjvkG84OCvIOEd5AdIvr2uAAeozdRulyMyOOT/qAG+gAtYXuWvYHsbZNW4QHGBowF+LPXGViq+gANOTSBSD99bt726YPSuL0oaAAeCfiqWvumBI4y5V+udnsgGQgBCZ4xna+iLvuWFA+zFPirKltTKfir/zj4L0n4qqN7qnzfrzRvki1jPHs6HiUzUIvcKLCB0BAAHWN4KFqDxQ6fOGl/qaUffgyPVkl44yhhKwCCEz5jj1TbaQC3zZ8vzhcOH8e5JQB9KFiB0uOCDg6MLwOB2DdcLitjCNh84Wt/unYKDY3/2a58qMLjuTl8gHlexV9fa6u7hFoDUsgDwVg3iPjiDi5j2sw/iUr9vws1BTm/1qaLviewKvP/uG58DFpkqVrdxBcL9dUyIn4Tu/j34eaL8iQz9o6ILAMLClQVeABg8iDChQgBZrhwEYbDhwokUK1pUaCHLRYtfZHCxYmVjxSskZYARSbGLQIIoF17RCACkwZct/2vavJnwZQMLDSRCNAhRJgCIEmOGHAoAjAUODXA6FcDBqUEvAoBKZegwaVWnXhZw2fnFKU2jM2FePWtQZdirV7qQlVoUzFanHMB8sSIDblakWNGihXq27VuxGrlYWIuz7t28hA0KHes3Mk6aVSXi4GIQx1uiWYX+/NJARlPJFQXMddqA5BUQe292YVx0MkyhN8c2iApABmLSNlW6DUzSAk+pryO2vvkTAGSbsS1gpsr7pmm0qoWPxslSuVnkB5fXtI1bd/TxFyFLFBDSSlXPAFQC+HgUol0AC06SRzhdcnKnMgrWl2qFV1zIsN13MH3hnHv3oeQbabTx5599YoWkEv9mOMUmwEkLXLdgaaeh9eBNXlzBRReaSXUFhc41BgCCJVrQYYwHcfBbe1F9lCJmDYzW2RVe7DgTAF2lKKNyquEW2FlcCHCFhE6BMVBBrh051UA1FjlRaqpdKRWQVy3ZpJIcXCEAly2NSZJbYB6FpUtUouWlVCOW+eWYdE5JEm4jLmBmm37+CWiggg5KaKGGHopoooouymijjj4KaaSSTkpppZZeimmmmm7KaaeefgpqqKKOSmqppp6Kaqqqrspqq66+Cmusss5Ka6223oprrrruymuvvv4KbLDCDktsscYei2yyyi7LbLPOPgtttNJOW2sXTHJgIbUxDsmmtjF2waH/t+NpeQWSrHrhFgcfihtdA2H9x+59Kh0Xr2QhwhobQ7hZC0BoMkT12hWi2WgFicFJWe9BAnAIxmgNnMSBDAOHJrBbD0MV8GEJc9Fkaxx3V6IMJGEm8r8zjdhFxBZ0K+69ANzJQRYcV9xvyek2sKG/9DqKXkI4hJVhF1ktbCEXmmWBAxhZWLFvwmnJsEBCClrQBRhHHWZhVzFZgK6P7+0mrgxd5EtfUzgDsGIDVVko9lAxe8FYn9QWLPJucrWo2QIaIfjeVFGTlMUXIGAm96KhKQSSYR8JdMXKYK7WF0MWZJit0xyw/JJEApOEQxZdLLD5W0oxlTDpZGueBdIlOVTw/xWd82XYAlaAHS8YUR+kuEyskQTR56GPtYAMVhTYaGiVG/QFDmrHZC68nOHe1brxko3zwsohDAAObklEG2gDx4umDDiYi7YXMGbBmEG2l8VXRBzA6HTkCisV1uAIad8XZFX/DKnxEwkAgrAgSCNd6MpJGvA8IWlkfQmzAhe4IDuMwA9uYUGX9rgwJtG9y0nToxcCR2OSFj0salnICF/A1Z4T1e4LEOSg4Lairgee5IIZHIsDDVO4Q6GJJAo5W1qYVCYI+sghKfshmY4nLiiFSSEZOsiQsCW0DUXFS9yKn40UkjzcjYklY2KaW7KCQSslbEgcNAjVDqLEk0TxNgCgkf/6SII9THnHin5RHB0dxLI7XoVsrfqC9PQopzIC0ileGSSIiGfIRCpykYxspCMfCclISnKSlKykJS+JyUxqcpOcLNXYaDeochHnCuGSjCh5k5ocdnKVx+ICCECQPkOxZiKQs0gWQJBHuOASKDs7ixVAgEhWCtNYCHzlWtY0vBYBsXA4K9cD7fQbKzSgYA34XCGn2RABYGaWDAEdtkqIS41kwZuYAdMCdnmQpXXFK9Q0IrYYYgWqeA2ARGINlLTZHiZtCCFaYsldvNDFtIBuNWbpQjKXZjGS2AdNdEJoT8JIpGFK9FTiAwMIwnNRAM4OB8LDgQoT8kvZZUR8eOHfK8X/BwILyAAEVVkNVEAQtVl6AaYcgGkDcMCaBsx0ATWN2krVhU7HgICjQ0XpF5LX0bz8EgerCeBKBTIUWFqApYITngBuZxCeWmGqX7gla3DqLo8WDJgHEVzUzvmFmnLgnCdZGQdwAKOl4tICOGAa/CaK11C9UHDnYylDcGlR9BB0IXA1CBduGZWZnmSWv9TILGu50qE45JwgmapyfkLZrYKgC369ZbcaK9mYANOiBampQcla09Shc5aubEtK61K5uzQOmJ4VEmBB0BTQdieAMM3eyn7pkCyMCaeilZJH0QPKvCoXUzUVyCu9UFvP/hI9IAElN/8aktoylqyP/QnkugsS/5nUcjXhHd4ua3sQ0G53aWRtLGgbi15uytR1sCwrR9VG2/Pi8r1kPQgCV1qQlIZXpzCFW1D6+7mp8m+5DM4UXEECQK+kVLi45Gx/hFu1/mYVBErTG1zHudnQqtchBLVoTB1i4ixAZzXoSjFVjJaRmn6Wu6wDJmf1RlfRagS+BQ6tZLMgAOh6NJ0wbUh+sxvOIg8Wdzg9EWWzMM1fxtOyuiWlkVXZ4Cwraqa4ceXgbsqaXRoYll9YwF0NKwCcHuY1KR3NekO7mqmSyMea7a0XcHqSOkcNzORFyIh13K+pto2/GlmNZuR7hY6c9EoAJKpqkRySmjo6IQDscpqH6sCnUl25v+dss5Y/vamegDiOmSklivajq5UmF9SsRhUABbyQMpOmlrvibC9bjetc63rXvO61r38N7GALe9jELraxj43sZCt72cxutrOfDe1oS3va1K62ta+N7Wxre9usCggAOw==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: The WHO Child Growth Standards. World Health Organization, Geneva, 2008. Available at file://www.who.int/childgrowth/standards/en/. Copyright &copy;2008 World Health Organization.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 629px\">",
"   <div class=\"ttl\">",
"    Height-for-age girls: 2 to 5 years (z-scores)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 609px; height: 406px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: The WHO Child Growth Standards. World Health Organization, Geneva, 2008. Available at file://www.who.int/childgrowth/standards/en/. Copyright &copy;2008 World Health Organization.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 627px\">",
"   <div class=\"ttl\">",
"    Weight-for-height boys: 2 to 5 years (z-scores)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 607px; height: 388px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: The WHO Child Growth Standards. World Health Organization, Geneva, 2008. Available at file://www.who.int/childgrowth/standards/en/. Copyright &copy;2008 World Health Organization.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 628px\">",
"   <div class=\"ttl\">",
"    Weight-for-height girls: 2 to 5 years (z-scores)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 608px; height: 396px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: The WHO Child Growth Standards. World Health Organization, Geneva, 2008. Available at file://www.who.int/childgrowth/standards/en/. Copyright &copy;2008 World Health Organization.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_40_32394=[""].join("\n");
var outline_f31_40_32394=null;
var title_f31_40_32395="Age-related changes in adaptive immunity";
var content_f31_40_32395=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F78986&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F78986&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Age-related changes in the adaptive immune system",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Cell type",
"       </td>",
"       <td class=\"subtitle1\">",
"        Age-related decrease",
"       </td>",
"       <td class=\"subtitle1\">",
"        Age-related increase",
"       </td>",
"       <td class=\"subtitle1\">",
"        No change",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thymic precursors",
"       </td>",
"       <td>",
"        <p>",
"         Thymus size",
"        </p>",
"        <p>",
"         Number of thymic precursors",
"        </p>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        T lymphocytes",
"       </td>",
"       <td>",
"        <p>",
"         Number of na&iuml;ve T cells",
"        </p>",
"        <p>",
"         Diversity of T cell repertoire",
"        </p>",
"        <p>",
"         Proliferative capacity",
"        </p>",
"        <p>",
"         Signaling intensity",
"        </p>",
"        <p>",
"         Regulatory T cell function",
"        </p>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        B lymphocytes",
"       </td>",
"       <td>",
"        <p>",
"         B cells precursors in the bone marrow (pre-B cells)",
"        </p>",
"        <p>",
"         Peripheral B cell numbers",
"        </p>",
"        <p>",
"         B cell repertoire",
"        </p>",
"        <p>",
"         Antibody response",
"        </p>",
"        <p>",
"         Opsonizing capacity of immunoglobulins",
"        </p>",
"       </td>",
"       <td>",
"        Autoreactive serum antibodies",
"       </td>",
"       <td>",
"        Immunoglobulin levels (may increase)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_40_32395=[""].join("\n");
var outline_f31_40_32395=null;
var title_f31_40_32396="Amine alkaloid sympath herbs A";
var content_f31_40_32396=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F50983&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F50983&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Herbal ingredients with amines, alkaloids or sympathomimetic action: part A",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Effect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Agnus Castus",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alfalfa",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aniseed",
"       </td>",
"       <td>",
"        Alkaloids, sympathomimetic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Arnica",
"       </td>",
"       <td>",
"        Betaines, choline",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bloodroot",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bogbean",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Boldo",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Borage",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Broom",
"       </td>",
"       <td>",
"        Alkaloids, amines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Calamus",
"       </td>",
"       <td>",
"        Amines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Capsicum",
"       </td>",
"       <td>",
"        Sympathomimetic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Centaury",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cereus",
"       </td>",
"       <td>",
"        Tyramine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cohosh, black",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cohosh, blue",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cola",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Coltsfoot",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Comfrey",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cornsilk",
"       </td>",
"       <td>",
"        Amines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Echinacea",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eyebright",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fenugreek",
"       </td>",
"       <td>",
"        Choline, trigonelline",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fumitory",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gentian",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ginseng, Panax",
"       </td>",
"       <td>",
"        MAOI potentiation, suspected phenelzine interaction",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals, The Pharmaceutical Press, London 1996, p.284.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_40_32396=[""].join("\n");
var outline_f31_40_32396=null;
var title_f31_40_32397="Criteria for treating acute stroke with tPA";
var content_f31_40_32397=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F71462&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F71462&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Eligibility criteria for the treatment of acute ischemic stroke with recombinant tissue plasminogen activator (alteplase)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Inclusion criteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clinical diagnosis of ischemic stroke causing measurable neurologic deficit",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Onset of symptoms &lt;4.5 hours before beginning treatment; if the exact time of stroke onset is not known, it is defined as the last time the patient was known to be normal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Age &ge;18 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Exclusion criteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Historical",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Significant stroke or head trauma in the previous three months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Previous intracranial hemorrhage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Intracranial neoplasm, arteriovenous malformation, or aneurysm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Recent intracranial or intraspinal surgery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Arterial puncture at a noncompressible site in the previous seven days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Clinical",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Symptoms suggestive of subarachnoid hemorrhage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Persistent blood pressure elevation (systolic &ge;185 mmHg or diastolic &ge;110 mmHg)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Serum glucose &lt;50 mg/dL (&lt;2.8 mmol/L)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Active internal bleeding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Acute bleeding diathesis, including but not limited to conditions defined in 'Hematologic'",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Hematologic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Platelet count &lt;100,000/mm",
"        <sup>",
"         3",
"        </sup>",
"        *",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Current anticoagulant use with an INR &gt;1.7 or PT &gt;15 seconds*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Heparin use within 48 hours and an abnormally elevated aPTT*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Current use of a direct thrombin inhibitor or direct factor Xa inhibitor with evidence of anticoagulant effect by laboratory tests such as aPTT, INR, ECT, TT, or appropriate factor Xa activity assays",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Head CT scan",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Evidence of hemorrhage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Evidence of a multilobar infarction with hypodensity involving &gt;33 percent of the cerebral hemisphere",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Relative exclusion criteria",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Only minor and isolated neurologic signs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spontaneously clearing stroke symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Major surgery or serious trauma in the previous 14 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gastrointestinal or urinary tract bleeding in the previous 21 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Myocardial infarction in the previous three months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Seizure at the onset of stroke with postictal neurologic impairments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pregnancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Additional relative exclusion criteria for treatment from 3 to 4.5 hours from symptom onset",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Age &gt;80 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Oral anticoagulant use regardless of INR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severe stroke (NIHSS score &gt;25)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Combination of both previous ischemic stroke and diabetes mellitus",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     aPTT: activated partial thromboplastin time; ECT: ecarin clotting time; INR: international normalized ratio; PT: prothrombin time; NIHSS: National Institutes of Health Stroke Scale; TT: thrombin time.",
"     <br/>",
"     * Although it is desirable to know the results of these tests, thrombolytic therapy should not be delayed while results are pending unless (1) there is clinical suspicion of a bleeding abnormality or thrombocytopenia, (2) the patient is currently on or has recently recevied anticoagulants (eg, heparin, warfarin, a direct thrombin inhibitor, or a direct factor Xa inhibitor), (3) use of anticoagulants is not known. For patients without recent use of oral anticoagulants or heparin, treatment with intravenous tPA can be started before availability of coagulation test results but should be discontinued if the INR, PT, or aPTT exceed the limits stated in the table.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     The available data suggest that under some circumstances &ndash; with careful consideration and weighting of risk-to-benefit &ndash; patients may receive fibrinolytic therapy despite one or more relative contraindications.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from:",
"     <br/>",
"     <ol>",
"      <li>",
"       Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359:1317.",
"      </li>",
"      <li>",
"       Del Zoppo GJ, Saver JL, Jauch EC, et al. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator. A science advisory from the American Heart Association/American Stroke Association. Stroke 2009; 40:2945.",
"      </li>",
"      <li>",
"       Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44:870.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_40_32397=[""].join("\n");
var outline_f31_40_32397=null;
var title_f31_40_32398="Survival in HIV not exposed to ART";
var content_f31_40_32398=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F56215&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F56215&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 545px\">",
"   <div class=\"ttl\">",
"    Survival estimate for HIV-infected patients not exposed to antiretroviral therapy, by age group",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 525px; height: 436px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cumulative mortality rate for patients who were not exposed to antiretroviral therapy, according to age group (patients aged &ge;50 years [older patients] and patients aged &lt;50 years [younger patients]). Survival time was measured from the date of enrollment in the cohort to a maximum of 1828 days.",
"    <div class=\"footnotes\">",
"     Cum surv: cumulative survival as a percentage.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Perez JL, Moore DR. Greater effect of highly active antiretroviral therapy on survival in people aged 50 years compared with younger people in an urban observational cohort. Clin Infect Dis 2003; 36:212. Copyright &copy;2003 University of Chicago Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_40_32398=[""].join("\n");
var outline_f31_40_32398=null;
var title_f31_40_32399="Insertion of needle";
var content_f31_40_32399=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F78323&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F78323&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Insertion of the TBNA needle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 248px; height: 269px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The TBNA needle should be inserted to its fullest extent into the airway wall in order to improve diagnostic yield.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Minai, OA, Dasgupta, A, Mehta, AC. Transbronchial needle aspiration of central and peripheral lesions. In: Bolliger, CT, Mathur, PN eds. Progress in Respiratory Research- Interventional Bronchoscopy. Karger, Basel, Switzerland, 1999.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_40_32399=[""].join("\n");
var outline_f31_40_32399=null;
